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Abstract 
Microneedle mediated drug delivery is an amalgam of the conventional transdermal 
patch and the hypodermic needle injection. It offers an improved drug delivery 
technique without the limitations of the above methods. The ability of microneedles to 
increase permeability of substances in the skin has been established in the literature. 
However, a quantitative method for predicting the performance of microneedle 
devices prior to their fabrication is yet to be fully developed. The contribution of this 
research is a theoretical framework for modelling and optimizing microneedle array 
design to obtain desired drug delivery rate while taking into account the transport and 
mechanical properties of the skin. This is achieved by exploring various theories 
surrounding transdermal drug transport. The existing theories are then used to develop 
models to link the microneedle array design parameters with drug transport properties 
such as permeability and drug concentration in blood.  
Numerical simulations and theoretical analyses that are carried out in this PhD 
research indicate that microneedle design has a significant effect on drug delivery. An 
algorithm was developed for solving the series of equations presented, thus obtaining 
a framework which is applied to predict performance of microneedle arrays in vivo. 
Some practical scenarios are also simulated to demonstrate the applicability of the 
developed framework. For example, numerical simulations of transdermal delivery of 
Fentanyl show that varying the design parameters such as penetrated length of 
microneedle and the tip radius of microneedles affected the peak blood concentration. 
Similarly, the developed framework was used to obtain the optimum microneedle 
design to calculate the desired peak blood concentration similar to that obtained using 
conventional patch system. This study is relevant as it provides a better understanding 
of microneedle mediated drug delivery process and it orchestrates the design and 
hence, fabrication of more efficient microneedle based drug delivery devices. 
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1. Introduction 
1.1.Problem Statement 
The skin is the largest organ of the body, covering up to 2m2 in an average adult 
human. One of its essential roles is to protect the internal organs from entry of foreign 
substances but it is also a vital route for drug delivery. Transdermal drug delivery is a 
desirable alternative to other forms of drug delivery methods such as oral route and 
intravenous injection; it avoids the first pass metabolism in the liver unlike the oral 
route and it does not pose the risk of disease transfer due to accidental needle reuse as 
is more likely to occur in hypodermic needle injection. This makes transdermal drug 
delivery a very broad field of research as it has attracted interest from various fields in 
an attempt to seek out a variety of ways to bypass the skin barrier without hindering 
the protective function it performs. 
In recent years various methods have been proposed towards this pursuit.  One of 
these includes the use of micron sized needles commonly referred to as microneedles 
(MNs) to partially pierce through the upper layer of the skin, thereby allowing a drug 
to permeate much faster into the blood stream. Although there have been various 
studies which outline the usefulness and feasibility of microneedles for transdermal 
drug delivery, there seems to be a dearth of detailed theoretical studies which look 
into how to implement the overarching advantage of microneedle mediated drug 
delivery into the design process. This is the ability to provide more controlled delivery 
owing to the ability to deliver drug in precise amounts. In order to capitalize on this 
advantage presented by microneedles, a quantitative relationship between the design 
parameters of microneedles and the drug delivery rate is required. Such is the aim of 
this doctoral research. 
 
1.2.Objective 
This research is aimed at developing mathematical frameworks for modelling and 
optimization of microneedle array design to improve and predict drug delivery 
efficiency in terms of permeability of the drug in the skin, concentration of the drug in 
blood following transdermal delivery and the insertion of the microneedle into skin. 
This involves gaining an understanding of the transport and mechanical properties of 
the skin and also the microneedle insertion mechanics. The thesis progressively 
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reports the various models that have been developed in this research and presents an 
overall optimization framework which is based on these models. The aims of this 
research are thereby outlined as the following: 
• Carry out numerical analysis to identify the effects of various design 
parameters on the permeability of drug through skin and the concentration in 
blood. The design parameters considered here are the radius of the tip and 
base of the microneedles,  penetrated depth and the number of microneedles 
in an array. 
• Formulate mathematical models to relate the design parameter of microneedle 
arrays to the drug permeability in skin. 
• Derive a framework to quantify the effects of microneedle design on the 
skin’s transport property. 
• Develop a model to relate the array arrangement with the microneedle 
insertion force. 
• Develop a framework to optimize microneedle array design to achieve a 
desired concentration of the drug in blood. 
 
1.3.Thesis Outline 
There are a total of 10 chapters which make up this thesis including a chapter 
dedicated to the conclusions and recommendations (Chapter 10) from this thesis. The 
first chapter (the present chapter) gives an introduction which states the aims and 
relevance of this work. The next chapter gives a brief background to this research. 
These include, skin structure, microneedle techniques and the numerical methods used 
in this research.  
 
Chapter 3 reports on an initial foray into hollow microneedles. The aim of this chapter 
is to study the delivery rational of hollow microneedles; comparing pressure driven 
fluid infusion with passive absorption of drug into skin. It demonstrates the 
limitations of infusion based drug delivery using hollow microneedles through 
experimental studies using Agarose gel and hollow glass microneedles. This chapter 
is aimed at justifying the reason for choosing to focus this research on solid 
microneedles rather than hollow microneedles.       
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Chapter 4 presents numerical analysis carried out to evaluate the influence of the 
design parameters considered here which are: tip radius, base radius penetrated length 
and number of microneedles per array, on the permeability. This is done through 
simulation of microneedle mediated drug delivery process.  This chapter introduces 
the numerical modelling used in this research for simulation of drug transport.  
 
Chapter 5 presents a framework that relates the design parameters with the 
permeability of drug through skin. In this framework, the effective diffusion 
coefficient is assumed to be constant and independent of the microneedle geometry 
used to disrupt the skin. A practical method to solve the developed framework is 
presented. 
 
In Chapter 6 the model is extended to include the effect of the force exerted by 
microneedles on the diffusion coefficient of the skin. The derived model is based on 
theoretical evaluation fitted to experimental findings. The derived model is 
implemented in the numerical modelling presented in chapter 4 and further analysis is 
carried out here to show the effect of each parameter on the permeability and blood 
concentration profile.   
 
Chapter 7 presents a framework for optimizing microneedle design where the 
effective diffusion coefficient is considered to vary due to insertion of microneedle. 
However drug transport through skin in this case is considered as diffusion through 
porous pathway. This model describes the change in diffusion coefficient as a result 
of decreased pore size such that other parameters such as porosity and tortuosity are 
included here.  
 
Chapter 8 presents theoretical and experimental studies to evaluate the effect of 
microneedle array design on the force required to pierce the skin. An evaluation of the 
mechanics of needle insertion into the skin was used to derive a quantitative 
relationship between the spacing of microneedle array with the force required to 
pierce the skin. The theoretical results were then fitted to experimental results to 
obtain a correlation which relates the insertion force with the interspacing between 
microneedles. 
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In chapter 9 the developed framework is extended to provide a practical optimization 
framework for obtaining the desired microneedle geometry to obtain desired 
concentration of the drug in the blood. The values obtained from the analysis are 
compared with clinical values and the technique for achieving controlled drug 
delivery using the presented framework is illustrated. Conclusion and 
recommendations are given in chapter 10. This final chapter highlights possible areas 
of research which could be a follow up of this research or other studies which could 
be significant to the field of transdermal drug delivery using microneedles. 
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2. Background 
2.1.Overview 
In this chapter a description of the underlying principles of transdermal drug delivery 
using microneedles (MNs) are discussed along with the most salient features of the 
technology, e.g., different types of microneedles. The physical structure of the skin is 
described as well as the variation in the skin structure as they determine the 
dimensions of the microneedles. The chapter also analyses the mode of drug transport 
through the skin and the mathematical models which quantify them. The final section 
then looks at the numerical techniques and simulation methods used in this doctoral 
research. 
 
2.2.Transdermal Drug Delivery 
Transdermal drug delivery has been used for up to two and a half decades to deliver 
drugs. One of the earliest transdermal patches released for commercial sales were 
scopolamine for motion sickness (Chandrasekaran, 1983) and nitroglycerin for 
treatment of angina pectoris (Momii et al, 1995). This has since been followed by the 
release of other new transdermal drugs such as GTS-21 used for Alzheimer’s diseases 
(Kawamata et al, 2002), Fentanyl for severe pain relieve (Gupta et al, 1992) and 
Estradiol used in the management of postmenopausal HRT (Higuchi, 1989). 
Transdermal drug delivery is an attractive option over other forms of drug delivery 
such as oral, nasal, rectal, pulmonary and intravenous or intramuscular injection. This 
is because it possesses certain advantages over other forms such as convenience, does 
not include the risk of disease transmission unlike in the use of hypodermic needle 
(Haq et al, 2009; Stachowiak et al, 2009). Transdermal drug delivery also avoids 
degradation and poor absorption associated with oral drug delivery (Sonaje et al, 
2009; Stoeber and Liepmann, 2000) which often leads to decreased bioavailability of 
the drug (Nomieir et al, 2009, Cross and Roberts, 2004). An overarching advantage of 
transdermal drug delivery is the ability to maximize effectiveness of the therapeutic 
compound by maintaining a desired level in the blood for long period of time with a 
reduced risk or severity of side effects (Tojo, 2005).  
This method of drug delivery is however limited by the outer layer of the skin, the 
stratum corneum (SC), which protects the body by preventing the entry of foreign 
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substances (Teo et al, 2006). For this reason a high concentration of the drug needs to 
be maintained in the reservoir to allow a required constant concentration on the skin 
surface. Therefore conventional transdermal drug delivery is limited to low molecular 
lipophilic substances that are inexpensive and have low potency (Farahmand and 
Maibach, 2009; Vecchia and Bunge, 2003; Schaefer and Redelmeier, 1996).  
Over the past few years, different methods have been proposed to increase the 
permeability of the SC. Such methods include the use of chemical penetration 
enhancers (Golla et al, 2009; William and Barry, 2004, Pathan et al, 2009), 
iontophoresis (Nair et al, 2009; Barry, 2001, Panchagnula et al, 2000) and 
sonophoresis (Mitragotri et al, 2000; Maruani et al, 2009). However, these methods 
are relatively expensive and complex and their application is rather impractical for 
convenient home usage. Furthermore the effectiveness of some of these methods is 
yet to be established (Koutsonanos et al, 2009; Power and McCormack, 2008; 
Howard et al, 1997).  
As a means to counter the limitation to transdermal drug delivery presented by the 
impervious outer layer, microneedles have been introduced as a more effective means 
to deliver drugs painlessly through the skin. It combines the advantages of 
transdermal drug delivery and hypodermic needle but without the disadvantages 
associated with these two methods (Henry et al, 1998). This method of drug delivery 
is discussed further in the following section.   
 
2.3.Microneedle Mediated Drug Delivery 
Microneedles have been developed as a minimally invasive means to deliver drugs in 
a painless manner while overcoming the barrier of the stratum corneum. The micron-
sized needles penetrate the upper layer of the skin without reaching the nerves, 
thereby delivering drugs through the skin in a painless manner (Henry et al, 1998). 
Wise et al (1970) first proposed the idea for fabricating ‘microprobes’ using an 
integrated circuit method to achieve more precision and reproducibility in the 
resulting structures. The microprobes designed were used in the recording of bio-
potentials generated by individual nerve cells. However, it was not until the mid-
1990s when the technique was more readily available that microneedles were applied 
to improve cell uptake of genes and molecules (Hashmi et al, 1995). Microneedles 
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were later proposed for application in transdermal drug delivery by Henry et al 
(1998). The group performed experiments which proved that inserting microneedles 
into the skin enhanced the permeation of substances through the skin. These 
pioneering works have since been followed by a wide range of studies on 
microneedles to explore the possibilities of their applications in drug delivery. Today, 
the possible benefits of their applications range from providing a more controllable 
Insulin delivery system that better mimics the body’s natural homeostatic condition 
(Martanto et al, 2004) to delivering vaccines to people faster than the disease can 
spread (Zhu et al, 2009).  
Research studies have shown that by avoiding the slow diffusion through the stratum 
corneum, thereby allowing molecules to permeate more easily through the viable 
epidermis (Koutsonanos et al, 2009), microneedles improve the permeability of 
substances in skin by several orders of magnitude and in so doing increases the range 
of drugs that can be delivered via the transdermal route (Coulman et al, 2009; Park et 
al, 2006; Chabri et al, 2004; McAllister et al, 2003; Henry et al, 1998). Table 2.1 is a 
comparison of different techniques for enhancing transdermal drug delivery obtained 
from a review carried out by Prausnitz et al (2004). 
 
Table 2.1. Comparison between methods of transdermal drug delivery (Prausnitz et al, 
2004) 
Delivery method Increased 
Transport 
Sustained 
delivery 
No pain/ 
irritation 
Low cost/ 
complexity 
Hypodermic needle √√√ √√ √ √√√ 
Chemical enhancers √ √√√ √√ √√√ 
Iontophoresis √√ √√√ √√√ √ 
Electrophoresis √√ √√√ √√ √ 
Ultrasound √√ √√√ √√√ √ 
Microneedle √√ √√√ √√√ √ 
Jet Injection √√√ √ √ √ 
Thermal poration √√ √√√ √√√ √ 
 
Microneedles can be fabricated in a variety of dimensions from different materials 
such as titanium and silicon for biomedical applications using technique borrowed 
from the microelectronics industry. Microneedles are usually designed to be hundreds 
of microns in length and also between tens to hundreds of microns at the base 
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extending to a sharp tip between a single micron and tens of microns wide (e.g. those 
designed by McAllister et al, 2003, Teo et al, 2006 e.t.c.).  
 
2.4. Microfabrication Techniques 
Microneedles can be classified as BioMEMS, that is, MEMS (microelctromechanical 
system) devices for biological application. The techniques developed by the MEMS 
industry have made it possible to fabricate microneedles of different sizes and shapes 
with precise dimensions. Microfabrication (also known as micromachining or micro 
manufacturing) can simply be explained as a method that makes use of a set of 
manufacturing tools based on the techniques for batch fabrication of thin- and thick-
films – techniques which are common to the electronics industry (Sammoura, 2007). 
Microfabrication is one of the many precision engineering disciplines. These 
disciplines combine the use of serial direct-write technologies with traditional 
precision machining methods which have been enhanced or modified for creating 
small three-dimensional structures with dimensions ranging from sub-centimetres to 
sub-micrometres (Sammoura, 2007). 
Since a variety of MEMS fabrication processes exist, it is difficult to define a general 
process for all the methods (Martanto et al, 2004). However, it is quite apparent that 
all microfabrication processes start with lithography, followed by a number of other 
stages (Sammoura et al, 2007; Martanto et al, 2004; Davis et al, 2004). Lithography is 
a process by which the master pattern of the desired material is transferred onto a 
solid material such as a silicon wafer; the most common type is photolithography. 
Photolithography involves creating a mask (a stencil used to repeatedly generate a 
desired pattern in resist-coated wafers) (Sammoura et al, 2007). A silicon substrate is 
first exposed to steam at about 900C to generate an oxide layer. This layer is then 
spin-coated with a photo resist layer. Photolithography is based on the fact that some 
materials such as metals are opaque to ultraviolet (UV) light, while others such as 
glass are transparent. When UV light is passed through a mask, depending on the type 
of photoresist used (negative or positive), the regions of the photoresist layer exposed 
will have their bonds either strengthened or weakened when exposed to UV light. 
Other types of lithography include X-ray lithography and charged particle beam 
lithography. Other techniques for lithography are also emerging, and these include 
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proximal probe lithography, holographic lithography, stereolithography, and 
lithography on nonplanar substrates (Sammoura et al, 2007).  
The next stages of microfabrication involve the selective addition or removal of 
substrates to or from a material chemically or physically. The most important removal 
process is etching – pattern transfer by chemical (wet etching) or physical (dry 
etching) removal of a material from a substrate. Etching can be in the dry or liquid 
phase (Sammoura et al, 2007), there are also subtractive processes such as focused ion 
beam, laser machining, ultrasonic drilling, electrochemical discharge machining, and 
traditional precision machining. Wet etching can be isotropic or anisotropic. Isotropic 
wet etching involves the chemical acting in one direction at a constant rate, while 
anisotropic etching is more specific, where the chemical acts in different directions at 
different rates to achieve more defined patterns. Dry etching is also of two types. 
Reactive ion etching (RIE) involves the release of chemical ions from a material to 
reactively etch out the desired structure. A second type of dry etching is the ion beam 
milling, which involves the use of ions that physically knock off materials to leave 
behind the desired structure.  
Various fabrication methods have been used in different studies, for example, 
microinjection moulding (Moon et al, 2003), laser cutting (Gupta et al, 2011), and 
inclined LIGA (li
Ito et al (2006) made self-dissolving microneedles loaded with Insulin, which they 
administered to mice, in an experiment to demonstrate the feasibility of microneedles 
thographie galvanoformun, abformung- lithography electroplating 
and molding) process (Jiang et al, 2007; Martanto et al, 2006; Haq et al, 2006). For 
example, to make solid metal microneedles, Jiang et al (2007) cut out microneedle 
structures that had been drafted previously by using AUTOCAD on 75μm thick 
stainless steel sheets. The needle structures were cut out of the stainless steel sheets 
using infrared laser. The metal sheet was then cleaned, after which the needles were 
bent at 90° to create out-of-plane needles. This was then followed by washing and 
electro polishing. The microneedles were cut out of the metal sheets using scissors. 
These microneedles were then coated with drugs and inserted into human cadaveric 
sclera and rabbit cornea in vivo. This study was the first to show that microneedles 
can be used for drug delivery to the eye as a minimally invasive means of treating 
diseases of the anterior and posterior segments of the eye (Jiang, 2007).  
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for percutaneous delivery of peptides such as Insulin. The microneedles were formed 
by mixing dextrin thoroughly with distilled water to form dextrin glue. Three different 
solutions of Insulin were formed in de-ionized water and added to the glue. The 
Insulin moulds were dried in a desiccator to obtain microneedles. The microneedles 
were inserted into the skin and a histological test showed that the drug was absorbed. 
Stability of the Insulin in the microneedles was maintained for a month at 400C.  
Furthermore, Jiang et al (2009) also used a micropipette puller to fabricate single, 
hollow glass microneedles for drug delivery to the eye in vivo and in vitro. A similar 
method is used by Martanto et al (2004) to determine the effect of retraction of 
microneedles after insertion on infusion efficiency. Fire-polished biosilicate glass 
pipettes were pulled using a micropipette puller. The resulting mostly blunt tips were 
then bevelled and cleaned using chromic acid and subsequently rinsed in filtered 
distilled water and acetone. The resulting microneedles had an opening tip radius of 
22–48μm with a bevel angle of 35–38°.  
Donnelly et al (2010) recently presented a novel fabrication method for polymer 
microneedles. This involved laser drilling the geometry of the desired microneedles 
into Silone moulds using CAD controlled galvanomer. The polymer was then poured 
into the moulds, centrifuged and allowed to dry at room temperature after which the 
resulting microneedles structures were manually separated from the micro moulds. 
The microneedles formed from optimized polymer mix where shown to be strong 
enough to pierce the skin without fracture. 
The various technologies that have been developed for the fabrication of microneedles 
make it possible to fabricate a wide range of needle sizes and shapes with precision. 
This makes it feasible to experiment with different geometries in order to optimize 
drug delivery using microneedles. There are various techniques of applying 
microneedles each involves piercing the upper layer of the epidermis but the manner 
in which the drug is delivered after piercing differs. This is discussed in the following 
section. 
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2.5.Microneedle Application Techniques  
Microneedles can be divided into two main types which are; solid and hollow. Each 
of these can be fabricated out of different materials and they can be applied to 
different functionality depending on their designs.  
 
2.6.1. Solid microneedles  
Solid microneedles are generally much stronger, sharper and easier to fabricate than 
hollow microneedles (Roxhed et al, 2008; Jiang, 2007). Their mechanical strength and 
sharper tips makes them effective for drug transport (Verbaan et al, 2008). Solid 
microneedles have been fabricated out of metal, silicon and polymers for delivery of a 
variety of substances such as 5-aminolevulinic acid, Insulin, DNA, and vitamins 
(Mikolajewska et al, 2010; Gill and Prausnitz, 2006; Lee et al, 2007; Mikszta et al, 
2002; Stoeber and Liepmann, 2000) both in vitro and in vivo. Till date, there are four 
common techniques of application of solid microneedles (Davis et al, 2004; Prausnitz, 
2004). These include the following;  
a. Skin Pre-treatment with Solid Microneedles 
This method is also known as the ‘poke with patch’ approach and is widely applied 
due to its simplicity. In this technique, microneedles fabricated out of silicon, polymer 
or metal are inserted into the skin to pierce through the SC and create micro-conduits 
through which drug can enter into the lower layers of the epidermis. The patch can be 
placed on the top of the skin either while the needle is still inserted or immediately 
after the needle has been removed.  
Silicon was the first material used to fabricate solid microneedles for pre-treatment of 
skin prior to patch application. Henry et al (1998) used solid silicon microneedles in 
experiments which showed that microneedles were able to increase skin permeability 
to Calcein by up to 3 orders of magnitude when compared to diffusion of Calcein 
through intact skin. In these experiments, silicon microneedles were inserted into the 
human skin obtained from autopsy; using a Franz diffusion cell, the group measured 
the permeability of Calcein through the epidermis for instances where the skin was 
first pre-treated with microneedles and compared this with the permeability of Calcein 
through intact skin without microneedles inserted (Figure 2.1). This experiment 
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proved this technique to be effective in increasing the transport of drugs through the 
skin by a great extent.  
 
Figure 2.1. Permeability of drug through skin with no MNs inserted, MNs inserted 
and remained inserted during topical application of drug MNs inserted then removed 
after 10 seconds and MNs inserted then removed after 1hour. Results are taken from 
Henry et al (1998). 
 
The second bar in Figure 2.1 shows the results for when the microneedles were 
inserted and left in the skin, the third shows the results for when they were inserted 
for 10 s and then removed, the fourth for removal after insertion for 1 h. Each data 
point represents the average of seven to nine experiments as reported in the study. The 
bars show standard deviation. Several other studies have used silicon microneedles 
(Donnelly et al, 2010; Haq et al, 2009; Li et al, 2010) and example of silicon 
microneedle array is shown in Figure 2.2.  
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Figure 2.2. Silicoon microneedle array used for gene delivery in skin (Mikszta et al, 
2002). 
Silicon is a rather brittle and expensive material (Chen et al, 2008) therefore as 
alternative silicon solid microneedles have been fabricated out of different polymer 
materials. Polymer is a cheaper option compared to silicon and simple mass 
producible methods of fabrication such as lithography in combination with hot 
embossing have been proposed for obtaining polymer microneedle structures (Oh et 
al, 2008, Park et al, 2004, Han et al, 2007). Microneedles have been fabricated from 
various types of biocompatible polymers such a poly-glycolic acid (PGA) (Park et al, 
2006) and polycarbonate (PC) (Han et al, 2007). These microneedles have been 
fabricated into various designs for example Park et al (2004) fabricated a 6 x 20 array 
with a center to center spacing of 1400μm in each row and 400μm center to center 
spacing in ach column on a 9 x 9mm area base plate. Park et al (2005) also fabricated 
an array of 1500μm long microneedles with a based diameter of 200μm tapering to a 
20μm tip diameter.  An example of polymer microneedle array is shown in Figure 2.3.  
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Figure 2.3. Tapered solid microneedles made of PGA (Park et al, 2005). 
 
On the other hand, polymers are limited by their mechanical properties – the tips of 
microneedles fabricated using polymers are inevitably blunt due to the low modulus 
and yield strength of polymers (Davis et al, 2003, Park et al, 2005; Park et al, 2007). 
Bevelled tip and tapered microneedles have been fabricated using biodegradable 
polymers (Park, 2005). Polyglycolic acid (PGA) has been chosen as the main material 
for the fabrication of many polymer microneedles because it is relatively inexpensive 
and believed to be mechanically strong with a lower melting point than silicon (Zhuo 
et al, 2009). Moreover the viscoelastic property of polymers may allow more 
mechanical flexibility of the materials, thus reducing chances of damage during 
handling (Ratner et al, 1996; Park et al, 2005). 
Microneedles fabricated out of metal which can be for example steel (Bal et al, 2008; 
Martanto et al, 2004) or titanium (Fermandez et al, 2009; Parker et al, 2007) are also 
commonly used in transdermal drug delivery application using the poke with patch 
method. For example, Martanto et al (2004) have also used laser-cut steel 
microneedles for transdermal Insulin delivery using the poke with patch method. The 
blood glucose level in the diabetic rats was observed to have decreased by as much as 
80% following Insulin delivery using microneedles. Figure 2.4 shows the results 
obtained when blood glucose levels after microneedle and hypodermic needle Insulin 
delivery were compared.  
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Figure 2.4. Changes in blood glucose level of hairless rat after Insulin delivery via 
different routes. Dark triangles indicate microneedle delivery while the X indicates 
delivery across untreated skin. Other symbols indicate delivery using hypodermic 
needles. Graph was taken from Martanto et al (2004). 
 
Other than the usual pre-treatment method, the dip and scrape method has also been 
used to deliver vaccine into the epidermis. The ‘dip and scrape’ method involves 
placing an array of microneedles in contact with the drug solution and then scraping 
multiple times across the skin to create micro abrasions. This method has been used to 
deliver DNA vaccines into mouse skin (Zhu et al, 2009; Mikszta et al, 2009). The 
results indicated an improved delivery as compared to topical application of the naked 
DNA plasmid onto untreated skin. 
  
b. Coated Microneedles 
Microneedles coated with the drug substance are applied to the skin in a technique 
also referred to as the ‘coat and poke’ approach. This involves coating the drug to be 
delivered around the surface of the microneedle. On inserting the microneedles 
through the skin, the drug coating dissolves in the skin fluid, and the dissolved drug 
diffuses through the skin into the blood capillaries (Gill and Prausnitz, 2006). The 
coating methods available are roll coating, spray coating, and dip coating. Gill and 
Prausnitz (2006) proposed a novel dip coating method suitable for efficient coating at 
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the micron scale. Coated microneedles can be fabricated out of both metal and silicon. 
The dip coating method has also been used in a number of other experiments for 
example Jiang used the dip coating method to coat drugs unto metal microneedles to 
insert into human cadaveric sclera tissue (Jiang et al, 2007). In another study the 
micro dip coating method has also been used to coat influenza vaccine unto solid 
metal microneedles with influenza vaccine (Koutsanamos , 2009). The vaccine coated 
microneedles were then inserted into mice to investigate the possibility of using 
microneedles for immunization in humans. 
An example of commercially developed coated metal microneedle device is the 
Microflux microneedle patch (Matriano et al, 2002; Cormier et al, 2004) which 
contains an array of 190 or 321 microneedles on a 1 or 2cm2 base plate and they are 
usually 330 or 200μm long with a thickness of 35μm and a 170μm. An example of 
such array is shown in Figure 2.5.  
  
Figure 2.5. array of metal microneedles with the left and right images showing 
different dimensions of the Macroflux®  patch left from Matriano et al (2002) and 
right Cormier et al (2004). 
 
c. Self-Dissolving Polymer Microneedles 
Microneedles with the drugs encapsulated within the microneedle structure are 
referred to as dissolving microneedles (Lee et al, 2007; Park et al, 2006). In this 
method, the microneedle is made from a polymeric material with the drug molecule 
encapsulated within the structure. The drug is released in a controlled manner as the 
microneedle dissolves when inserted into the skin. Kolli and Banga (2008) designed 
microneedles from maltose containing drug compounds to be delivered into the skin. 
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The microneedles were able to dissolve into the skin within minutes. Kolli and Banga 
(2008) introduced solid maltose microneedles, which were found to be more suitable 
for self-dissolving microneedles compared to those made of biodegradable polymer. 
This is due to the fact that sugar based dissolving microneedles dissolve within 
minutes unlike polymeric microneedles, which take a longer period to dissolve (You 
et al, 2011; Kolli and Banga, 2008; Lee et al, 2007). Fabrication of polymer 
microneedles usually involves melting of the polymer at high temperatures and 
sometimes encapsulating microneedles using a non-biocompatible polymer. Other 
studies have (e.g. Lee et al, 2007; Donnelly et al, 2010) have designed novel methods 
for making dissolving microneedles that do not require such high temperatures and 
which allow for the delivery of sensitive molecules such as protein. An example of 
the dissolving microneedles fabricated by the group is shown in Figure 2.6. 
 
Figure 2.6. Dissolving microneedles containing bovine Serum albumin fabricated by 
Lee et al (2007). 
 
d. Phase Transition Hydrogel Microneedles 
This is a novel microneedle system which combines the idea of the solid microneedle 
for skin penetration, the dissolvable microneedle for drug release from the 
microneedle structure and the hollow microneedle for constant infusion for prolonged 
controlled delivery. These forms of microneedles were recently proposed as a result 
of the need to overcome the limitation of the other microneedle techniques (Tuo et al, 
2010; Woolfson et al, 2009). These microneedles are made of polymeric materials 
which are cross-linked such that they are strong enough to pierce the SC in their dry 
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state and when inserted into the skin they absorb moisture and undergo a transition 
into hydrogel form (Singh et al, 2009; Singh et al, 2008). In this wet state, the 
compounds entrapped within them or delivered from a reservoir can permeate from 
the microneedles into the skin (Tuo, 2010). The hydrogel could be formed from a 
combination of different monomer, cross-linker and co-monomers such as 
Polyethylene glycol (PEG) and Polyvinyl alcohol (PVA), PVA and dextran, PEG and 
polymethyl vinyl ether-co-maleic acid. The combination of polymers used has been 
shown to have a significant effect on the rigidity, swelling rate and drug release rate 
of the hydrogel material (Singh, 2009; Tuo et al, 2010). 
These types of microneedles show a promising future in controlled transdermal drug 
delivery using microneedles as they can be cheaply manufactured using simple 
casting techniques and the amount of drug that can be delivered is not limited to the 
size of the microneedles. Hydrogel patches have also been applied for vaccine 
delivery into intact rat skin (Ishii et al, 2008). This method of vaccination takes 
advantage of the presence of some langerhans cells in the epidermis for more 
effective immune response and the ability of the hydrogels to keep the vaccine viable 
for the duration of penetrating through the SC. Figure 2.7 shows an array of phase 
transition hydrogel microneedle array before and after patching (i.e. insertion into 
skin) (Tuo et al, 2010).  
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a. 
    
b. 
Figure 2.7. (a) design an technique of hydrogel MNs and (b) array of phase transition 
hydrogel microneedle array before and after patching (Tuo et al, 2010). 
 
2.6.2. Infusion with Hollow Microneedles 
Hollow microneedles are used for fluid infusion of liquid drug and nanoparticles into 
the skin. However they are less widely used due to the expensive fabrication methods 
required however less expensive methods of fabricating hollow microneedles are 
emerging (Zhu et al, 2010). Despite the complex fabrication methods required to 
obtain them, hollow microneedles require less complicated formulations without the 
need to formulate a coat solution. McAllister et al (2003) fabricated hollow 
microneedles which were used into inject Insulin to hairless rat skins. Results from 
analysis of blood sample showed significant decrease in blood glucose level. 
Although hollow microneedles are more prone to fracture on insertion into skin than 
solid microneedles, they pose the advantage over most solid microneedles of being 
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able to provide continuous infusion into the skin. Furthermore there have been some 
efforts into resolving the limitations associated with infusion using hollow 
microneedles such as blockage of the tip while inserted in the skin. Martanto et al 
(2004) and Roxhed et al (2008) showed that partial retraction of microneedles 
following insertion could increase infusion rate. Roxhed et al also designed side 
opened hollow microneedles to address the decreased infusion rate caused by 
blockage at the microneedle tip. Fabrication of pocketed microneedles as an 
intermediate between Hollow and solid microneedles can be used to deliver 
nanoparticles and larger solids into the skin (Gill and Prausnitz, 2007). 
Hollow microneedles have been fabricated out of silicon, metal as well as Polymer 
materials. For example Wang et al (2009) presented hollow microneedles fabricated 
using the photolithography process in combination with the micro-moulding 
technique to fabricate arrays of hollow microneedles which were shown to 
successfully allow flow of fluid (Nile blue solution). Figure 2.8 shows hollow 
microneedles fabricated from polymer material; SU-8 and Figure 2.9 shows hollow 
microneedles fabricated from metals. 
 
Figure 2.8. SEM image of hollow microneedles fabricated from polymer material a. 
bird’s eye view of array b. image of pyramidal tip revealing the lumen opening of the 
microneedle c. highly magnified SEM image of microneedle tip with a diameter of 
13.2μm (Wang et al, 2009). 
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Figure 2.9. Array of 500μm long hollow microneedles fabricated from metal placed 
next to a conventional hypodermic needle. Image obtained from Jiang (2006). 
 
2.6.Skin structure 
In order to develop microneedle based devices for efficient transdermal drug delivery, 
knowledge of the skin structure is required. This section discusses the theoretically 
accepted concept of the skin characteristics under normal physiological condition. 
The different layers of the skin are characterized in terms of their biological properties 
as well as variations from individual to individuals. 
Skin is also called the integumentary tissue surface area making it the largest organ in 
the human body (Banga, 1999). The skin functions to protect the internal organs from 
mechanical stress, excessive water loss and radiation from the sun. It also helps 
maintain the body temperature and prevents entry of foreign substances. The skin has 
a self-renewal mechanism which allows it to get rid of old dead skin tissues and 
replace them with new ones (Holbrook, 1994, Suhonen et al, 1999). The skin is 
divided into two distinct macroscopic layers known as the dermis and the epidermis 
(Parker, 1991; Phipps, 1988) each region varies in transport properties and structures 
contained within it. Figure 2.10 shows a representation of the layers of the skin and 
their constituents. 
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Figure 2.10. Skin Structure. Adopted from McNeil (2007). 
 
2.6.1. Dermis 
The dermis is the lower layer of the skin below the epidermal layer. It is made up of a 
composite network of fibrous tissues such as collagen, elastin and reticulin (Riviere 
and Heit, 1997) and elastic tissue consisting of sparsely distributed cells (Downing, 
1992). The dermis is responsible for supplying the rest of the skin with nutrients and 
also sending stimuli from the skin surface to the brain. For this purpose it contains a 
dense network of blood vessels, nerve endings and lymphatic vessels. The dermis is 
assumed to act as a sink for substances diffusing through the skin as it contains 
capillary beds which exchange substances between the skin and other organs 
(Scheuplein and Bronaugh , 1983; Tojo, 1989). The capillaries in the dermis are also 
involved in heat regulation (Schaefer and Redelmeier, 1996). The subcutaneous 
glands, sweat glands, hair follicles and other projections are rooted in the dermis and 
extend into the upper layers of the skin. The dermis serves as a cushioning which 
absorbs mechanical stresses placed on the skin (Forslind, 1994). Thickness of the 
dermis varies in different parts of the body and the typical values for the dermis 
thickness between 1.5 and 3mm (Lambert and Laurent, 2008), although the dermis on 
the back can be up to 4mm thick (Rushmer 1966).   
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2.6.2. Epidermis 
The epidermis is a multilayered and multifunctional region of the skin. The epidermis 
is free of blood vessels. However it is supplied with nutrients that diffuse from the 
dermis through the fluid filled interstitial space (Schaefer and Redelmeier, 1996). It 
mostly consists of cells known as coenocytes or keratinocytes, these cells exists in 
every layer of the epidermis and are constantly undergoing renewal at a rate of every 
28-42 days on average (Odland, 1991). The renewal occurs as a result of enzymatic 
processes which alters the chemical composition and arrangement of the cells 
resulting in upward migration of old cells from the lower layer of the epidermis to the 
surface of the skin where they are shed. The thickness of the epidermis also varies in 
different regions of the body but has an average thickness of between 20 and 100μm 
(Matteucci et al, 2008; Schaefer and Redelmeier, 1996). The epidermis is subdivided 
into four other layers known as the stratum basale (or stratum germinativum), stratum 
sinosum, stratum graulosum and the SC (Holbrook, 1994). The outermost layer of the 
skin, the SC has been defined as the main barrier to transdermal transport as it is 
designed as the first defence of the skin from the immediate environment. It therefore 
prevents the entry of foreign substances (Holbrook and Odland, 1974; Scheuplein and 
Blank 1971).  The stratum Corneum on average between 10 and 20 μm thick and this 
thickness varies in different regions of the body and amongst different groups of 
people (Holbrook and Odland, 1974).  Figure 2.11 shows a schematic of the different 
layers of the skin. 
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Figure 2.11 schematic of the different layers of the skin (Schaefer and Redelmeier, 
1996). 
     
2.6.3. Variation in Skin Thickness 
The requirement of different anatomical sites varies from one anatomical region to 
another, for example the foot undergoes more mechanical stress than the abdomen in 
most individuals while underneath the abdomen there are some sensitive organs. The 
requirement also varies amongst individual with respect to gender, race, age and 
individual variation. For this reason the physiological properties of the skin, for 
example; thickness of individual layer and barrier function varies in different 
anatomical region and amongst individuals (Holbrook, 1994, Scheuplein and Blank, 
1971). The following section discusses how the skin thickness varies with age, 
gender, race and anatomical region. 
 
a. Age 
The skin structure has been shown to vary significantly between different age groups 
and this variation in skin structure should be taken into account when administering 
medicaments through the transdermal route as this may affect the diffusion process. 
There have been extensive research on the skin thickness and some have focused on 
the thickness of the skin in different age groups. One such studies was done by 
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Seidenari et al (2000) where values of skin thickness where obtained from adult and 
children subjects at various anatomical sites. The results showed that the skin 
thickness does vary with age as the values obtained between adults and children 
where different in different anatomical site with the highest difference existing in the 
forehead. The general difference between age and skin thickness therefore suggests 
that the skin thickness of an individual should increase as they grow older. In other 
studies carried out on adult group, similar relationship persists between age and skin 
thickness (Whitmore and Sago, 2000; Whitmore and Levine, 1998; Shuster et al, 
1975; Shuster and Bottoms 1963). However as indicated by findings from other 
research, the increase in skin thickness with age may not always be continuous.  
Dirridollou et al (2001) observed that skin thickness increases until the age of 20, 
however between the ages of 20 to 60 years the skin thickness remains constant after 
which it starts to decrease. Data obtained from different reports therefore vary for 
instance Gniadeuca and Jemec (1998) observed that between the age of 20 and 30 
years old the skin thickness decreases and this is consistent with other studies 
(Takema et al, 1994; Tan et al, 1982). Table 2.2 shows a comparison of skin thickness 
between adults and children at different anatomical regions (Seidenari et al, 2000).  
 
Table 2.2. Skin thickness in millimetres, of adults and children at different anatomical 
regions (Seidenari et al, 2000).  
             Age(Years) 
Location 
25-40 2-13 2-3 4-10 11-13 
Forehead 1.99+0.34 1.43+0.43 1.18+0.22 1.50+0.49 1.56+0.36 
Cheek 1.84+0.27 1.22+0.21 1.15+0.12 1.20+0.22 1.38+0.20 
Upper abdomen 2.01+0.32 1.38+0.27 1.28+0.1 1.34+0.32 1.63+0.33 
Iterscapular region 2.34+0.26 1.70+0.41 1.48+0.26 1.72+0.73 1.97+0.31 
Volar forearm  1.30+0.24 1.01+0.16 0.98+0.10 0.98+0.17 1.12+0.14 
Dorsal forearm 1.45+0.24 1.21+0.17 1.18+0.12 1.18+0.17 1.34+0.17 
Elbow crease 0.98+0.10 0.89+0.14 0.86+0.10 0.89+0.17 0.95+0.09 
Lower leg 1.49+0.23 1.27+0.20 1.23+0.14 1.23+0.21 1.42+0.18 
 
b. Anatomical Region 
Different parts of the body serves different function and are exposed to varying 
degree of mechanical stress. As the protective layer of the body, the skin thickness 
varies accordingly, as stated in the previous section. This variation in skin thickness 
influences absorption of substances from different anatomical region as has been 
shown in some studies (Korinth et al, 2005; Poet and McDougal, 2002; Wilkinson and 
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Williams, 2002; Lundh et al, 1997). The thickness of each layer of the skin has also 
been shown to vary with anatomical region (Lee and Hwang, 2002). Holbrook and 
Odland (1974) observed differences in the thickness of adult male and females 
between the age of 25-31years old, SC was obtained from biopsy by rotary drilling 
from the abdomen, flexor forearm, thigh and back, the thickness of each sample was 
measured by microscopic imaging. Mean values obtained were; 8.2μm, 12.9μm, 
10.9μm and 9.4μm respectively. Thickness of the dermis and the full epidermis has 
also been shown to vary significantly at different anatomical region as observed by 
Lee and Hwang (2002). On a study based on 452 living Korean adults between the 
age of 16 to 50 years, skin samples of 28 different anatomic regions from the fore 
head to the sole of the foot, where obtained from biopsy during medical procedures 
such as cosmetic surgery and skin flaps. The epidermis thickness measured using 
staining and microscopic imaging was found to range between 31 and 637μm and that 
of the dermis ranged between 469 and 1942μm. The thickest skin (dermis + 
epidermis) was found to be in the back (1,977μm). Wester and Maibach (1989) found 
that the permeability at different anatomic regions varied significantly. However this 
variation did not always correspond with the thickness of the SC therefore signifying 
that permeability was not only a function of SC thickness but also depends on the 
thickness of the other layers of the skin (Rougier et al, 1987). 
c. Gender 
The skin thickness has also been shown to vary by gender although the variation in 
skin thickness between gender proves to be rather complex. Using optical coherence 
tomography (OCT) Gambichler et al (2006) observed no significant difference in 
epidermis thickness with respect to gender. However, based on microscopic 
measurement of skin samples obtained from biopsy Lee and Hwang (2002) observed 
that korean women had thicker skin than Korean men in up to 12 anatomic regions. A 
similar difference between skin thickness of males and females was observed by 
Rudolph et al (1980) Artz et al (1979) and Southwood (1955) in Caucasian subjects. 
Other studies confirm that the differences between males and females depended on 
the anatomic region measured. For instance Dirridollou et al (2001) observed that 
males had thicker skin in the volar forearm than females and this is consistent with 
findings from other studies (Escoffer et al, 1989; Seidenari et al, 1994); while Laurent 
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et al (2007) observed that apart from the waist region, skin thickness in males was 
generally higher than in females and this is shown in Figure 2.12.  
 
  Figure 2.12 Skin thickness for male and female in different anatomical regions 
(Laurent et al, 2007). ‘CI’ in the Figure implies confidence interval. 
 
d. Race 
The definition of race used here is that which refers to a group of people sharing 
similar genetic formation (Rawlings, 2006). Measurements of skin thickness for 
different races have been reported in literature. For example Lee and Hwang (2002) 
measured skin thickness for Korean adults while Southwood (1995) and Artz et al 
(1979) measured skin thickness for Caucasian adults. Results obtained from similar 
anatomic regions for the two races are compared in Table 2.3 (Al-Qallaf, 2009). 
Overall the results indicate that epidermis is thicker in Korean adults (classified as 
belonging to the Asian race (Lee and Hwang, 2002) than in Caucasian adults. This is 
shown in Table 2.3. 
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Table 2.3 Skin thickness for Caucasian and Korean skin types  
                  Race  
Location 
Caucasian Korean 
Southwood 
(1955) 
Artz et al(1979) Lee and Hwang 
(2002) 
Chest 44 39 98 
Back 66 62 76 
Abdomen 41 40 79 
Medial arm 42 44 69 
Lateral arm 50 49 83 
Medial forearm 52 48 74 
Lateral forearm 55 53 102 
Medial thigh 54 47 87 
Lateral thigh 57 60 94 
Posterior thigh 57 64 102 
Medial leg 55 50 91 
Lateral leg 58 60 109 
Posterior leg 58 63 129 
 
However in other studies (Whitmore and Sago, 2000) using the Hapenden Caliper 
measured and compared skin thickness of Caucasian women with that of Black 
women within the ages of 20-69 and no statistically significant difference were 
observed (Withmore and Sago, 2000). 
 
The skin thickness seems to vary in no quantifiable manner for different ages, gender, 
race and anatomic regions. However it is important to be able to determine the length 
of microneedle that can be used for the desired purpose. Microneedles that are 
sufficiently long to bypass the SC will suffice to significantly increase the 
permeability of skin (Henry et al, 1998; McAlister et al, 2003). However studies have 
also shown that increasing the length of microneedles and hence the depth to which 
the microneedle penetrates could further increase the permeability and blood 
concentration (Al-Qallaf et al, 2008, Yan et al, 2010, Oh et al, 2008). Laurent et al 
(2002) carried out a skin study specific to microneedles aimed at determining the 
acceptable microneedle length which could be used to deliver antigen into the dermal 
layer. Skin thickness measured using ultrasound echography were; 2.54mm, 2.02mm, 
1.91mm and 1.55mm at the suprascapular, deltoid, waist and thigh respectively and it 
was concluded that a 1.5mm long microneedle inserted perpendicularly could deliver 
antigen to the dermis regardless of age, gender, race and anatomic region. It should 
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however be noted that for painless transdermal drug delivery, the microneedles should 
only pierce the viable epidermis and not reach the dermis.   
 
From the above discussion it is apparent that there have been several studies which 
attempted to measure a correlation between skin thickness and age, gender, 
anatomical region and race. Several methods such as biopsy, OCT and ultrasound 
have been employed for the measurement of skin thickness and the results obtained 
vary for different studies. Thickness of skin is an important parameter for transdermal 
drug delivery as it defines the distance for diffusion and the rate of permeation of the 
substance to be delivered through the skin. Another factor which should be considered 
in the designing microneedle arrays for transdermal drug delivery is the mechanical 
property of the skin as this influences the insertion of the microneedles into the skin. 
This is discussed in the next section.     
 
2.7.Mechanical Properties of the skin and Microneedle insertion 
So far various microneedle geometries and fabrication methods have been discussed. 
Microneedles (MN) (50-900 μm in height, up to 200MN cm-2) in diverse geometries 
have been produced from silicon, metal, carbohydrates and polymers using various 
microfabrication techniques (Henry et al, 1998; Prausnitz, 2004). Recently, there has 
been an increasing interest in investigating the influence of a variety of variables 
related to the use of microneedles, in order to reach an optimum microneedle design 
and, hence, improve MN-mediated transdermal drug delivery (Aggarwal et al, 2004; 
Davis et al, 2004; Verbaan et al, 2008; Badran et al, 2009).  
 
In order for microneedle technology to become a clinical reality, there are a number 
of challenges that need to be overcome. Firstly, there is a greater need to understand 
the force required for reproducible skin penetration to be achieved for a given 
microneedle design. This will aid in the development of an appropriate applicator 
design and process, such that microneedle technology can be easily amenable for 
clinicians and the intended target patients.  MN arrays should be able to demonstrate 
sufficient strength to penetrate into the skin or other biological tissue without breaking 
or bending before or during insertion (Aggarwal et al, 2004). The major factors 
accountable for MN performance are type of material, needle height, tip-radius, base 
diameter, needle geometry and needle density, which, in turn, determine the overall 
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insertion and fracture force of the MN (Davis et al, 2004). However, the inherent 
elasticity and irregular surface of the skin remains a major challenge to the 
reproducibility of MN penetration. It has been shown that the skin can become folded 
around MN, which results in either partial or incomplete piercing depending upon 
MN height (Verbaan et al, 2008). Badran et al (2009) highlighted that there was a 
positive correlation between MN height and penetration depth and diameter of MN-
induced pores in excised full thickness human skin.  
 
 In order to fully understand the MN insertion process, and how this is influenced by 
the density of MN on an array, it is necessary to develop a model that identifies each 
of the forces and stages that are involved in the penetration of MN into skin. Soft 
tissue such as skin, in reality, is a homogeneous material that exhibits non-linear 
anisotropic, elastic and viscous behaviour. These properties makes the modelling of 
skin deformation rather complex, and is an area which is still open to much research 
and is an area that has attracted considerable amount of attention in recent years 
(Dimaio, 2005; Okamura et al, 2004; DiMaio and Salcudeen, 2005; DiMaio, 2004; 
Simone and Okamura, 2002). This interest is down to the fact that accurate modelling 
of needle insertion is useful for medical purposes such as training through realistic 
surgical simulation and planning prior to surgery and monitoring of robot assisted 
surgeries (Qin et al, 2009; Yan et al, 2009).  
 
A novel approach to modelling and simulation of needle insertion into soft tissue was 
presented by DiMaio and Salcudean (2003). The pair inserted a needle into marked 
and calibrated tissue phantom. Using computer visualization, they measured the 
needle and tissue deformation on insertion. The force distribution along the needle 
shaft was then estimated through computer aided visual observation (DiMaio and 
Salcudean, 2003). This was then followed up by their work to present a novel 
interactive virtual needle insertion simulation. The deformation of both the tissue and 
needle was modelled in 3D and solved using fast numerical techniques which they 
developed (DiMaio and Salcudean, 2005). 
 
In other studies, (Mavarsh and Hayward, 2001; Maurin et al, 2004), needle insertion 
was separated into 3 phases based on results obtained from experiments performed in 
bovine liver tissue. These forces include Deformation (without penetration), steady 
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state penetration, relaxation and extraction. Azar and Hayward (2008) related crack 
size, needle diameter and tip geometry to insertion force. The process of insertion is 
accounted for as an interchange of energy between work done by the needle, work of 
fracture of tissue, work against friction and change in recoverable strain energy. 
Fracture toughness forces where obtained from porcine liver at different velocities 
and the results were within reasonable ranges.   
In a separate study, Yan et al (2009) proposed a spring beam damper model to 
describe needle-tissue interaction during insertion. The work is aimed towards 
developing physically based needle steering systems to achieve more accurate needle 
placement during medical procedures such as biopsies and treatment injections, by 
taking into consideration, the needle deflection during insertion and the in-
homogeneity of tissue. The developed model allows an online parameter estimation 
that allows the depth varying parameter to be controlled, thereby preventing 
inaccurate targeting. 
 
2.8.Modeling Drug Transport in Skin  
For the purpose of transdermal drug delivery the skin is characterized into two distinct 
layers; the dermis and the epidermis. The dermis which consists mainly of connective 
tissues is in most cases considered as a sink where most of the drug is absorbed into 
the microcirculation as this region is supplied with blood vessels unlike the epidermis. 
It also consists of nerve cells and as discussed earlier by avoiding this layer 
microneedles take advantage of the relatively fast absorption from this region for drug 
delivery but without causing pain. The epidermis is a stratified layer of the skin made 
up of epithelial cells. The epidermis is divided into other layers with the outermost 
layer being the stratum Corneum which is the major barrier for conventional 
transdermal drug delivery.  
 
There are three possible routes by which substance can pass through the skin; the 
diffusion through the intercellular spaces; diffusion through the cells or through the 
hair follicles (Goyal et al, 2007; Amsden and Goosen, 1995; Williams and Barry, 
1992). Various models such as the brick and mortar model (Tojo, 2005), the Fick’s 
law model and the porous pathway model (Tezel et al, 2000) have been proposed for 
analyzing transdermal drug transport. 
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Transdermal drug transport is shown to be best defined by a two layer diffusion model 
and various studies have adopted this method for modelling transdermal transport 
(Tojo, 2005; Yamashita et al, 1994; Okamoto et al, 1989; Tojo et al, 1987).  A model 
which has been widely adopted is the Fick’s Law diffusion model which is based on 
partitioning and diffusion of the drug through the skin. This model has been widely 
adopted in different studies; for example Tojo et al (2005) analyzed various practical 
scenarios of drug transport through skin and it distribution, absorption, metabolism 
and elimination in the body using the Fick’s law model to model the diffusion of drug 
through the skin.  
The porous pathway model has also been applied to passive and enhanced transdermal 
drug delivery. For example Kushner et al (2007) evaluated the porosity, tortuosity and 
hindrance factor of skin following ultrasound treatment. Experiments were also 
carried out the demonstrate the existence of highly permeable localized transport 
regions following application of low frequency ultrasound wave Kushner et al (2004).  
 
2.9.Modeling Microneedle Mediated Transdermal drug Delivery 
Most of the established models of transdermal drug transport are based on 
experiments on full thickness skin where the diffusion through the stratum corneum is 
assumed to be the rate limiting barrier. Although it has been shown that by using 
microneedles the permeation of substances through the skin is significantly enhanced 
(Henry et al, 1998; McAllister et al, 2003; Bal et al, 2008; Donnelly et al, 2010; Li et 
al, 2010; Meidan and Michniak, 2004; Milewski et al, 2010b; Prausnitz and Langer, 
2008; Gomaa et al, 2010) the mechanism of drug transport using microneedles is yet 
to be fully established.  
There have been studies that have looked at the effect of various parameters on 
permeability of the skin using microneedles; for example Milewski et al (2010a) 
studied the effect of various formulations of naltrexone hydrochloride on flux through 
skin. It was observed that a high amount of propylene glycol in the excipient limited 
flux through skin when microneedles where used. In a different study Oh et al (2008) 
studied the effect of array design in terms of microneedle length, density and drug 
loading on the permeability of Calcein through rat skin. The results indicated that 
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permeability is highest for longer microneedles, denser arrays and a high drug 
loading. Yan et al (2010) also looked at the effect of microneedle length and density 
on the flux through skin, however in this study a threshold was observed at a 
microneedle length of 600μm beyond which increasing the microneedle length had no 
advantage on flux. It was also found that a less dense microneedle achieved a higher 
flux through skin.      
 
2.10. Drug Absorption, Distribution, Metabolism and Elimination (ADME) 
Following transdermal transport, the drug molecule is absorbed into the body and is 
then distributed, metabolized (some drugs are not metabolized (Al-Qalaf, 2009c; 
Haberland et al, 2006) and eliminated from the body (Tojo, 2005). The ADME 
mechanism for each drug varies and it is defined by specific pharmacokinetic models. 
These models are achieved from experimental studies, several of which are available 
for specific drugs as reviewed in a book by Hacker et al (2009). The most common 
pharmacokinetic model is a compartmental model which could range from one-
compartment to several compartments. Parameters such as volume of distribution, 
elimination rate constant and transfer rate constants are usually included in such 
models. The values of these parameters vary for different individuals and the 
concentration profile of specific drug is affected by the ADME model as well as the 
skin property. Figures 2.13 and 2.14 give examples of the blood concentration profile 
for Fentanyl for different pharmacokinetic parameters (Tojo, 2005; Gupta 1992) and 
that of human growth Hormone (HGH) for different skin thickness (Al-Qallaf, 2009). 
It can be seen from these two Figures that the overall concentration profile of 
Fentanyl differs from that of Insulin; Fentanyl shows a sharp peak followed by a 
gradual tailing drop while HGH shows a flat peak followed by a sharper drop. 
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Figure 2.13 Blood concentration profile of Fentanyl for different individuals (Al-
Qalaf, 2009; Tojo, 2005; Gupta, 1992)  
 
 
Figure 2.14 Blood concentration profile of HGH following transdermal drug delivery 
of different skin thickness (Al-Qallaf, 2009) 
 
2.11. Numerical Techniques for Solving Drug Transport Models 
Many of the equations presented to model transport of drugs through the skin and 
blood are partial differential equations (PDEs) and it is required to solve these 
equations to obtain values of parameters such as concentration and flux in different 
dimensions. For this purpose, two main numerical methods seem to have employed 
for solving the drug transport models; finite difference method (FDM) and the finite 
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element method (FEM). For example, two simulations software which implement 
these methods are:  COMSOL software, which is based on the finite element method 
and the other is SKIN-CAD, a software which simulates the transdermal transport 
ADME in blood using the finite difference method. The main principles of FDM and 
FEM are discussed if the following section. For completeness of the discussion on 
numerical techniques, another method, i.e., finite volume method (FVM) is also 
discussed briefly.  
 
2.11.1. Finite Difference Method 
This is one of the earliest numerical solution techniques available. In this method a 
PDE such as Fick’s equation with the initial boundary conditions is converted into a 
series of ODEs. The PDE contains two independent variables which are time and 
space (for example concentration varying with both time and distance). By 
discretizing one of the space coordinates a system of solvable ODEs can be obtained 
using the finite difference scheme (Madsen and Sincovec 1974). The solutions of 
these series of ODEs obtained can then be obtained by using ODE integrators such as 
Gear’s stiffy stable formulas or Runge-Kutta-Gill formulas (Carver, 1981). The 
SKIN-CAD (Biocoms systems, 2006, Mori and Tojo, 2001) software that simulates 
the transdermal transport through skin and the ADME in blood makes use of the finite 
difference method and it is used in this research. It has also been used in other 
transdermal drug delivery studies (Tojo and Hikima, 2007; Isowaki et al, 2003; Mori 
et al, 2003; Kimura and Tojo, 2007). The simulations have been shown to be 
independent of mesh size (Al-Qallaf et al, 2009) and the numerical method used by 
this software has been validated with analytical solutions to a maximum of 0.87% 
error. It has also been validated with experimental results by comparing simulation 
results with blood concentration obtained from experiments on animal and human 
subjects following conventional patch delivery of Fentanyl and iontophoresis driven 
delivery of Insulin using microneedle arrays (Tojo, 2005). 
 
2.11.2. Finite Element Method 
Another method which is commonly used for numerical solutions is the finite element 
method (FEM). It has been used in several chemical engineering applications such as 
mass transfer (Kim et al, 2009; Tan et al, 2009), heat transfer (Johansson et al, 2009; 
Marra et al, 2009) and fluid dynamics (Al-Baghdadi 2009; Motiagh and 
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Hashemabadi, 2008). It has also been previously applied to simulate transdermal drug 
delivery using microneedles (AL-Qallaf et al, 2009; Al-Qallaf and Das, 2008, 
Davidson et al, 2009) and for solving stress distribution during microneedle insertion 
(Choi et al, 2006). In the finite element approach, the whole region to be analyzed is 
discretized (subdivided) into small finite elements of meshes. The mesh elements 
could be points on a line for 1D problems or it could be triangle in the case of 2D or 
cubes in the case of 3D problems. Each individual element is connected by nodes; the 
points connecting individual elements with other elements such that no gaps exists 
between the elements (Nassehi and Das, 2007). The properties and boundary 
conditions are defined at each node such that there are enough equations available to 
solve the number of unknowns:  the PDE is reduced to a series of more solvable 
equations which are then numerically solved. Various commercially available 
software packages exist which implement the finite element method such as ANSYS 
and ABAQUS. COMSOL has been chosen here as it provides a user friendly interface 
and it allows solutions of various engineering problems without requiring complex 
programming since the diffusion equations are already implemented. Different 
geometries can be created in COMSOL with ease and the properties such as diffusion 
coefficient and concentration can be defined at specific sub domain or boundaries 
either by entering the values or defining additional equations using expressions. The 
post-processing mode then allows various solutions to be obtained from a desired 
point, edge, domain or sub-domain.  
 
2.11.3. Finite Volume Method     
This method has been used as early as the 1960’s in the solution of convective 
diffusion problems (Tichonov and Samarskii, 1962; Samarskii, 1965; Eymard et al, 
2006; Versteeg and Malalasekera, 2007). The finite volume method comprises a 
variety of methods such as the control volume finite element method and the box 
method.  The finite volume method is quite similar to the finite difference and finite 
element method. The method is able to handle discontinuities and more complexity in 
geometry than the finite difference method. The finite volume method also requires 
less computational space than the finite element method as it solves problems in 
volumes defined around boundary nodes rather than solving solutions for each node.  
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The studies discussed so far have shown various aspect of research in various fields 
into development of microneedle technology. Microneedle mediated drug delivery 
have been shown to be an effective method for transdermal drug delivery validated 
through various in vivo and in vitro experiments. For every method of drug delivery 
the effectiveness is dependent upon the level of control and predictable outcome. It is 
required to develop a method through which the rate of drug delivery can be 
controlled using the drug delivery device. Microneedle based drug delivery poses the 
advantage of precise drug delivery rate down to microliters (Prausnitz, 2004). 
Furthermore the design parameters of microneedles such as the tip radius, base radius 
and the number of microneedles in the array can be effectively controlled using the 
various MEMS fabrication techniques that have been discussed in this chapter (ref). 
To capitalise on this, the thesis presents a framework for optimizing the design of 
microneedles to obtain the highest or desired rate of drug delivery. A theoretical 
approach is used to develop relationship between the design parameters of 
microneedles and the rate of drug delivery in the form of flux of drug through skin 
and the concentration of the drug in blood. 
In this research, the mode of transport of drug through skin is analysed as passive 
absorption process and simulated using the finite elemnt method. This is then 
combined with the drug ADME in the blood using the compartment models (Tojo, 
2005). The use of theoretical analysis has the advantage of focussing on the factors to 
be tested without the possible attenuations that often occur in experimental studies 
hence allowing a theory to be developed in ideal conditions which may be difficult to 
control in experiment. Furthermore such experimental studies are rather costly and 
time consuming, by first developing mathematical framework a significant 
understanding of microneedle mediated transdermal drug delivery is developed thus 
identifying the parameters and constraints which need to be tested. Hence the 
framework orchestrates the focus of future studies. Which is what has been done in 
this research, experimental studies have been used to obtain required constants (for 
example chapter 6) and to validate developed theoretical analysis (for example 
chapter 8).   
For the purpose of this research phase transition hydrogel microneedles have been 
considered because they pose advantage over other types of microneedle designs such 
as the coated microneedle and the hollow microneedle, Hydrogel microneedles are 
chosen as they can be used for more sustained delivery since the amount of drug that 
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can be delivered is not limited to the size of the microneedles.These types of 
microneedle when inserted into the skin tend to swell gradually as they absorb water 
into the skin (ref). The precise kinetics of their swelling is not yet quantified therefore 
to accommodate for this, the developed models make certain assumptions. It is 
assumed that the swelling occurs once the microneedles have been inserted into the 
skin; the drug to be delivered then saturates the swollen hydrogel before partition into 
the immediate skin surface followed by diffusion across the skin surface. Using this 
form of microneedles means the rate of drug delivery can be controlled by varying the 
design parameters of the microneedle array.  
The thesis is arranged in a manner to present each model chapter by chapter 
explaining the developed theory gradually. Finally in the developed models are 
incorporated into a single optimization famework. The framework is designed such 
that the known parameters can be inputed at the start and based on the scenario the 
appropriate route of solution is chosen and the series of equations are solved to return 
the optimum microneedle array design parameters reuired to achieve the desired 
outcome which is the peak drug concentration. The softwares (COMSOL and 
SKINCAD) serve as tools for obtaining solutions for the equations. However it is 
relevant to note that the crutial contribution is the method of applying these solutions 
and the models that have been developed. The equations can be solved using other 
similar tools and, as shown within the thesis, the framework can also be solved 
manually albeit in a more time consuming process. Therefore to address this, a VBA 
program is written to obtain solutions to the framework in a less time consuming 
manner. 
The thesis is relevant as it provides better understanding of microneedles by bringing 
together theories from various fields which includes biomedical and chemical 
engineering. The practical finidings from studies on microneedle mediated 
transdermal drug delivery have been used to develop theories to provide better 
explanation of microneedles. Using available engineering tools we are able to analyse 
the process and provide methods to utilize the practical findings in order to optimize 
utility of microneedles for transdermal drug delivery. Like all ideal research, this 
research does not completely solve the existing problem but it opens up a new area to 
be explored.  
The following chapter discusses observatory studies using physical models of 
microneedles. Two modes of microneedle mediated drug delivery; pressure driven 
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flow and passive absorption under atmospheric pressure are examined such that in this 
part of the thesis hollow microneedles are considered while the rest of the thesis refers 
only to hydrogel microneedles.  
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3. Observatory Study of Hollow Glass Microneedles  
 
3.1.Overview 
Hollow microneedles have seemingly received less attention than solid microneedles 
due to a number of reasons which include the complexity in their fabrication process, 
fragility compared to solid microneedles as well as leakage problems during drug 
infusion. This chapter is aimed at observing the flow pattern from hollow 
microneedles and thereby configuring the problems associated with fluid infusion 
using hollow microneedles. More importantly the chapter aims to justify why this 
thesis focuses on drug delivery using solid MNs. Agarose gel is used as a skin 
phantom for this study. For this purpose borosilicate glass microneedles are fabricated 
using the standard pulling techniques. These are then used to deliver a solution of Nile 
red and acetone into water and Agar respectively. Leakage of fluid occurred after a 
small volume has been delivered. In another experiment Nile red/Acetone solution 
was allowed to penetrate from the tip of hollow microneedles into Agarose gel in 
order to observe passive absorption in Agarose gel. The conclusion drawn is that the 
flow is limited by the rate of permeation into the skin phantom. Nile red delivered 
using syringe was absorbed after a few hours; indicated by a colour fade and 
approximately 6mm3 of Nile red was completely absorbed into a 2cm x 2cm x 1.5cm 
volume of Agarose gel after 1-2 hours when left to diffuse from the tips. This study 
demonstrates the limitation of fluid infusion using hollow microneedles and shows 
that diffusion based drug delivery using solid microneedle design is a more practical 
option. The rest of the thesis therefore focuses on drug delivery based on solid 
microneedle designs. 
 
3.2.Introduction 
Infusing fluid using hollow microneedles is an attractive option for painless drug 
delivery as this allows the delivery of medicaments without the need for a coating 
formulation as in solid coated microneedles and it also delivers the substance into the 
pierced hole compared to the case of poke and patch approach where some of the drug 
comes in contact with the stratum corneum (Prausnitz, 2004; Ashraf et al, 2011). 
Other than transdermal drug delivery hollow MNs have also shown applicability in 
ocular drug delivery (Jiang, 2006; Jiang et al, 2009). Jiang et al (2009) fabricated 
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hollow glass microneedles which were used to infuse 10 to 15μl of sulforhodamine 
solution into human cadaver sclera.  
 
However the use of hollow microneedles is associated with certain major demerits 
such as leakage and blockage problems as were also observed by Jiang et al (2007), 
complexity of the fabrication process and fragility of hollow microneedle walls 
(Davis et al, 2003; Griss and Stemme, 2003).  In the absence of void space in the skin, 
transdermal drug delivery based on passive diffusion of drug through the moisture 
filled spaces in skin seems to be the more practical route. Furthermore diffusion based 
delivery devices requires less complexity such as an electrically operated micro 
pumps required for hollow microneedles (Roxhed et al, 2006; Ashraf et al, 2011).  
The studies on the mechanism of fluid infusion into skin using hollow MNs (Martanto 
et al, 2004; Martanto et al, 2006; Wang et al, 2006, Hou et al, 2008) seem to  suggest 
that infusion of fluid into skin using microneedles may be limited by compression of 
the skin during insertion. This flow problem was then solved by partially withdrawing 
the microneedles from the skin which then allowed more fluid to be infused with an 
increase of up to 10μl. Retracting the microneedles simply provides more volume for 
the drug to occupy before being absorbed into the skin, therefore the limitations to 
pressure driven flow using microneedles still persists. The present chapter reports 
experiments which evaluate the mechanism of pressure driven flow compared with 
diffusion based delivery using models of hollow microneedles (i.e. micron size tip of 
micropipette). 
  
3.3.Method and Materials 
 
Materials 
Fire polished borosilicate glass pipettes with outer diameter of 1.0mm and inner 
diameter: 0.58mm (BI00-58-15) where obtained from Intracel. Hertfordshire, 
England. Micropippette puller was supplied by Sutter Instruments, UK.  Syringe 
pump was supplied by Harvard Apparatus, USA and Agarose powder was purrchased 
from Sigma Aldrich, UK. 
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Microneedle Preparation 
Glass microneedles have been used in this study as they are easy to fabricate for small 
scale laboratory experiments. Although they cannot be used in clinical applications 
due to their brittleness, these glass microneedles serve as a model for hollow 
microneedles that have been fabricated using conventional microfabrication 
techniques. In addition to this, the walls of glass microneedles are inert and 
transparent for easy visualization of the fluid within the lumen.  A micropipette puller 
was used to pull fire polished borosilicate glass pipettes (outer diameter: 1.0mm, inner 
diameter: 0.58mm, BI00-58-15, Intracel. Hertfordshire, England). The resulting 
structures had tips similar to those of micro-fabricated hollow microneedles and these 
were used as glass microneedle. The pipette puller is programmed to produce 
microneedles of various tip sizes. For this study we prepared microneedles with 40 
and 60μm tip diameters. These tips where viewed and measured using a micro forge 
optical microscope (Intracel, Hertfordshire, England MF-830).  
 
Preparation of Agarose gel 
Agarose gel was made by mixing 1.5g of Agar powder into 100ml of water in a 
beaker. This was then heated to a temperature of about 1000C by placing in a 750W 
microwave for less than two minutes followed by cooling resulting in a viscose gel. 
The gel was cut into equal squares of 2cm by 2cm for each experiment. 
 
Flow test in Water 
In order to confirm flow through the glass microneedles a standard flow test in water 
was carried out. Such methods have been used by Wang et al (2009) to confirm flow 
in microfabricated polymer microneedles. The experiment was set up as shown in 
Figure 3.1. A syringe filled with an Acetone-Nile red solution was attached to a 
syringe pump (Harvard Apparatus, USA). Tubing was used to attach a blunt needle to 
the fabricated microneedle. The pump was set at 10ml/hr and the dye filled up the 
tube and then the lumen of the microneedle and into the water (Figure 3.2). Fluid flow 
was assessed based on visual observation of dye in water.  
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Fluid infusion into Agarose  
To test the infusion of fluid into a skin-like environment, Agarose gel was used as a 
model for the skin. Other studies have used artificial soft media as a skin phantom for 
needle insertion (DiMaio and Salcudean, 2003) and in particular using Agarose gel 
for diffusion studies (Johnson et al, 1996; Lead et al, 2003; Sebti et al, 2004). In this 
study the experiment was set up as shown in Figure 3.2. A syringe filled with an 
Acetone-Nile red solution was attached to a syringe pump (Harvard Apparatus, USA). 
Tubing was used to attach a blunt needle to the fabricated microneedle. The fluid was 
first passed through the syringe to get rid of air bubbles. The microneedle was then 
inserted into the Agarose gel to a depth of 1.5cm after which the pump was started for 
55ml/h, 25ml/h and 10ml/h tests. 
 
Absorption into Agarose from microneedle tip 
As an experimental model for absorption of drugs into skin; a hollow glass 
microneedle at the end of a 2.5cm long capillary was filled with Acetone-Nile red 
solution. This was then inserted into Agarose gel to allow the Acetone-Nile red 
solution to passively diffuse into the Agarose gel. The drop in fluid level was 
measured every 10 minutes until the solution had completely disappeared. This was 
repeated 3 times for both 60 and 40μm tip diameters. 
 
3.4.Results and Discussions 
 
3.4.1 Fabricated Microneedles  
Observations reported here are based on the experiments carried out with 40 and 
60μm tip diameter microneedles. Microneedles with 20μm diameter tips cracked 
easily when observed under microscope following flow test and are therefore 
excluded. The microneedles were fabricated according to the method described above. 
Each microneedle was then viewed under an optical microscope (Narishige Japan, 
Supplied by Intracel, Hertfordshire, UK. MF-830) in order to confirm tip diameter 
(Figure 3.1). 
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 (a)   (b) 
Figure 3.1. Microscopic image of Hollow Glass Microneedle fabricated using pipette 
puller showing a) 60μm tip and b) 40μm tip. 
 
Flow test in water 
The flow test in water was used to confirm a lumen existed and that there was indeed 
flow through the fabricated hollow glass microneedles. The apparatus was set up as 
shown in Figure 3.2. The flow rate of the syringe pump was set to 10ml/h, 25ml/h and 
55ml/hr respectively. Flow was observable at each of these flow rates confirmed by 
release of the dye from the syringe into the tube and out through the microneedle tips 
into the beaker containing fresh water. As shown in Figure 3.3 in all cases a water 
stream is formed which is then projected upwards. The upward projection of th stream 
is thought to be due to the buoyancy of water.   
 
 
Figure 3.2. Syringe pump set up for flow test. 
100μm 200μm 
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Figure 3.3. Nile red solution was successfully delivered from microneedle tip. 
It should be noted that the results presented in the following subsections are based on 
repeated experiments in order to ensure repeatability of the results obtained. 
 
Infusion into Agarose gel 
A similar set up as that shown in Figure 3.2 was used to infuse Nile red solution in 
Agarose gel Figure 3.4. At all flow rates (55ml/h, 25ml/h and 10ml/h) leakage 
occurred and this points out the limitation of hollow microneedles to the rate of 
permeation through the skin/Agarose gel. This is illustrated in Figure 3.5. When a 
microneedle is inserted into skin, a gap exists between the skin and the microneedle 
surface and this gap is called the annular gap. When pressure is applied, the fluid exits 
the microneedle tip and fills up this annular gap. Since the rate of absorption into 
skin/Agarose gel is much slower than the delivery rate from the syringe, the amount 
of drug that can be delivered depends on the volume of the annular gap and once this 
is filled up leakage occurs. In this case approximately 0.9mm3 was delivered into 
Agarose gel just before leakage occurs. Retracting the microneedles as suggested by 
Martanto et al (2005) will simply increase the volume of space for the fluid to fill. 
However continuous infusion remains limited by the rate of absorption into Agarose 
gel. To observe this in the present work, the microneedles where retracted by 0.5 cm 
from the Agarose gel after insertion to a depth of 2.5cm. Fuid was then pumped via a 
syringe into the Agarose. The amount of solution delivered then increased to 1.2mm3 
prior to leakage. In addition to retracting the microneedles, it is important to note that 
300µm 
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the pressure used in this experiment are much higher than that used in other 
experiments (Roxhed et al, 2006) therefore increasing the chance of leakage. The 
leakage problems can be avoided by applying lower pressure.  This is seen in the 
second experiment where the pump is removed and the rate of drug release is equal to 
the rate of absorption into agarose. Furthermore, although agarose might have similar 
absorption properties to skin, the mechanical properties differs from that of skin. The 
annular gap using agarose is larger than that in skin (McAllister et al, 2003) and 
unlike agarose, skin would relapse unto the microneedle surface leaving much smaller 
annular gap which will permit less leakage. 
  
 
Figure 3.4 Glass hollow microneedles inserted into Agarose gel a) before Nile red 
solution was delivered b) after Nile red solution was delivered and c) leaking of the 
fluid after the annulus has been filled.  
 
a b 
c 
1000µm 1000µm 
1000µm 
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Figure 3.5 Schematics showing fluid flow pattern in hollow microneedles.  
 
Since the pores in the skin/ Agarose gel is filled up with fluid, diffusion based drug 
delivery should be a more practical option to pressure driven fluid infusion. To assess 
the ability of Agarose gel to be absorbed in Nile red solution, the Agarose slices were 
washed with fresh water and left in a covered Petri dish to allow absorption (Figure 
3.6 a and b). When the microneedles were observed after 2 hours, the Nile red had 
been absorbed completely into the Agarose gel, as shown in Figure 3.6c, the colour 
had completely faded.  This procedure was then followed by a second experiment to 
observe disappearance of Nile red solution from the microneedle tip.  
 
 
 
 
 
 
 
 
 
Pressure  
Microneedle 
Agarose/skin 
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Figure 3.6. a) Nile red solution in Agarose gel after washing off leakage a) side view 
b) top view and c) after absorption. 
 
Absorption into Agarose Gel  
Previous studies have looked at the diffusion of different molecules in Agarose gel. 
For example Lead et al (2003) studied the diffusion of humic substances in Agarose 
gel and compared this with diffusion in water with pH ranging from 3 to 10 and 
Agarose concentration ranging from 0.7 to 3%. The present experiment examines the 
diffusion of Nile red/acetone solution from microneedle tips into 1.5% Agarose gel as 
illustrated in Figure 3.7. The result presented here shows the absorption of Nile red 
into Agarose as the level in the capillary drops over time. The diffusion is faster when 
a microneedle with 60μm tip diameter is used compared with when using a 
microneedle with a 40μm tip diameter. This is expected since a wider tip provides a 
larger surface area for diffusion. The values plotted are based on an average from 
three repeated experiments. 
a b 
c 
600µm 600µm 
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Figure 3.7 Schematics showing diffusion from hollow microneedle tip into Agarose 
gel. 
 
 
Figure 3.8 Drop in capillary level as Nile red diffuses into Agarose gel. Diffusion 
takes place faster for microneedles with 60μm tip diameter than those with 40μm tip 
diameters. The reults shown are based on average of repeated experiments. 
 
As can be seen in Figure 3.8, the results for 60µm is less steady than the 40µm 
microneedle this could be due to slight variation in the manner of absorption for the 
two cases. Using the diffusion based method the microneedles showed no leakage as 
the release of fluid from the microneedle tip was determined by the rate of absorption 
into the Agarose gel. Therefore microneedles can be used to deliver drugs which 
require continuous release over long periods for example Insulin (Nordquist et al, 
2006; Pickup and Williams 1994). In the diffusion based design, the drug can diffuse 
easily through the viable epidermis and is easily absorbed by the capillaries in the 
dermis. Studies have shown this to be a feasible method for Insulin delivery 
(Nordquist et al, 2007). In the said experiment an infusion device was designed to 
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deliver up to 12μl of Insulin to diabetic hairless rats. The advantage of being able to 
deliver in such precise amounts is that it gives more control over glucose levels and 
decreases amounts of adverse effects. Results presented by Roxhed et al (2006) also 
points out the limitation of hollow microneedles; the group showed that a flow rate of 
1μl/min was too much for the skin to absorb as there was leakage of fluid unto skin 
surface of human subject at such high flow rate. However at a lower flow rate of 
1.8μl/h Insulin was successfully delivered to diabetic hairless rat without leakage and 
with pharmacological effect. This is similar to the amount of time required for 
diffusion of fluid through skin or a skin phantom. This shows that diffusion based 
drug delivery using microneedles is a suitable option. Henceforth chapters 4-9 of this 
thesis will focus transdermal drug delivery based on solid microneedles.   
 
3.5.Chapter Summary 
In this chapter pressure driven flow through hollow microneedles has been examined 
and compared with passive absorption into Agarose gel. Hollow microneedles are 
prone to leakage as the fluid fills up the annulus between the microneedle surface and 
the material surrounding it e.g. skin/Agarose. Therefore in order to deliver larger 
amounts over a longer period of time using hollow microneedles, the infusion rate is 
limited to the rate of absorption into the skin. This indicates that more study into the 
design of microneedles for diffusion based drug delivery is relevant. We have been 
able to show in this study that microneedles of 40 and 60μm can be used to deliver 
fluid into a skin phantom (Agarose gel) if left embedded within the skin such that 
passive absorption under atmospheric pressure will suffice for controlled delivery. In 
this regard, this thesis therefore commences towards studies on solid type microneedle 
devices where transport is based on diffusion. 
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4. Parametric Study of Solid Microneedles 
  
4.1. Overview 
Having discussed the limitation of fluid infusion using hollow microneedles in the 
previous chapter, this chapter then proceeds with a parametric study on solid 
microneedles. Studies have shown microneedles to increase the skin permeability but 
the extent to which they do so is affected by the design of the microneedles due to 
certain parameters such as tip radius, base radius, spacing, number of microneedles on 
the patch and penetrated length of the microneedle. The focus of this chapter is to 
carry out simulations to investigate the effect of these design parameters on drug 
delivery efficiency using microneedles. In doing so, we analyze the steady state flux, 
effective skin thickness and concentration profile in blood for a model drug, fentanyl 
following insertion of microneedle array of various designs.  
 
4.2. Introduction 
Feasibility of microneedles for transdermal drug delivery has been shown in different 
studies (e.g. Cormier et al, 2004, Martanto et al, 2004) and it has also been shown that 
the size and distribution of the microneedle array could affect the effectiveness of the 
drug delivery (Yan et al, 2010, Teo et al, 2006). For example Yan et al (2010) 
observed a difference in amount of drug permeated when arrays containing different 
number and lengths of microneedles were inserted into skin. In another study Oh et al 
(2008) also studied the effect of drug density and penetration depth of polycarbonate 
microneedles on the permeability of calcein through rat skin. Their results showed 
that permeability of calcein in skin was increased by using longer microneedles and a 
more densely packed array. Gill et al (2010) also carried out studies on human 
subjects which revealed that microneedles are less painful than the conventional 
hypodermic needles. Furthermore Chu et al (2010) fabricated dissolving polymer 
microneedles containing sulforhodamine B such that the drug was highly concentrated 
and localized at the tip of the microneedles. The fabrication method which either 
involved casting the polymer encapsulated with the model drug at the tip of the 
microneedle or placing a bubble above the polymer, allows higher drug loading and 
minimum wastage of drug by localizing the drug loading to the tip of the microneedle. 
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However studies are still lacking in the area of developing mathematical frameworks 
to quantify and analyse the effects of the microneedle dimensions on permeation 
through the skin.  Such studies are important in making the best use of microneedle 
based drug delivery devices. Similar studies have been done by Al-Qallaf and Das 
(2008) where frameworks were developed for optimizing the dimensions of 
microneedles in a square array in order to increase drug permeability in skin, this was 
also extended to non-square arrays (Al-Qallaf and Das, 2009). Their study looked at 
optimizing the microneedle dimensions which included microneedle radius, pitch, 
area of patch and number of microneedles. The optimization framework was based on 
the top view of a microneedle array such that the length of microneedle and the tip 
radius could not be included in the framework. In other studies Al-Qallaf et al (2009) 
showed the effect of different microneedle shapes such as the arrow shaped and 
bevelled geometry on blood concentration. The presented data further adds to the idea 
that there is a dependency on the design parameter and drug delivery efficiency using 
microneedle. This work seeks to investigate that further and it starts here by carrying 
out a parametric study to analyse the effect of microneedle array design on the drug 
transport through skin and its absorption in blood. 
For efficient drug delivery it is required to be able to predict the delivery rate and the 
concentration profile of drugs in blood. This helps to avoid overdose and achieve 
desired effectiveness. Bearing this in mind, the present chapter carries out the 
parametric study to evaluate the relationship between the design parameters of solid 
microneedle array and the effectiveness of drug delivery in the form of steady state 
flux and blood concentration profile. The design parameters in consideration include; 
tip radius (r), base radius (R), penetrated length (L) and number of microneedles per 
array (n).  
 
4.3. Methodology 
Various microneedle geometries are chosen based on the values that have been 
fabricated in reported experiments (e.g. Davis et al, 2004; McAlister et al, 2003; Gill 
and Prausnitz, 2006; Kolli and Banga, 2008). A tapered geometry is selected with idea 
being to establish a relationship between various design variables and drug transport 
in skin and concentration in blood based on numerical simulations. The skin and drug 
properties for transdermal delivery of fentanyl are listed in Table 4.1. These values 
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are based on studies on results obtained following administration of transdermal patch 
on human skin (Tojo ,2005; Gupta, 1992).  
 
Table 4.1. Skin properties and Pharmacokinetic Properties of fentanyl as used in this 
study (Tojo, 2005) 
Parameter Value 
Thickness of epidermis, h (m) 
Thickness of stratum corneum, hsc(m) 
0.0001  
0.00001 
Diffusion coefficient in viable epidermis, D (m2/s) 
Diffusion Coefficient in Stratum Corneum, Dsc (m2/s)  
9.75 x 10-12  
9.75 x 10-15  
Volume of distribution, Vd (ml) 731000  
Elimination rate constant, Ke (s-1) 0.0000284  
Concentration of drug on skin surface, Cs (μg/ml) 15800  
 
4.3.1. Modelling Drug Transport Through skin  
3D simulations in COMSOL® (COMSOL 3.0, Multiphysics Software from Comsol, 
2005) were used to solve the diffusion equation in order to obtain flux values for 
various microneedle geometries. COMSOL is based on the finite element method (see 
discussion on FEM in chapter 2). It consists of practical interface that is able to solve 
problems in different dimensions. COMSOL has been used in various chemical 
engineering application such as mass and heat transfer (Kim et al, 2009; Tan et al, 
2009; Johansson et al, 2009; Marra et al, 2009) and it has also been applied to MN 
based transdermal drug delivery studies (Al-Qallaf et al, 2009; Davidson et al, 2008). 
Using COMSOL, the model structure can be drawn with the built in model builder 
and the properties of each region defined with boundary conditions imposed as 
required. In this particular study, a microneedle inserted into a given area of skin is 
modelled as a tapered structure inserted in a block as shown in Figure 4.1. The 
boundary conditions are then defined such that the base of the block serves as a sink 
and the sides of the block are regions where no diffusion occurs (i.e. zero flux). A 
constant concentration is defined on the surface of the microneedles and the focus 
here is on microneedles that are left embedded in the skin for controlled delivery and 
particular examples will be discussed in later sections. The sub-domain settings are 
used to define the diffusion properties of the model drug (fentanyl) in the skin (Table 
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4.1). The problem is then solved to obtain steady state flux values at the base of the 
skin for the different geometries considered.  
 
Figure 4.1. Schematic of microneedle inserted into skin.  
 
Diffusion through the stratum corneum is eliminated by the use of microneedles; 
therefore the diffusion coefficient that is used in this case is that of the viable 
epidermis. We model the steady state diffusion of fentanyl from the surface of 
microneedle into the skin (Kobota et al, 2002; Goyal et al, 2007). The steady state 
flux is calculated from Fick’s first law of diffusion. The diffusion theory has been 
widely applied to transdermal drug delivery (Moss et al, 2001; Jackson et al, 2008; 
Zatz, 1992; Franz et al, 1991; Albery and Hadgraft, 1979; Michaels et al, 1975): 
dx
dCDJss −=        (4.1) 
Where Jss is the steady state flux of a drug across skin, D is the diffusion coefficient of 
the drug, C is the concentration of the drug and dC/dx is the concentration gradient. 
At the initial condition i.e. t=0 drug concentration in skin is 0:   
 0C =  at hx0 ≤≤   for  0t =      (4.2) 
Where h is the epidermis thickness and x is the distance from the microneedle surface 
into the skin. The concentration of drug on the microneedle surface is Cs and this 
remains constant throughout the duration of application. This is applicable since the 
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concentration of drug on transdermal devices is often very high compared to the 
concentration in the body (Roy et al, 1996). 
sCC =  at  Lx0 ≤≤  for 0t >       (4.3) 
Assuming 100% absorption, that is, as drug diffuses through the epidermis it is 
immediately absorbed into the microcirculation in the dermis; therefore at the 
epidermal/dermal junction (x = H) the concentration remains constant as 0.  
0C =  at hx =  for 0t >       (4.4) 
Similar assumptions and boundary conditions have been used in other transdermal 
drug transport studies (Davidson et al, 2008; Moss et al, 2001; Jackson et al, 2008). 
Under the described assumption and using the identified equations and boundary 
conditions; values of steady state diffusive flux at the epidermal/dermal junction was 
calculated for the different dimensions of tapered microneedle (listed in Table 4.2) 
using 3D simulations in COMSOL®. 
Table 4.2. Range of values tested in this study. 
Parameter Range tested  
Number of microneedles, n 
Penetrated Length. L 
Base radius, R 
Tip radius, r  
10 – 50 (-) 
60 – 90 (μm) 
40 – 80 (μm) 
5 – 30 (μm) 
 
4.3.2. Simulation of Drug ADME in Blood 
Following skin penetration, the drug is assumed to be immediately absorbed into the 
blood through the microcirculation existing underneath the epidermis in the dermis. 
The paths through which drugs are absorbed, distributed metabolized and eliminated 
(ADME) in the body vary for different drugs and amongst patients and also depend on 
method of administration (Tojo, 1987; Tojo, 1989; Guy and Hadgraft 1985; Nucci and 
Cobelli, 2000). fentanyl is chosen here as a model drug since it is a good candidate for 
transdermal drug delivery being a potent drug that is highly metabolized by up to 80% 
in the liver leading to low bioavailability (Gupta et al, 1992). There are also some 
accessible data on its transdermal transport properties as well as pharmacokinetics 
reported in literature and these are listed in Table 4.1.  
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A one compartment model is adopted for the simulation of the ADME of fentanyl as 
it has been shown to be applicable for transdermal drug delivery since this mode of 
delivery bypasses absorption in the stomach and intestine. This model, shown in 
Equation 4.5, has been validated against experimental results (Tojo, 2005; Gupta et al, 
1994) in literature. Data on concentration profile following transdermal delivery of 
fentanyl using a conventional patch was obtained from various patients and were 
shown to fit simulations carried out in SKIN-CAD (Tojo, 2005) based on the one 
compartment model. The SKIN-CAD software is also used for the simulations in this 
study.  
dbea
b
d VCKSdt
dQ
dt
dCV −=                   (4.5) 
Vd is the volume of distribution in the blood, Cb is the concentration of the drug in the 
blood, t is time Ke is the elimination rate constant, dQ/dt is the rate of skin 
penetration, Sa is the area of the drug releasing surface of the delivery system (Tojo, 
1988; Guy and Hadgraft, 1985).  
 
The surface area of application in SKIN-CAD® was taken as the total drug area in 
contact with the epidermis (i.e. surface area of Microneedles inserted into VE 
excluding the base) while the effective skin thickness following microneedle insertion 
into skin is calculated as heff which is obtained from the steady state flux equation by 
implementing Equation (4.2-4.4) into (4.1) the effective skin thickness is obtained 
from: 
eff
ss h
CDJ =       (4.6) 
Using the methods described above the following results are obtained from simulation 
of various microneedle array designs inserted into the skin. This allows a relationship 
to be established between the design parameter r, R, L and n and the drug delivery 
efficiency in terms of steady state flux and blood concentration profile achieved 
following drug delivery.  
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4.4. Results and Discussions 
The following subsections present the results that were obtained from the numerical 
simulations. First the effects of each parameter on the drug flux through the skin are 
presented. Subsequently the results showing the predicted concentration profile of 
fentanyl in the blood following microneedle delivery are discussed.  
 
4.4.1 Effect of Microneedle Array Design on Effective Skin Thickness 
Figure 4.2 shows an example of simulation of microneedle inserted into skin. Figure 
4.2a shows concentration profile at steady state with the scale showing minimum and 
maximum concentration. Figure 4.2b shows the flux of drug from the microneedle 
surface into the skin and the arrows indicate direction of flux.  
When microneedles are inserted into skin the distance between the drug delivery 
device and the microcirculation in the dermis varies for different geometries since 
unlike the conventional flat surface of a patch system, the microneedle protrudes into 
the viable epidermis. Simulations in SKIN-CAD require defining a thickness for the 
viable epidermis and this is obtained from COMSOL by implementing Equation (4.6). 
Figures 4.3-4.4 show how the various microneedle design parameters affect the 
effective skin thickness. For an array containing 40 by 40 microneedles with a 
penetrated length of 90μm, increasing the simulated tip radius from 5μm to 30μm 
resulted in a decrease of the effective skin thickness from 80 to 50μm (Figure 4.3). 
Similarly using a tip radius of 5μm, when the base radius of the penetrated 
microneedle is increased from 40μm to 80μm, the effective skin thickness obtained 
from 3D simulations decreased by 50μm from 135μm. Varying the penetrated length 
and number of microneedles in an array in the simulations also resulted in a change in 
effective skin thickness as shown in Figure 4.4. The result of the simulations show 
that the effective skin thickness decreases from 730μm for a microneedle array 
containing 20 by 20 microneedles with a penetrated length of 60μm to 100μm for a 
microneedle array containing 50 by 50 microneedles with penetrated length of 90μm. 
These results show that that the diffusion distance is indeed affected by the design of 
the microneedle array inserted into skin. As the effective skin thickness is related to 
the steady state flux by Equation (4.6), by varying these parameters the rate of drug 
penetration through the skin can be controlled. 
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a. 
 
b. 
Figure 4.2. MN inserted into skin showing (a) drug concentration in skin at steady 
state (values on scale shown in mol/m3) and (b) arrows showing flux of drug from 
microneedle into the skin. 
h 
R 
L 
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Figure 4.3 Effect of tip radius and base radius on effective skin thickness. Where L= 
90μm, n=1600 and A= 10000μm2  
 
 
Figure 4.4 Effect of Penetrated Length and number of microneedles on effective skin 
thickness. Where r= 5μm, R=40μm and A= 0.0001cm2 
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4.4.2. Effect of Microneedle Array Design on Diffusive flux  
Flux values were calculated from various simulations varying the tip radius (r), base 
radius (R), penetrated length (L) and number of microneedles (n). The effects of each 
of the aforementioned parameters on drug delivery efficiency in the form of steady 
state flux are shown in Figures 4.5-4.6. Increasing the number of microneedles from 
100 to 2500 caused a change in flux value from 2.31 x 10-7mol/m2/s to 3.46 x 10-6 
mol/m2/s and from 1.61 x 10-7 mol/m2/s to 2.31 x 10-7 mol/m2/s when the penetrated 
length is increased from 60μm to 90μm. Similarly increasing the tip and base radius 
also had an effect on the flux of fentanyl in the skin. The flux for a base radius of 
80μm and 40μm were 5.71 x 10-6 mol/m2/s and 3.47 x 10-6 mol/m2/s respectively and 
when the tip radius was increased from 5μm and 30μm the steady state flux increased 
from 5.13 x 10-6 mol/m2/s to 8.43 x 10-6 mol/m2/s. The results therefore indicate that 
increasing the size and density of microneedles in an array should result in increased 
permeation rate per unit area, this is expected since increasing the size and number of 
microneedles corresponds to increased drug loading area thereby decreasing the 
effective skin thickness as shown in Figures 4.5-4.6.  
 
Figure 4.5 Effect of penetrated Length and Number of Microneedles on Diffusive flux 
of fentanyl in skin. Where r= 5μm, R=40μm and A= 0.0001cm2. 
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Figure 4.6 Effect of Tip radius of Microneedles on Diffusive flux of fentanyl in skin 
at different and Base radius. Where L= 90μm, n=1600 and A= 0.0001cm2. 
 
The flux obtained here shows the effect of varying microneedle geometry on the rate 
at which the drug leaves the skin and enters the dermis where it is absorbed into the 
blood stream. To analyse the effect this has on blood concentration profile 
Simulations from COMSOL are linked to SKIN-CAD by inputing the effective skin 
thickness values obtained here to obtain the blood concentration profile for the 
various microneedle array designs. 
 
4.4.3. Effect of Microneedle Array Design on Drug Concentration in Blood 
Using SKIN-CAD the concentration profile of fentanyl in blood following drug 
delivery for microneedle arrays of different tip radius, base radius, penetrated length 
and number of microneedles were studied. Firstly, to compare microneedles with 
conventional transdermal patch system, the concentration profile for full thickness 
skin is compared with that of when microneedles are inserted into skin bypassing the 
stratum corneum. In agreement with results from other studies (e.g McAllister et al, 
2003), the peak concentration of the model drug, fentanyl in the blood was up to 3 
orders of magnitude higher than with full thickness skin (Figure 4.7). The diffusion 
and pharmacokinetics properties used in this simulation and the following ones are 
listed in Table 4.1.  
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Figure 4.7. Concentration of fentanyl in blood following transdermal delivery for skin 
with and without SC. 
 
Further numerical simulations are carried out to analyse the effect of each design 
parameter on the concentration profile of drug in blood for microneedle mediated 
TDD. The results were obtained as discussed in the methodology (section 4.3) and are 
shown in Figure 4.8-4.11. In general the simulation results show that the 
concentration of the drug in blood can be varied by varying the values of the 
parameters r, R, L and n. Since the effective skin thickness is decreased by increasing 
L, R, r and n, it is expected that similar variation in array design parameters will result 
in an increase in blood concentration profile. The blood concentration increased from 
0.1ng/ml to 2.5ng/ml when the number of microneedles was increased from 400 to 
2500 and increasing the penetrated length of the microneedles from 60μm to 90μm 
resulted in an increase in peak blood concentration from 0.0015ng/ml to 0.0037ng/ml. 
Varying the tip and base radius can also be used to achieve desired change in blood 
concentration as can be seen in Figures 4.10 and 4.11. When the base radius of the 
microneedle in the skin was increased from 50μm to 80μm, the peak blood 
concentration increased from 1.5ng/ml to 4.2ng/ml and when the tip radius was 
increased from 10μm to 25μm, the peak concentration increased from 4.5ng/ml to 
7.9ng/ml. 
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Figure 4.8. Concentration of fentanyn in blood following delivery with microneedles 
of varying Penetrated Length. Here r=5μm, n=100, R=40μm and A= 1cm2 
 
 
Figure 4.9. Concentration of fentanyl in blood following delivery with microneedle 
array of varying number. Here L= 90μm, r= 5μm, R=40μm and A= 1cm2 
 
 64 
 
 
Figure 4.10. Concentration of fentanyn in blood following delivery with microneedles 
of varying tip radius. Here L= 90μm, n=1600, R=80μm and A= 1cm2 
 
Figure 4.11. Concentration of fentanyn in blood following delivery with microneedles 
of varying base radius. Here R= 80μm, n=1600, L=90μm and A= 1cm2 
 
 
 65 
 
The concentration profile observed here are typical of the concentration profile of 
fentanyl in the blood where the concentration rises to a peak and then shows a quick 
drop followed by a slower drop after the drug loaded device is removed from the skin 
following a 24 hour period of application (Tojo, 2005; Gupta, 1992). The difference 
in the peak concentration obtained here for different geometries is significant as it 
suggests that microneedles can be designed to achieve relatively precise controlled 
drug delivery, which is desired for optimum effectiveness of the drug being delivered.  
 
In previous studies, Al-Qallaf and Das (2008) presented a framework for optimizing 
the dimensions of microneedles in a square array in order to increase drug 
permeability in skin. Their study looked at optimizing the microneedle dimensions 
which included microneedle radius, pitch, area of patch and number of microneedles 
for any given microneedle. The results from al-Qallaf and Das indicated that 
increasing the radius and number of microneedles will increase the drug permeability 
in skin, their results are in agreement with the values obtained here. However in order 
to develop a framework that can be used to optimize the full microneedle array design 
to achieve desired blood concentration profile other parameters must be considered. 
The effect of the tip radius, base radius, penetrated microneedle length and number of 
microneedle in the array has been considered here. 
 
4.5. Chapter Summary 
The numerical simulations that have been carried out here on drug delivery rate using 
microneedles shows a dependency on tip radius, base radius, penetrated length and 
number of microneedles in an array. These data provides a theoretical basis for 
venturing into optimization of these variables for the purpose of improving efficiency 
of drug delivery using microneedles, as it has shown that the skin penetration rate and 
the peak blood concentration achieved could be significantly affected by these 
parameters. 
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5. Optimization of Microneedle Design for 
Controlled Drug Delivery: Constant 
Diffusion Coefficient  
 
5.1. Overview 
The numerical simulations in the previous chapter indicate that the geometry and 
distribution of microneedles have an effect on the drug flux through skin and 
subsequently concentration in the blood. The effectiveness of drug delivery by 
microneedle arrays is therefore determined by the permeability of the drug compound 
through skin. In this chapter, a theoretical approach is presented to directly relate the 
permeability of drug through the skin with the microneedle array design parameters, 
hence providing a quantitative basis for analysing the dependency of microneedle 
mediated transdermal drug transport on each individual parameter R (base radius). r 
(tip radius), L (penetrated length) and n (number of microneedles). This study 
provides a predictive assessment of the performance of microneedles prior to 
fabrication using a practical framework which can be solved using widely available 
spread-sheet functions. 
 
5.2. Introduction 
The initial patented idea of using microneedles for transdermal drug delivery (Gerstel 
and Place, 1976) connotes that bypassing the stratum corneum would increase the rate 
of drug permeation through skin; therefore the microneedles must be long enough to 
project past the stratum corneum into the viable epidermis. Owing to the later 
developments that led to available technology to fabricate such projections, it is now 
possible to design such micron size needles to pierce the skin without causing pain. 
Various designs of microneedles have been reported since the 90’s when first 
experimental study that showed microneedles to significantly increase permeability of 
calcein through the skin using 150μm long microneedles with sharp tips (Henry et al, 
1998) were reported. For example Cormier et al (2004) fabricated 200μm long 
microneedles, 170μm wide and 35μm thick with 320MNs per array over a 2cm2 area, 
coated with desmopressin. In their experiment they showed that these microneedles 
were able to safely deliver variable doses of desmopressin to hairless guinea pigs.  
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Some studies have focused on the effect of microneedle design on the rate of drug 
delivery (Yan et al, 2010; Badran et al, 2009; Oh et al, 2008) and difference in values 
has been observed for drug delivery when different microneedle designs have been 
used. For instance Badran et al (2009) noted a higher drop in glucose level in the 
blood when microneedles of different lengths were used to deliver insulin to rats. Yan 
et al (2010) evaluated the permeation of acyclovir through skin following pre-
treatment with microneedles ranging in length from 100 to 1100μm and observed that 
longer microneedles resulted in a higher flux reading. In a separate study Oh et al 
(2008) presented results that showed that a higher permeation profile when 500μm 
long microneedles are used to permeate rat skin compared with using 200μm long 
microneedles. The group also presented results from experiment using 45, 99 and 154 
MN/cm2 to penetrate rat skin to enhance calcein permeation. Higher permeation 
profile was observed when microneedle density in an array is increased.  
 
The discussions above establish a practical relationship between microneedle array 
design and efficiency of transdermal drug delivery. However in order to capitalise on 
these findings a system of assessing the performance of a given microneedle design 
prior to fabrication is required. The aim of this chapter is therefore to provide a 
quantitative basis to relate the drug delivery efficiency of a microneedle based system 
to the geometry parameters. 
 
5.3. Model Outline 
It is known that due to the presence of nerves in the lower layers below the epidermis, 
the microneedles should not pierce deeper than the thickness of the epidermis (Henry 
et al, 1998, McAllister et al, 2003). However, the fabricated length of microneedles is 
often longer than the desired depth to which microneedles are to pierce into the skin 
(Bal et al, 2010; Donnelly et al, 2011, Kolli and Banga, 2008; Martanto et al, 2004; 
Henry et al, 1998). This is due to the skin’s elasticity and the presence of wrinkles 
which prevent the full length from piercing the skin (McAllister et al, 2003). Laser 
scanning microscopy in combination with florescent dye staining has been used to 
visualize the geometry of conduits created by microneedles in vivo (Bal et al, 2010). 
The holes created by 300μm long microneedles were visualized to be as deep as 
170μm and up to 130 x 103μm3 in volume. For these reasons discussed the present 
study considers the part of the microneedle which penetrates the skin therefore the 
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dimensions of the microneedles defined are those of the portion of the microneedle 
that has inserted into the viable epidermis as illustrated in Figure 5.1. 
 
The model presented here applies to microneedle application techniques that require 
the microneedles to remain inserted into the skin over the duration of medication an 
example of such are phase transition hydrogel microneedles (Singh et al, 2009; 
Woolfson et al, 2009; Tuo et al, 2010) which are discussed in chapter 2 section 2.6.1d 
of this thesis. These novel types of microneedle delivery system are designed to 
provide controlled drug delivery while avoiding the limitations of the typical solid or 
hollow microneedle based drug delivery system. Furthermore holes created by 
microneedles are prone to resealing when the microneedles are removed in the case of 
pre-treatment technique as experiments carried out by Zhou et al (2010) showed. In 
the said experiment Evans blue staining confirmed the formation of holes following 
microneedle application and the resealing of holes after a maximum of 8hrs for MNs 
250, 500 and 1000µm in length. The resealing of the holes was shown to affect the 
rate of drug delivery as the rate of insulin absorption (which manifests as the drop in 
glucose level) dropped with time as the SC gradually reforms.   
 
Figure 5.1 Schematic of a. Microneedles inserted into the viable epidermis (VE) 
 
Rate of transdermal drug delivery is dependent on the rate at which the drug 
permeates through the skin and in the case of microneedles this is the rate at which it 
permeates through the viable epidermis (VE) since the Stratum corneum (SC) is 
bypassed. This can be expressed as the permeability K, which is the ratio of steady 
state diffusive flux, Jss to concentration of drug on the skin surface, C (Chen et al, 
2009); 
C
JK ss=      (5.1) 
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Given that at steady state the flux can be defined as; 
eff
ss h
CDJ =      (5.2) 
effh
DK =      (5.3) 
Where D is the effective diffusion coefficient and heff is the effective skin thickness 
which is the distance from the drug loading surface to the point of absorption. When 
considering the skin as a homogeneous medium with a transdermal patch placed on 
the surface of the viable epidermis, and if the drug is assumed to be 100% absorbed in 
the dermis, heff can be taken as the thickness of the viable epidermis. However when 
microneedles are inserted into the skin the effective skin thickness is obtained from 
numerical simulations (Al-Qallaf et al, 2009). 
In a similar manner in which McAllister et al (2003) estimated the permeability from 
the fractional skin area based on the top view of the microneedle, the effective skin 
thickness is estimated here from a derived equation explained as follows. Envisage an 
array of microneedles inserted into the skin. Unlike a transdermal patch placed on the 
surface of stripped skin (with the stratum corneum removed), the path length for 
diffusion is no longer the epidermis thickness h. The distance the drug travels to get 
from the microneedle surface to the bottom of the epidermis where it is absorbed is 
expressed as effective thickness, heff* derived from Equation 5.4; 
  
n
needle*
eff A
nVAhh −=       (5.4) 
Where for any given array of microneedle inserted into the skin, Vneedle is the volume 
of each microneedle, n is the number of microneedles in the array, An is the surface 
area of microneedles and A is the area of the patch containing the microneedle array. 
The permeability can therefore be calculated as; 
  
nVAh
AD
h
DK n*
eff −
==      (5.5) 
By substituting Equation (5.4) into (5.5), the ratio of permeability to effective 
diffusion coefficient can be expressed as the permeability function, g. which relates 
the drug delivery efficiency to the geometry parameters of the microneedle; 
 
nVAh
A
D
Kg n
−
==      (5.6) 
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Equation (5.4-5.6) can be used to calculate the geometry required to obtain desired 
drug delivery rate.  For a square array of conical microneedles, Equation (5.6) can be 
expressed as; 
)rRrR(Ln3Ah
)r)L)rR()(Rr((ng 22
222
++π−
π++−+π
=    (5.7) 
Equation 5.7 allows separate analysis of each parameter as well as a single solution to 
find the optimum design which gives the highest permeability. However necessary 
constraint must be placed on the equation in order to obtain a valid range of values, 
the first of which is: the base radius should be larger than the tip radius; 
rR ≥          (5.8) 
We impose a second constraint is to ensure that the length (L) of microneedle in the 
skin does not exceed the epidermis thickness (h) in order to achieve painless 
penetration.   
hL ≤        (5.9) 
As a third constraint is that the microneedles in an array should not overlap therefore 
the pitch, which is the centre to centre spacing between the microneedles, should be 
greater than the product of the base radius and the aspect ratio; the ratio of pitch Pt 
(centre to centre spacing of microneedles) to radius which has a minimum value of 2. 
RPt α≥        (5.10) 
Specifically for a square microneedle array, the pitch is the ratio of the squared area to 
the number of microneedles in a row of array n* 
*t n
AP =       (5.11) 
A final constrain is that g should always be a positive value. Therefore for Equation 
5.6 to be valid the denominator must be a positive value. 
nVAh >       (5.12) 
For these reasons the range chosen for the analysis of r, R, n and L were chosen with 
consideration given to the above constraints and the constraint in Equation 5.8 to 5.12 
where monitored using the IF function in the optimization algorithm as discussed in 
the next section.  
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5.4. Method of Solution  
The equation was solved by iterating through all the possible values of the 
permeability function g, while observing every constraint listed in Equations (5.8–
5.12). The highest value of g is chosen which corresponds to the maximum 
permeability. The values of the variables at this point are chosen as the parameters for 
the optimum design, within the range tested. To achieve this, the equation was entered 
into excel and solved for all the possible combinations of r, R, L and n using the scale 
and parameters as given in Table 5.1. A method was then devised in Microsoft excel 
using the built in IF, MAX and CONDITIONAL FORMATTING options. This 
option allows the elimination of values outside the constraints, then selects and 
highlights the maximum value of g. The combination of the parameters at this g value 
is therefore the optimum microneedle geometry and distribution within the range 
tested. Furthermore a VBA program has been developed within this research to 
provide automated solution of MN optimization framework and this is discussed in 
more detail in chapter 9. 
 
Table 5.1 Values for Parameters used in this study 
Parameter Value  Scale 
Base Radius R (μm) 
Tip radius r (μm) 
Penetrated length L (μm) 
Number of MNs n (-) 
Area of MN patch A (μm2) 
Thickness of VE h (μm) 
Diffusion coefficient D (m2/s) 
Concentration C (mol/m3) 
50 - 100 
5 - 30 
120 - 170 
10-20 
1 x 108 
180 
1 x 10-10 
1 
10 
5 
10 
1 
Constant  
Constant 
Constant 
Constant 
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Figure 5.2 Algorithm used to solve model. 
 
Further to solving the optimization equation, 3D simulations of microneedle drug 
delivery into skin is carried out to compare flux values for various chosen geometry 
using an arbitrary model drug with properties listed in Table 5.1. For the purpose of 
this study, permeability at steady state is considered and this assumes a zero 
concentration at the epidermis/dermis junction as given in Equation 5.13 so that 100% 
absorption occurs at this point. In addition to this the concentration of drug on the 
microneedle is assumed to be constant throughout the delivery process (Equation 
5.14) with a starting concentration of zero at an initial time before delivery (Equation 
5.15). This assumption is applicable since the concentration of drug on transdermal 
delivery systems are usually much higher relative to that in the blood and the drugs 
and given the small amount of drug relative to the large volume of the body to which 
the drug is absorbed. The concentration gradient therefore remains at steady state 
values throughout the delivery process (Davidson et al, 2008).  
0C =  at Hx =  for 0t >       (5.13) 
 sCC =  at  Lx0 ≤≤  for 0t >       (5.14) 
0C =  at Hx0 ≤≤   for  0t =     (5.15) 
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With the Fick’s equation implemented into the FEM program and the boundary 
conditions imposed, values of steady state diffusive flux at the epidermal/dermal 
junction was calculated for the different dimensions of tapered microneedle using 3D 
simulations. 
 
5.5. Results and Discussions 
 
5.5.1. Optimum Microneedle Geometry  
Solving the model using the outlined method, an optimum value of 1832m-1 was 
obtained for g. This value occurred at L=170µm, R=100µm, r= 30µm and n=20. This 
is supposing it is required to find the highest permeability therefore the widest tip and 
base, longest length and a densely packed array will result in higher drug permeability 
in the skin. Equation 5.5 would suggest this to be an expected theoretical outcome 
since an increase in each of these variables gives rise to a decreased value of the 
denominator resulting in a higher permeability function. Likewise as the surface area 
An of the microneedles increase the distance for diffusion is decreased. This model 
can also be used to determine the microneedle array design required to obtain a 
desired permeability or flux value (Equations 5.1-5.3). An example is given here to 
illustrate this. By solving the equations, a range of values are tested to obtain the 
permeability function for all possible microneedle design parameters in the range. The 
permeability can then be obtained from Equation 5.3. The Conditional Formatting 
option in Excel is then used to select the desired permeability value and the 
corresponding values of n, L, r and R. Table 5.2 gives an example of some of the 
values of permeability and corresponding parameters.  
 
Table 5.2. Some examples of permeability functions g and corresponding parameters 
of microneedles arrays. 
g (m-1) n (-) R (μm) r(μm) L(μm) 
1491 400 100 5 170 
323 100 70 30 170 
940 256 100 5 170 
417 100 100 30 160 
481 121 100 30 150 
954 400 60 15 170 
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To analyse the framework further, the effect of each individual parameter; L, r, R and 
n on drug permeability in skin is considered separately. Calculations from the 
proposed model are presented alongside flux values obtained from 3-D simulation in 
COMSOL. By keeping every other variable constant while testing for individual 
variable, the effect of tip radius r, base radius R, penetrated length and number of 
microneedles on drug flux through skin are analysed. 
 
5.5.2. Effect of the Length of Microneedle on Drug Delivery 
In this section, simulation results showing the effect of the microneedle length on the 
permeability function are discussed. It is expected that a longer needle will decrease 
the distance for diffusion and result in higher permeability. Based on the algorithm 
presented here the effect of L on permeability is theoretically analysed independent of 
the other variables. Figure 5.3 shows that as the length of microneedles increases the 
permeability increases. This can be said to be as a result of the decreased diffusion 
distance as the microneedles penetrates further into the viable epidermis. The steady 
state flux obtained from 3D numerical simulations is also shown to increase as the 
penetrated length of microneedles increases. This is shown in Figure 5.4. The similar 
trends in permeability and flux for increasing penetration length are in accordance 
with Equations 5.2 and 5.3. 
There have also been reported experimental studies that confirm a relationship 
between the length of microneedles in an array and the flux through the skin. One 
such study was done by Yan et al (2010); where human epidermal membrane was 
treated with arrays of microneedles with various length and densities 
(microneedles/exposed area) prior to transdermal delivery of acyclovir saturated PBS 
solution. The results showed notable increase in flux values for arrays with longer 
microneedles for the various configurations tested. The precise geometry of the 
microneedles and skin thickness was not reported in this study (Yan et al, 2010) 
therefore the comparison is based on the increasing trend rather than the specific 
values.   
A similar study was carried out by Zhou et al (2010) which showed that the decrease 
in blood glucose following microneedle administration of Insulin to diabetic rats, was 
the highest for 1000μm long microneedles than for microneedles which were 500μm 
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in length and lowest drop in blood glucose level occurred with 250μm long 
microneedles. The decrease in blood glucose corresponds to the delivery of insulin to 
the diabetic rats (Martanto et al, 2004; Zhuo et al, 2010; Wang et al, 2005) this result 
therefore supports the results presented here. In a separate study Badran et al (2009) 
reported experimental results that showed an increase in cumulative amount of radio 
labelled mannitol that permeated the skin following pre-treatment with different 
lengths of Dermaroller® microneedles. It was found that the percentage of the applied 
dose that remained in the receptor was higher when longer microneedles were used. 
The results from the analysis of the presented framework therefore is in line with the 
experiments discussed above as shown in Figure 5.3 and 5.4 which indicates an 
increase in the permeability function and flux as the penetrated length is increased. 
The method presented is therefore useful for predicting the effect of increasing the 
penetrated length of microneedles on the permeability of drug through skin.  
 
Figure 5.3. Predicted effect of microneedle Length based on presented model. 
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Figure 5.4 Flux values from 3-D simulations for varying microneedle length and base 
radius   
 
5.5.3. Effect of Radius of Microneedle on Drug Delivery 
There have been a number of studies that examined the effect of microneedle 
radius/width in the drug delivery scenario. For example Gill et al (2008) looked at the 
effect of the width of microneedles on their ability to cause pain during insertion. 
Their results showed no significant effect of the width on the amount of pain caused 
when three different widths; 160, 245 and 465μm were tested. However results by 
Davis et al (2003) showed that the width of microneedles is a significant factor to 
consider for strength and ease of insertion. The group carried out insertion force 
experiment on microneedle devices which showed the increasing strength of 
microneedles when the tip radius and wall angle which depends on base radius and 
length, is increased. The group also showed results indicating that microneedles with 
smaller tip radius required less force to insert into the skin than microneedles with 
wider tips when a tip radius between 30 and 80μm were tested.  
Some experimental studies have been focused on the effect of the radius/ width of 
microneedles on permeability. Yan et al (2010) measured flux of acyclovir through 
human epidermal membrane for different geometries of microneedles with varying 
radius, The results generally showed a variation in flux values as the geometries 
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varied however their study was aimed at studying effect of length and number of 
microneedles in an array, they therefore did not vary radius independently. Simulation 
results by Al Qallaf et al (2008) studied the effect of microneedle radius on the 
permeability and developed a model that relates the radius of microneedles and other 
parameters on permeability. They concluded that as the radius increases the 
permeability should also increase. The model was based on the top view of the 
microneedle therefore only base radius was considered. According to the results from 
calculations based on the model presented in this study, increasing the tip radius and 
base radius should result in an increase in the permeability and flux as shown in 
Figure 5.5-5.6 indicating that a wider microneedle should result in a higher drug flux 
through the skin.  
 
Figure 5.5 Permeability function calculated at different tip radius and base radius. 
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Figure 5.6 Flux values from 3-D simulations for varying tip and base radius. 
 
5.5.4. Effect of number of microneedles on Drug Delivery 
The number of microneedles affects the drug loading capacity of the microneedle 
array therefore it is a significant parameter to consider when designing a microneedle 
array. The presented framework can be used to find the number of microneedles to 
obtain the highest permeability and it could also be used to find the number of 
microneedles to atain a desired permeability or flux. In this section the effect of 
varying the number of microneedles while keeping other variables constant is 
discused. Oh et al (2008) carried out experiment on exiced rat skin where calcein was 
permeated through the skin using microneedels of varying densities; 45, 99 and 154 
MNs/cm2 arrays. The amount of calcein permeated was higher when more 
microneedles were used per cm2. This agrees with the results obtaind here which 
showed that permeability and steady state flux values increases when the number of 
microneedles in an array is increased (Figures 5.7 and 5.11). Similar results were 
reported by Al-Qallaf and Das (2008) where calculations based on the framework 
they developed showed permeability to increase as the number of microneedle is 
increased.  
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Figure 5.7 Permeability function calculated for varying number of microneedles. 
 
For all the results obtained in this study, the effective diffusion coefficient is assumed 
to be independent of the size and number of inserted microneedles; the change in 
permeability is thought to be due to the variation in path length for drug delivery as 
microneedle of different sizes are considered. To some extent this applies and is 
evident in the experimental results that have been refered to in this section. However 
when the mechanical force exerted during microneedle insertion is included in the 
framework, a variation in the diffusion property of the skin is expected. The next 
chapter looks at this in more details. 
 
5.6. Chapter Summary 
In this chapter, a theoretical framework has been presented to directly relate the 
permeability with the design parameters of microneedle hence providing a 
quantitative basis for analysing the dependency on each individual variable R (base 
radius). r (tip radius), L (penetrated length) and n (number of microneedles). More 
importantly the framework can be used to optimize the design of an array to obtain 
the highest permeability and it can also be used to determine the microneedle array 
design required to achieve a desired permeability. It should be noted that this 
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framework considers the diffusion coefficient to be independent of the geometry of 
the microneedles inserted; this may not always apply, as is discussed in the next 
chapter. 
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6. Modelling the Effect of Microneedle Array 
Design on Drug delivery: Effect of Tissue 
Compressibility 
 
6.1. Overview 
Studies have shown that compression of tissue could affect the diffusion coefficient of 
substances through the tissue. To this point diffusion coefficient has been considered 
to be independent of the microneedle array design however the design of the 
microneedle array could alter the effective diffusivity of the drug through the skin 
tissue. For this reason it is important to have a quantifiable relationship between the 
microneedle design parameters and the diffusion properties of the skin, which is what 
this study aims to achieve. A model is derived by fitting empirical equation to some 
experimental data provided in literature. Using the developed model various scenarios 
of practical importance were then considered. For all the scenarios analysed, the 
predicted blood concentration was found to be lower when the effect of skin 
compression due to microneedle insertion was accounted for.  
 
6.2. Introduction 
There have been some studies that considered the effect of microneedle geometry on 
the drug permeability (Davidson et al, 2008; Al-Qallaf and Das, 2008; Al-Qallaf and 
Das, 2009). For example, Davidson et al (2008) identified the effect of using different 
microneedle geometry on the permeability of drug in skin. The permeability values 
were obtained by first calculating effective skin thickness which was estimated from 
steady state flux values obtained from numerical simulations. In this study the 
diffusion coefficient of the drug in the skin was assumed to be the same when the 
microneedles were inserted and removed. However, other studies (e.g, Evans and 
Quinn, 2005; Heneghan and Riches, 2008) have shown that permeability through soft 
tissue may be significantly altered when a mechanical strain is exerted. In transdermal 
drug transport the efficiency of drug delivery is dependent on the rate at which the 
drugs diffuse through the skin. Therefore, the change in the intrinsic diffusion 
property of the skin when microneedles are inserted must be given careful 
considerations. 
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The effect of tissue compression on solute or drug permeability has been shown to be 
important in some studies. These include experiments on articular cartilage (Evans 
and Quinn, 2005; Leddy and Guilak, 2008; Jackson et al, 2008; Reynaud and Quinn, 
2006; Evans et al, 2005; Quinn et al, 2000) and nucleus pulposus and fibrosus 
(Heneghan and Riches, 2008; Jackson et al, 2008) to analyse the effect of placing 
compressive force of specimen on the permeation of solutes. In these studies, it was 
shown that compressive straining of tissue will cause the permeability of molecules 
through it to decrease. Permeation of molecules through tissue is vital especially for 
avascular tissues in order to supply nutrients to these regions. Such studies play an 
important role in treatments of health defects such as back pain. 
When microneedles are inserted into the skin, regions of the skin are compressed in a 
manner which could alter the diffusion coefficient of the skin relative to its unstrained 
position (Roxhed et al, 2004). This is in accordance with other permeation studies on 
cartilage tissues that compared diffusivity of strained and unstrained tissues. Indeed, 
for the case of hollow microneedles a solution to this problem was proposed by 
Martanto et al (2005). This involved partial retraction of the MNs to allow delivery of 
more drugs/fluids to the skin (Martanto et al, 2006; Wang et al, 2006). However the 
limitations of hollow microneedles such as leakage and the flow limitation 
demonstrated in chapter 3 of this thesis still persist making solid microneedles a 
predominant option. However for solid microneedles, which may need to be applied 
for a long duration, the implications of the microneedle geometry on the drug 
diffusion should be considered carefully. For example, phase transition hydrogel 
microneedles discussed in chapter 2 of this thesis (Woolfson et al, 2009; Tuo et al, 
2010). Moreover other problems associated with hollow microneedles still remains 
therefore delivery techniques of solid microneedles still persist over hollow 
microneedles due to their structural and storage advantages (Gill and Prausnitz, 2006) 
and the main mode of delivery of such microneedles is by diffusion through skin 
therefore it is important to consider the changes in diffusion properties when such 
microneedles are inserted. 
Considering the above issues, the present chapter aims to develop a quantitative basis 
for analysing the relationship between the microneedle geometry and the diffusion 
properties of skin. The conceptual model is discussed in detail in the following 
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section. It is envisaged that the developed model will allow the design of the 
microneedle to be optimized for more efficient drug delivery.   
 
6.3. Outline of the Conceptual Model 
 
6.3.1. Structure and Permeability of Compressed and Uncompressed Skin 
For the purpose of this work the skin is defined to be made up of two distinct layers 
namely the epidermis and the dermis. The epidermis is further divided into two main 
layers which are the SC and VE in consistent with other studies (e.g., Stalheim-Smith 
and Fitch, 1993). As discussed in previous section the dimensions of the microneedles 
defined here i.e. tip radius, base radius and length of microneedles are those of the 
part of the microneedle which has penetrated the skin (see Figure 5.1, Chapter 5). 
Similarly to the preceding chapter the microneedles being considered in this study are 
those that are designed to remain embedded in the skin throughout the period of 
medication.  
Various forms of transport mechanisms have been suggested to describe transdermal 
transport (Hadgraft, 2004; Nemanic et al, 1980; Bodde et al, 1991; Micheals et al, 
1975; Neelissen, 1998). In this study, the Fick’s diffusion law is used to describe the 
diffusive transport in skin based on average properties (e.g., average diffusion 
coefficient). It has been shown that since the intercellular spaces contain both 
hydrophilic and lipophilic regions through which substances must pass through by 
diffusion, the mode of transport can be modelled using Fick’s law (Hadgraft, 2004; 
Barry, 1999).  The permeability in this case (i.e. transdermal drug delivery) is that 
related to the diffusion coefficient over a characteristic length scale rather than an 
intrinsic permeability in terms of porous flow as used in the Darcy’s law. The 
efficiency of transdermal drug delivery is therefore significantly dependent on the 
diffusion properties of the skin. It has been observed that when microneedles are 
inserted into the skin, regions of the skin are compressed in a manner which could 
alter the diffusion properties of the skin relative to its unstrained position (Roxhed et 
al, 2004). This is in accordance with other permeation studies on cartilage tissues that 
compared diffusivity of strained and unstrained tissues.  
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The change in the permeability when a tissue undergoes compression is said to be due 
to the realignment of the molecules of the tissue structure (Leddy and Guilak, 2008, 
Leddy et al, 2006). Other studies suggested that diffusion of certain substances occurs 
faster along the fibre than parallel to the fibre according to microscopic observations 
(Leddy et al, 2006; Leddy and Guilak, 2008; Han and Herzfeld, 1993; Lubkin and 
Wan, 2006). When tissue is compressed this causes extrusion of interstitial water from 
the tissue. Diffusion is thus slower through a less moist region as demonstrated in the 
study by Jackson et al (2008) where tissue water content was plotted against diffusion 
coefficient, indicating a positive correlation between diffusion coefficient and tissue 
water content. Similar observations were also made by Das et al (2009) where it was 
also found that diffusion coefficient decreases as molecular weight decreases for inter 
vertebral disc tissues. The solute/drug permeability in the tissue is a product of the 
diffusion coefficient and the partition coefficient divided by the effective skin 
thickness (Moss et al, 2001). This relationship implies that the change in permeability 
is a combination of the effect of the change in skin volume, diffusion coefficient and 
partition coefficient when microneedles are inserted into the skin. We discuss this 
point further in the following section. 
 
6.3.2.  Force Exerted on the Skin by the Microneedles 
First the manner in which the skin contracts following insertion of microneedle is 
analysed in the context of this work and a model is then derived. When microneedles 
are inserted into the skin, each exerts a pressure on the skin as it occupies a volume 
equivalent to the volume of the microneedle. For example, a schematic of the stress 
distribution in deformed skin when two microneedles are inserted is shown in Figure 
6.1. The non grey regions indicate the non deformed skin while the coloured region 
show the deformed skin with microneedle inserted. The darker grey areas show the 
region where the needle exerts a compressive mechanical force on the skin.  
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Figure 6.1 A schematic showing compressive force exerted by microneedles when 
inserted into the skin. 
 
In this study the skin is considered as a homogeneous layer since the only layer being 
considered is the viable epidermis. Although the stress distribution varies across the 
skin at distances away from the needle the exerted pressure shall be assumed to be 
distributed evenly over the area of the skin under the microneedle array. This is 
thought to be a valid assumption made in the present study since the skin is a non 
rigid surface and the microneedles are micron sized objects. Therefore the force 
exerted by the microneedle will not spread too far away from the area of insertion, 
hence a low stress gradient. 
The work needed to compress the skin by (∆V) to allow microneedle insertion is 
defined to be equivalent to the work required to move the needle from the surface of 
the epidermis (h0) after puncturing the SC (Stratum Corneum) to a depth h1 into the 
epidermis. To relate the geometry of the microneedles to the force applied to insert 
the microneedle into the epidermis, we employ the principle of work done. 
 VPW r∆=        (6.1) 
)hh(FW 10 −=       (6.2) 
 VP)hh(F r10 ∆=−       (6.3) 
Where Pr is the pressure exerted on the viable epidermis over the surface area of the 
needle in contact with the viable epidermis and ΔV is the change in volume of the 
skin when the microneedle is inserted into the skin which is equivalent to the volume 
of the needle Vneedle that has penetrated the skin. ho represents the original distance of 
the microneedle from the epidermal/dermal junction and h1 is the distance of the 
microneedle from the epidermal/dermal junction after it is inserted into the epidermis 
such that it is the same as the penetrated length of the microneedle L;  
Microneedles on skin surface prior to insertion 
Microneedles 
inserted into skin 
Un-deformed skin 
Compressive force is exerted on skin when microneedles are 
inserted 
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L)hh( 10 =−       (6.4) 
The force necessary to cause the skin to deform by ∆V can be defined by force 
displacement equations determined from fitting experimental results to appropriate 
models;   
)hh(fF 10 −=             (6.5) 
An example of such experiment was done by Davis et al (2004) fitted experimental 
results to obtain the following functional form for human skin displacement.  
   )hh(00019.0insertion 1oe66.0F
−=      (6.6) 
However this force includes friction forces Ffriction and the force required to cut 
through the skin tissue Fcutting; subtracting the cutting and friction forces from 
Equation (6.6) will give the force required to deform the skin by ∆V  
frictioncutting
)hh(00019.0 FFe66.0F 1o −−= −     (6.7) 
This force can then be substituted into Equation (6.3) to obtain the pressure exerted on 
the viable epidermis to deform it by ∆V the pressure obtained can therefore be 
inserted into an expression relating pressure exerted and diffusion coefficient such as;  
  )P(DfD ri =        (6.8)   
Where f(Pr) is an expression of pressure as a function of diffusion coefficient. The 
forces defined above are significantly affected by the experimental condition therefore 
a more versatile equation is required such that the diffusion coefficient can be related 
to the geometry of the microneedle inserted. This study therefore proceeds towards 
this aim. Given that the change in volume of the skin is as a result of the volume of 
microneedle inserted (Vneedle); 
needleVV =∆        (6.9) 
Change in volume is as a result of the work done to exert a pressure Pr on the skin 
therefore the diffusion coefficient can be related to the volume of microneedle as 
follows; 
 )V(DfD needlei =       (6.10) 
 
6.3.3. Change in diffusivity due to compressive force exerted by microneedle. 
There have been experimental studies which show that the diffusion of compounds 
through tissue is affected by the strain or compression exerted on the tissue (Leddy 
and Guilak, 2008; Jackson et al, 2008; Quinn et al, 2000). However there is a dearth 
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in such experiments on human skin tissue. Therefore here linear regression analysis is 
carried out on experiment reported in literature on annulus fibrosis in order to obtain a 
theoretical relationship between diffusion coefficients and strain (Jackson et al, 2008). 
For this purpose the strain function φ  is defined as;   
skin
needle
V
nV
=φ
     (6.11) 
Regression analysis obtained were carried out on experimental values reported by 
Jackson et al (2008) the experiment carried out involved exerting different level of 
strain (0, 0.1 and 0.2) on annulus fibrosus tissue to compare diffusion coefficient of 
glucose in the tissue at different strains. Analysis carried out here on the results show 
the relationship between the strain and diffusion coefficient to be best fit to a linear 
equation given as; 
)q1(DDi φ−=
        (6.12) 
Di is the effective diffusion coefficient when pressure is exerted on the skin i.e. with 
the microneedle inserted and q is a dimensionless constant. The permeability and 
diffusion coefficient are related as follows (Moss et al, 2001); 
effh
DP =     (6.13) 
heff is the effective skin thickness and P is the permeability. Equation 6.13 can 
therefore be adjusted to find permeability with microneedle inserted Pi 
eff
i h
)q1(DP φ−=      (6.14) 
Substituting (6.13) into (6.14) gives; 
)q1(PPi φ−=       (6.15) 
This equation relates geometry parameters of microneedle to permeability since it 
includes the strain function φ  defined in Equation (6.11). The dimensionless 
parameter q is dependent on the property of the skin and the drug substance and is 
generally determined for specific cases from experiment; this is discussed in the next 
section.  
The particular Equations (6.12) and (6.15) are ideal in this case as they contain 
dimensionless parameters that allow the model to be tuned. The ability to tune the 
model is important in this case since skin is a tissue which has its properties varying 
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in a rather eccentric manner and it is important to tune the model to represent a 
specific case.  
From the above discussions it is apparent that the permeability is a function of the 
force applied to the microneedle, effective skin thickness and the size of the 
microneedle. The force acting on the skin is determined by the amount of force 
required to insert the microneedle which depends on the size and shape of the 
microneedles. In addition, the effective skin thickness is dependent on the geometry 
and distribution of the microneedles and this affects the permeability. In general the 
entire framework relates the microneedle geometry with the skin permeability to 
drugs. The presented framework is robust as it allows consideration for various MN 
dimensions as well as variation in skin properties. The presented framework is 
outlined in Figure 6.2.  
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Figure 6.2. The developed framework.  * indicates original value adjusted by adding 
or subtracting a correction factor. 
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6.4.Drug Transport Behaviour 
 
6.4.1. Drug concentration in skin  
Since diffusion through the SC is eliminated by the use of microneedles, the diffusion 
coefficient that is relevant in this case is that of the viable epidermis. The transport of 
drug through the viable epidermis is represented by Fick’s law (Kubota et al, 2002; 
Goyal et al, 2007). The drug diffusive behaviour in skin is determined by rearranging 
the Fick’s first law equation for steady state diffusion (Moss et al, 2001; Singh and 
Singh, 1993) as follows: 
dx
dCDJss =      (6.16) 
Where Jss is the steady state flux of a drug across skin, D is the diffusion coefficient of 
the drug, C is the concentration of the drug and dC/dx is the concentration gradient. 
The following approximation is then applied at steady state; 
dx
dC =constant = 
eff
10
h
CC −             (6.17) 
Where C1 is drug concentration at the drug loaded surface of microneedles, C0 is the 
concentration at the epidermal/dermal junction. By combining Equation (6.12) with 
Equation (6.13), we obtain the following equation for steady state diffusive flux Jss: 
eff
01
ss h
)CC(DJ −=                             (6.18) 
When C0 is defined to be zero (i.e., sink condition), the effective diffusion coefficient 
is defined as follows: 
1
sseff
C
JhD =                            (6.19) 
D is the effective diffusion coefficient of the drug through the viable epidermis, C is 
the drug concentration at a given position and dC/dx is the concentration gradient 
(Moss et al, 2001; Singh and Singh, 1993; Jackson et al, 2008). The effective skin 
thickness is also obtained by rearranging Equation (6.19). It is taken that the full 
penetrated length (L) of the microneedle acts as a drug releasing surface.  
Using the identified equations and boundary conditions used in previous chapter 
(Equation 5.13-5.15); values of diffusive flux was calculated for the different 
dimensions of tapered microneedle using 3D simulations in Comsol®.  
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6.4.2. Drug Concentration in Blood  
The blood concentration profile of a drug after microneedle delivery is predicted 
using SKIN-CAD (See Section 2.10). Here insulin is used as the model drug and 
various models have been proposed to model the pharmacokinetics of insulin 
absorption and elimination in the body and these have been reviewed by Nucci and 
Cobelli (2000), here a two compartment model is adopted (Equation 6.20).  
dbe12tt21n
b
b VC)kk(VCKAdt
dQ
dt
dC
V +−−=          (6.20)        
Vd is the volume of distribution in the blood, Cd is the concentration of the drug in the 
blood at time t, Ke is the elimination rate constant, dQ/dt is the rate of skin 
penetration, An is the area of the drug releasing surface of the delivery system, K12 
and K21 is the transfer rate constant between the tissue and blood compartment, Ct is 
the concentration of the drug in the tissue compartment and Vt is the volume of 
distribution in the tissue compartment. In order to allow for drug degradation in the 
skin Vt is taken to be 0. This means the middle term on the right hand side vanishes 
and k12 indicates loss of drug due to degradation as it passes through the skin 
(Duckworth, 1998). An is calculated as the surface area of the microneedles in contact 
with the viable epidermis. Table 6.1 lists the properties of skin and drug as used in the 
simulations carried out here. 
 
Table 6.1. Parameters Used In this Study for insulin 
Parameter Value 
Thickness of viable epidermis, h (m) 0.00015 (Lee and Hwang, 2002) 
Diffusion coefficient in viable epidermis, D 
(m2/s) 
1.3 x 10-10 (McAllister et al, 2003) 
Volume of distribution, Vd (ml) 12000 (Nucci and Cobelli, 2000) 
Elimination rate constant, ke (min-1) 0.09 (Nucci and Cobelli, 2000) 
Transfer rate constant, k12 (min-1) 0.00297 (Nucci and Cobelli, 2000) 
Concentration of drug on skin surface, C 
(μg/ml) 
2.27 (estimated from Martanto et al 
(2004)) 
 
6.5. Tuning of Developed Model using Experimental Results 
In order to tune the developed model, the following procedures are followed. Based 
on available experimental results the proposed framework is compared with 
experimental results from McAllister et al (2003) which showed how permeability 
 92 
 
values varied when microneedles are inserted and removed. In the said experiment 
(McAllister et al, 2003), sample molecules namely Calcien, insulin and Bovine serum 
albumin (BSA), were allowed to permeate cadaver skin under two situations; with the 
microneedls left inserted and with the microneedles inserted and then removed. The 
results showed permeability to be higher with the microneedles removed than when 
the microneedles where inserted. The difference in permeability is thought here to be 
due to the decreased effective diffusion coefficient when the microneedle remains 
inserted in the skin thereby exerting a compressive force on the region. 
In this work, the effective skin thickness is calculated from Equation (6.19) where 
steady state flux Jss is derived from simulations in COMSOL for the microneedle 
geometry used in the experiment; the hole created by the microneedle when inserted 
was assumed to be a cylindrical one with radius of 10μm, penetration depth of 50μm  
and a patch area of 900μm2. These values are chosen according to the data given in 
the reported experiment (McAllister, 2003). The effective skin thickness calculated is 
approximately 49µm resulting in value of compression ratio of about 0.985. The 
permeability with the needle inserted is estimated using Equation (6.15) for Calcien, 
BSA and insulin and compared with the experimental values of McAllister et al 
(2003). Values for q in Equation (6.15) is then estimated by tuning the equation to the 
results obtained from experiment by McAllister et al (2003). There are no direct data 
available for diffusion of drugs (e.g., Insulin) through skin (specifically viable 
epidermis) under compression.  For this reason, the model is tuned to obtain an 
equation that fits with the experimental result. This resulted in values of the 
dimensionless parameters q of 0.014 for insulin and 0.029 for calcein and 0.031 for 
BSA. Figure 6.3 shows the results after the model has been tuned. The form of 
equation for calculating permeability obtained from the tuning is given as Equation 
(6.21). 
)014.01(PPi φ−=       (6.2) 
Since the effective diffusion coefficient and permeability are related by Equation 
(6.13), Di and D can be substituted for Pi and P in Equation (6.21). To obtain more 
suitable values experiment on human skin may be relevant. Such experiment will 
involve permeating substances through a skin sample under varying compressive load 
or strain, analysis of the results will then be used to derive a relationship between the 
apparent diffusivity or permeability and the compressive strain or load. The proposed 
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framework gives the algorithm within which such parameters can be implemented for 
predictive microneedle design studies, especially with the skin having erratic 
properties each experiment has to be tailored to a particular range of substance 
permeating through skin of given property.  
 
Figure 6.3 Permeability of Calcien, BSA and insulin with microneedles inserted.  
 
6.6. Effect of MN design on Permeability 
Here the effects of some geometry parameters on the drug permeability are discussed. 
Values of permeability were obtained while varying each parameter of microneedle; r, 
R, n and L in turn, keeping other variables constant while varying one. The 
permeability is calculated using Equation (6.13-6.15), skin thickness of 150μm and 
initial diffusion coefficient of 1.3 x 10-10 m2/s for a frustum shaped microneedle. 
Insulin is used throughout the rest of the studies since there is available data for q 
obtained from tuning the derived model with experiment. The simulation results are 
shown in Figures 6.4 and 6.5. As evident, the permeability decreases as the base 
radius, tip radius and length of microneedle is increased. The permeability generally 
decreased as the size of microneedles was increased. This is due to the increased 
compressive force on the skin as the needle gets bigger. Although the effective skin 
thickness decreases as the size of the MN increases, the diffusion coefficient 
subsequently decreases causing a decrease in permeation for this case study. For 
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example the results shown in Figure 6.4, when the penetration depth was increased 
from 0.0001m to 0.00015m, the permeability decreased from 0.00056cm/h to 
0.000000018cm/h. Also increasing the tip radius from 0.000005m to 0.000025m 
resulted in a decrease in permeability from 1.66cm/h to 0.000023cm/h. The 
permeability also decreased from 0.25cm/h to 0.00046cm/h when the base radius was 
increased from 35μm to 55μm as shown in Figure 6.5.    
 
Figure 6.4 Effect of penetration depth and number of microneedle on permeability for 
R=0.000045m, r=0.00001m, A= 0.000009m, n=400 
 
Figure 6.5 Effect of tip radius and base radius on permeability for L=0.00014m, 
A=0.000009, n=400 
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6.7.  Comparing simulations with experimental results 
We begin by comparing the predicted insulin concentration profile with experimental 
data carried out by Martanto et al (2004). In the said experiment, insulin was 
delivered into hairless rats’ skin using stainless steel solid microneedles and blood 
concentration profiles for two different insulin dosages were obtained. To compare 
the simulations used to solve the proposed framework with the experimental work, 
simulations are carried out using the same amount of insulin and the same 
microneedle geometry while assuming diffusion properties of rat skin (which is taken 
to be similar to that of humans (Scott et al, 1991) and the pharmacokinetics of insulin. 
The pharmacokinetics of insulin delivery is complex, with different pharmacokinetic 
model available for different formulations, as reviewed by Nucci and Cobelli (2000). 
The two compartment model as presented preceding section has been used here with 
elimination rate constant taken as 0.09min-1, transfer rate constant between tissue and 
blood compartment taken to be 0.00297min-1 and volume of distribution as 12000ml 
(Nucci and Cobelli, 2000).  
In the experiment by Martanto et al (2004) the poke with patch approach was used. 
That is the case when microneedles were inserted into the skin followed by a drug 
solution being placed in contact with the skin (Lin et al, 2001; Prausnitz, 2004). Their 
aim of the study was to test the possibility of using microneedles to deliver 
therapeutic proteins leading to pharmacodynamics response for instance delivering 
insulin to create significant drop in blood glucose levels. 100U/ml and 500U/ml 
formulations were tested.  
To compare the experimental values with our simulation values we assume that when 
the microneedles are removed, the surface area of the residual hole in the skin will be 
about 60 percent of the surface area of the hole when the microneedles is inserted. 
This assumption is based on study by McAllister et al (2003) who observed that after 
microneedles have been removed a residual hole still existed indicating that there is 
an amount of strain that remains after the needles have been removed. Therefore the 
effect of the previously inserted microneedles still manifests as a change in the 
permeability (Leddy and Guilak, 2008; Quinn et al, 2000). The hole is assumed to 
shrink to 60 percent of the hole created by the microneedles after the microneelde is 
removed McAllister et al (2003) reported a residual hole of radius 6µm following 
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insertion of microneedles with radius of 10µm) such that the area of contact between 
the skin and the drug is taken to be 60 percent of the surface area of the microneedles. 
It was reported that an array of 105 microneedles, 200µm by 50µm width and 
1000µm long were fully inserted into a rat’s skin (Martanto et al, 2004) and these 
parameters were incorporated into the simulations.  Since insulin is a relatively large 
molecule and permeation studies have shown that it will not diffuse through intact 
skin (Martanto et al, 2004), the drug will only enter the body through the holes that 
have been created by the microneedles. Using the same assumptions and boundary 
conditions described in previous sections, the peak blood concentration was predicted 
using SKIN-CAD.  
 
 
Figure 6.6. Comparism of the developed model with results from Martanto et al 
(2004) 
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blood stream but remain on the skin surface. Moreover there is much work yet to be 
done in the area of developing acurate pharmacokinetic model for different Insulin 
formulations.  
In this case the microneedles were inserted and then removed herefore only the 
residual strain is considered here. Nevertheless, this was useful in showing the 
validity of the simulations and as the design of solid microneedles which remain 
embeded in the skin for long periods persists over the poke and patch approach, it is 
important to consider the effects of the microneedle on diffusion propertioes of the 
skin when left inserted in the skin. Overall all results shown in this study indicate that 
the geometry of the microneedles could affect the permeablity significantly enough to 
alter the predicted blood concentration by a pharmacologically relevant amount. This 
point is discussed further in section 6.8.  
 
6.8.  Effect of Microneedle Array Design on Diffusive Flux and Blood 
Concentration  
To further illustrate the significance of the effect of the compressive force exerted by 
the needle on the diffusivity of the drug in the skin the diffusive flux and 
concentration profile are obtained for different microneedle geometries. Here the 
diffusion coefficients from two separate cases are used. In the first case, the effect of 
the compressive force exerted by the microneedle is ignored and the diffusion 
coefficient of unstrained skin is used. Such an approach was used by Davidson et al 
(2008) and Al-Qallaf et al (2009). , and in the second case the diffusion coefficient is 
recalculated for a compressed state as suggested in the proposed framework using 
Equation (6.15). Using the effective skin thickness from the 3D diffusive flux allows 
us to combine the diffusion pattern due to the needle geometry with the effect of the 
compressive force exerted by the microneedles. The 3-D simulations for drug 
transport in skin are carried out using Comsol® (COMSOL 3.0, Multiphysics 
Software from Comsol, 2005). Figure 6.7 shows the drug transport behaviour in skin 
for a conical needle inserted into skin.  
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Figure 6.7 Simulation showing microneedle inserted into skin. Lines show 
concentration gradient. 
 
It is expected that if the size of microneedles are increased, this will allow more 
surface for drug loading for solid microneedles. This expected pattern is seen when 
the effective diffusivity is assumed to be independent of the needle inserted as the 
simulation results from previouis studies indicated (Davidson et al, 2008; Al-Qalaf et 
al, 2009). However, the theory available suggest that this might not be the case when 
the compressive force exerted by the microneedle is accounted for  as discussed in the 
preceeding sections. This is shown in Figures 6.8-6.10 where the diffusive flux at the 
skin/blood interface for both the above cases are compared.  
These results have taken account of both the diffusion pattern and the mechanical 
force exerted on the skin when the microneedle is inserted by using 3D simulations in 
cobination with the framework presented in this study to determine the diffusion 
coefficient and compression ratio. From the results shown in Figures 6.8-6.10, it is 
evident that the flux is higher for the case where diffusion coefficient is assumed to be 
constant. Furtermmore, we are able to observe the combined effect of the needle 
geometry and the diffusivity; in Figures 6.8, 6.10 and 6.11, increasing the tip and base 
radius decreased the flux when the effect of compression was accounted for using 
Min 
Max 
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Equation (6.9). However in Figure 6.9, using a relatively small microneedle 
(R=0.000035m; r=0.000005m), increasing the penetration depth has less effect on the 
diffusivity of the drug such that the advantage of decreasing the path length by 
increasing the penetration depth, manifests as an increase in flux. The results shown 
in Figure 6.11 which shows the effect of increasing number of microneedles on drug 
flux through skin, is in accordance with the results from experiments done by Yan et 
al (2010). In the said study it was shown that when the density of microneedles in an 
array is increased, the flux of acyclovir through human cadaver epidermis decreases. 
It was also shown that increasing the lenght of the microneedles resulted in increased 
flux (Yan et al, 2010) which agrees with the results of Figure 6.9. 
 
Figure 6.8 Effect of Tip radius on insulin diffusive flux at the skin/blood interface 
where L=150µm, R=45µm, n=400  
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Figure 6.9 Effect of Penetration depth of microneedle on insulin diffusive flux at the 
skin/blood interface where R=35µm, r=5µm, n=200 
 
 
Figure 6.10 Effect of base radius (R) on insulin diffusive flux at the skin/blood 
interface where r=5µm, L=150µm, n=200  
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Figure 6.11 Effect of number of microneedles (n) on insulin diffusive flux at the 
skin/blood interface where r=2µm, L=150µm, R=45μm  
 
To further elucidate the significance of the compressive force, the next step was then 
to obtain the blood concentration profile after the microneedle has been inserted into 
skin for 4 hours. For this purpose insulin has been used as the model drug. 
Concentration of insulin on the skin surface is taken to be 2.72mg/ml. The different 
needle geometry considered here are the same as those considered by Davidson et al 
(2008) and Al-Qallaf et al (2009), These have been fabricated in reported experiment 
for example model A has been fabricated by Xie et al (2005), model B by Henry et al 
(1998), model C by Gill and Prausnitz (2007), model D by Chu et al (2011) and 
model E by Martanto et al (2004). The geometries and some results are shown in 
Figures 6.12-6.13.  
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Figure 6.12b FEM simulations showing concentration gradient for model A and B  
    
Figure 6.12c FEM simulations showing concentration gradient for model C, D and E. 
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Figure 6.13. Comparisons of predicted peak blood concentration for the cases where 
effect of compression is included with when diffusivity is assumed to be independent 
of compressive force exerted by the microneedle when inserted. 
 
The results indicate a decrease in peak blood concentration when the compressive 
force of the microneedle array is taken into account, compared to when assumed to be 
constant despite microneedle insertion. Blood concentration for model C for example 
decreases from 1.26ng/ml to 0.974ng/ml. The compression ratio was 0.988 indicating 
that even for such low compression ratio the effect on the diffusivity is significant 
enough to indicate a lower value for the predicted concentration of the drug in the 
blood.  
Although model C gave the highest concentratiom, model B is used in further analysis 
as it allows for more control over the design parameters. In addition to this model B is 
a simpler geometry to fabricate and is the more common design (Badran et al, 2009; 
Oh et al, 2008). Peak blood concentration was then calculated for different 
dimensions and densities of a conical microneedle (model B in Figure 6.11) in order 
to test the effect of varying the tip radius (r), base radius (R) penetrated length (L) and 
number of microneedles (n), on the drug delivery rate using insulin as a model drug. 
As was done with the different microneedle shapes mentioned above, the simulations 
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results are shown in Figures 6.14-6.17. In all cases the predicted peak blood 
concentration was higher when the effect of compression on diffusivity was ignored. 
Although increasing the size and number of microneedles in an array decreases the 
path length of diffusion, it however may cause a drop in diffusion coefficient that it 
may get to an extent where the advantage of increasing the size and density of 
microneedles may become obsolete. This is evident in the results displayed in Figure 
6.16 and 6.17.  
Increasing the tip radius increased the peak concentration of the drug in the blood, 
however increasing the tip radius beyond 0.000015m resulted in a decreased peak 
concentration. A similar pattern is seen when the number of microneedles is 
increased. Using this framework the intrinsic property of the tissue may be capitalized 
on for an optimized design. These differences in peak blood concentration are 
relevant as insulin concentration in the blood is approximately 4.5ng/ml (Gellhorn et 
al, 1941). The relevance of this FEM analysis is to study the effect of distorted skin 
structure due to mechanical force exerted by microneedles resulting alteration of the 
skin’s intrinsic diffusion properties. This study therefore presents a framework within 
which this can be accounted for in TDD analysis. 
The results from the concentration profiles are also equally important to show the 
time to reach peak and zero concentration in the blood. If the effect of the 
compressive force on diffusion coefficient is ignored the time the drug spends in the 
body could be predicted to be shorter than it is and the time it takes to reach peak 
concentration could also be estimated wrongly. This is particularly important for 
drugs that need to be taken at certain times before meals such as insulin (Pickup and 
Williams1997). For instance, the results shown in Figure 6.23 indicate that insulin 
concentration drops to zero after 4.5 hours while Figure 6.22 indicates that about 
0.05ng/ml still remains at this time.   
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Figure 6.14 Effect of base radius (R) on peak concentration of drug in blood when L= 
0.00015m, r=0.000005m, n=200, A=0.000018m2 (Model B) 
 
 
 
Figure 6.15 Effect of Penetration depth (L) of microneedle on peak concentration of 
insulin in blood when R=0.000045m, r=0.000005m, n=200, A=0.000018m2 (Model 
B) 
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Figure 6.16 Effect of tip radius (r) on the peak concentration of insulin in blood when 
L=0.00015m, R=0.000045m, n=200, A=0.000018m2 (Model B) 
 
 
Figure 6.17 Effect of number of microneedles (n) on the peak concentration of insulin 
in blood when L=0.00015m, R=0.000045m, r=0.00002m, A=0.000009m2 (Model B) 
 
 107 
 
 
Figure 6.18. Effect of base radius on insulin concentration profile in the blood 
following microneedle delivery. Here the effect of compressive force exerted by the 
skin is taken into account (Model B) 
 
 
Figure 6.19. Effect of base radius on insulin concentration profile in the blood 
following microneedle delivery. Contrary to the results in Figure 6.18, here the 
diffusion coefficient is assumed to be constant before and after insertion of 
microneedles (Model B) 
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Figure 6.20. Effect of penetration depth, L on insulin concentration profile in the 
blood following microneedle delivery. The effect of compressive force exerted by the 
skin is taken into account here  (Model B) 
 
 
Figure 6.21. Effect of penetration depth, L on insulin concentration profile in the 
blood following microneedle delivery. Contrary to the results in Figure 6.20, here the 
diffusion coefficient is assumed to be constant before and after insertion of 
microneedles (Model B) 
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Figure 6.22. Effect of tip radius, r on insulin concentration profile in the blood 
following microneedle delivery. Here the effect of compressive force exerted by the 
skin is taken into account  (Model B) 
 
 
Figure 6.23. Effect of tip radius, r on insulin concentration profile in the blood 
following microneedle delivery. Contrary to the results in Figure 6.22, here the 
diffusion coefficient is assumed to be constant before and after insertion of 
microneedles (Model B) 
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Figure 6.24. Effect of tip radius, r on insulin concentration profile in the blood 
following microneedle delivery. Here the effect of compressive force exerted by the 
skin is taken into account  (Model B) 
 
 
Figure 6.25. Effect of number of microneedles, n on insulin concentration profile in 
the blood following microneedle delivery. Contrary to the results in Figure 6.24, here 
the diffusion coefficient is assumed to be constant before and after insertion of 
microneedles  (Model B) 
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6.9. Chapter Summary 
In this chapter various theoretical principles have been explored and necessary terms 
have been redefined in the given concept to obtain a quantitative method for relating 
the geometry of microneedles to permeation of drug through the skin for the purpose 
of transdermal drug delivery from microneedles. The diffusion properties of the skin, 
the mechanics of microneedle insertion and the effects of this on the diffusion 
property of the skin have been taken into consideration. This has been demonstrated 
using results from mathematical simulations to show predictions of insulin 
concentration profiles which are compared with experimental results. Results obtained 
indicated that increasing the size and density of microneedles in an array would 
increase the compressive force exerted by the microneedles on the skin and this may 
lead to a decreased permeability. The mechanical property of the skin determines the 
level of strain in relation to the stress exerted when microneedles are inserted and this 
level of strain will determine the effect on permeability. The presented framework 
provides a theoretical method for combining the mechanical and diffusion property of 
the skin when predicting the drug delivery rate from microneedle devices. 
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7. Modelling the Effect of Microneedle Geometry on Effective Diffusion 
Coefficient: Inclusion of Tortuosity Effect 
 
7.1.Overview 
Following from the previous chapter, the aim of this chapter is to develop a model 
which provides a quantifiable relationship between the microneedle design parameters 
and the diffusion properties of the skin. However here this is done using porous 
pathway theory where the transport of drug in skin is assumed to be via diffusion 
through hypothesised pores such that parameters such as toruosity and porosity are 
implemented into the model. The framework is therefore extended to provide 
alternative transport phenomena for the case where λ<0.4. The model is then also 
used to analyse various scenarios of practical importance. In particular, we combine 
the transdermal diffusion with the pharmacokinetics of drug to predict its 
concentration profiles in skin and blood for different microneedle geometries. For all 
the scenarios analysed, the predicted blood concentration was found to be lower when 
the effect of decreased pore radius due to microneedle insertion was accounted for, 
compared to when diffusion coefficient was assumed to be independent of decrease in 
pore size when microneedles of different geometries are inserted into skin.  
 
7.2.Introduction 
Having established the basis for relating the microneedle design parameters with the 
diffusion coefficient in the preceding chapter, this chapter is aimed at expanding the 
developed framework for cases where the drug transport through skin may be 
modelled as diffusion through porous pathways. The Fick’s diffusion model has been 
validated against experimental results as an acceptable model for transdermal drug 
delivery (Moss et al, 2001; Guy and Hadgraft, 1985). However other models have 
also been presented to represent drug transport through skin as explained in chapter 6. 
For this reason it is therefore important that such framework for microneedle design 
optimization is robust enough to accommodate more than one TDD model. This 
chapter therefore extends the framework to the porous pathway model.  
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7.3. Outline of the Conceptual Model 
Various forms of transport mechanisms have been suggested to describe transdermal 
transport such as the brick and mortar model (Hadgraft, 2004; Nemanic et al, 1980; 
Bodde et al, 1991; Micheals et al, 1975; Neelissen, 1998) and the Fickean diffusion 
models (Okamoto et al, 1989; Kalia and Guy, 2001; Yamashita and Hashida, 2003). 
Each model has been shown to fit experimental data for drug transport (e.g. Roy et al, 
1994; Okamoto et al, 1989; Hadgraft, 2004). In this study, transdermal drug transport 
is considered as diffusion through the porous pathway in the viable epidermis (Tang 
et al, 2000, Tezel et al, 2002, Kushner et al, 2007). First the manner in which the skin 
contracts following insertion of microneedle is analysed in the context of this work 
and a model is then proposed.  
When microneedles are inserted into the skin, each exerts a pressure on the skin as it 
occupies a volume equivalent to the volume of the microneedle. This exerted pressure 
on the skin causes a decrease in the pore size in the viable epidermis. The total 
decrease in pore size is therefore equal to the total volume of microneedles. Where 
drug diffusing through the VE is modelled as diffusion through the porous pathway 
within the tissue (Tezel et al, 2002, Tang et al, 2000), the hypothesized pores are 
assumed to be of equal sizes and arranged in parallel in the same direction as the 
general direction of concentration gradient between the solid microneedle surface and 
the sink that is assumed to exist at the epidermal/dermal junction (Bernado and 
Saraiva, 2007; Bodde and Joosten, 1985). The diffusion coefficient discussed here is 
assumed to be isotropic and since the stress is distributed evenly over the region 
where diffusion takes place, diffusion coefficient is also defined to be isotropic when 
microneedles are inserted. In other words, the diffusion coefficient is strain-dependent 
however it does not vary with directions and positions. The permeability of drug 
through the skin is therefore given as (Kushner et al, 2007; Tang et al, 2000; Peck et 
al, 1994); 
 
h
DK r
τ
ε
=       (7.1) 
Where Dr is the diffusion coefficient of the drug through the water filled pores within 
the viable epidermis; ε is the skin porosity, τ is the tortuosity and h is the thickness of 
the VE (viable epidermis). Dr relates both the drug and skin properties and is given as 
)(HDDr λ=
∞       (7.2) 
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Where D∞ is the diffusion coefficient of the drug at infinite dilution and H(λ) is the 
hindrance factor. Where λ < 0.4 the hindrance factor is given by (Peck et al, 1994; 
Tang et al, 2000):   
)095.009.2104.21()1()(H 532 λ−λ+λ−λ−=λ     (7.3) 
λ is the ratio of the hydrodynamic radius of the drug rp and rs the radius of the 
hypothesized pores in the viable epidermis 
s
p
r
r
=λ          (7.4) 
When microneedles are inserted into the skin, the total volume of the skin under the 
patch is decreased by nVneedle, which is the total volume of n microneedles inserted. 
Figure 7.1 shows a diagrammatic representation of MNs inserted into skin with a 
Transdermal therapeutic system (TTS) patch. In this particular case study the drug 
patch acts as a reservoir and the microneedles act as the drug releasing surface. This 
mode of delivery applies with microneedles designed to remain inserted in the skin 
for longer periods such as the phase transition hydrogel microneedles (Tuo et al, 
2010; Woolfson et al, 2009). 
 
Figure 7.1  Schematic of microneedles left inserted in skin  
 
The size of the pores will therefore be decreased, however it is assumed here that the 
length of the pores will not vary, rather the decreased volume will be as a result of the 
decrease in the size of the hypothesized pores from rs to rsi. 
needleip
2
sip
2
sporeipore nVxnrxnrVV =π−π=−      (7.5) 
Where Vpore and Vporei represents the volume of the pores before and after 
microneedles have been inserted; rs and rsi represent the radius of the pore before and 
TTS 
Patch 
Microneedles 
Skin 
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after microneedles have been inserted into the skin. Path length of diffusion, x, is 
defined as:  
hx τ=       (7.6) 
The subscript i indicates microneedle inserted and h represents the skin thickness, np 
is the number of pores in the skin area, and this is obtained from the total area of the 
pores in the skin divided by the area of a single pore.  
2
s
p r
An
πτ
ε
=      (7.7) 
A is the area under the microneedle array, ε is porosity and τ is tortuosity. We can 
therefore relate this decrease in pore size due to microneedle inserted with the 
diffusion coefficient. Where the radius of pores with microneedles inserted given as: 
 
xn
nVV
r
p
needlepore
si π
−
=      (7.8) 
Where Vpore is the volume of pores in the skin prior to microneedle insertion; Vneedle is 
the volume of each microneedle, n is the number of microneedles in the array. This 
solution for rsi can then be substituted into Equation 7.2 to find λ giving the diffusion 
coefficient with microneedle inserted as 














π
−
=
xn
nVV
r
DHD
p
needlepore
p
r      (7.9) 
Using this model the geometry of microneedle can thus be related to drug 
permeability in the skin (Equation 7.1). It can be noted that where microneedles are 
not used n becomes zero (n = 0) and Equation (7.9) gives the diffusion coefficient for 
skin without microneedle inserted based on the porous pathway theory. The values for 
the necessary parameters used in this study are listed in Table 7.1. Skin thickness 
varies in different parts of the skin (Hwang et al, 2002) the value used here is the skin 
thickness in the arm which is a practical region for placing a microneedle array. 
 
7.4. Simulation of Drug ADME in blood  
Drug transport through skin is modelled in COMSOL using the same equations and 
boundary conditions outlined in chapter 4, Equation (4.1)-(4.4). Fentanyl is also used 
here as the model drug with the properties listed in Table 7.1. To incorporate the 
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porous pathway model into COMSOL such that the Fick’s law is applicable, the 
length of the block (Skin) is obtained from Equation 7.6. Similarly the drug 
concentration profile is obtained from simulations in SKIN-CAD following the one 
compartment model given in Equation 4.5 (Chapter 4). The effective skin thickness 
obtained from COMSOL is then used to calculate the concentration profiles in SKIN-
CAD.   
 
7.5. Results and Discussions 
7.5.1. Comparing Model with Experimental Results 
Here we compare effective diffusion coefficient values determined from the proposed 
framework with experiment carried out on bovine annulus fibrosus (AF) given that 
there seems to be no available experimental results in literature on diffusion under 
compression for skin tissue. Experiment on AF will suffice for a qualitative 
comparison since drug transport in both tissues can be considered as diffusion through 
porous pathways. Jackson et al (2008) studied the effect of strain level on the 
diffusion coefficient of glucose through bovine AF. Results for 0%, 10% and 20% 
strain showed a decrease in diffusion coefficient as strain level increased. To compare 
these results with the model proposed in this study, microneedle geometries were 
determined to exert similar strains on similarly porous tissue with porosity of 0.1 and 
tortuosity of 2. These values were chosen based on corresponding high values given 
for a molecule of similar size to glucose (Kushner et al, 2007). This is assuming that 
AF tissue would be more porous than the skin.  Strain was calculated using Equation 
(6.11) expressed in %. Geometry with base radius, tip radius and length of 110μm, 
10μm and 130μm, respectively, caused a 10% strain and likewise 110μm, 75μm and 
130μm caused a 20% strain for a 1x10-7μm2 array containing 100 microneedles. 
Hydrodynamic radius and diffusion coefficient (in interstitial fluid) of glucose was 
taken to be 3.8x10-10m (Schultz and Solomon; 1961) and 1.63 x 10-10m2/s (Bashkatov, 
2003), respectively. The model and experiment both show lower diffusion coefficient 
at higher strain level as shown in Figure 7.2 with comparable values of effective 
diffusion coefficient. Hence the available experimental data supports the conceptual 
model which indicates that the diffusion coefficient of drug through skin should 
decrease as more strain is applied due to insertion of several microneedles. The 
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difference between the experiment and proposed model is attributed to the estimated 
parameters used. Other experiment which demonstrate the concept of strain having an 
effect on the permeation of substances through tissue such as nucleus fibrosus, muscle 
and cartilage tissue has been presented in several texts (e.g. Gefen et al, 2008, Leddy 
and Guilak, 2008; Leddy, 2006; Quinn et al, 2000; Reynaud and Quin, 2006; Riches 
et al, 2002). 
 
Figure 7.2 Effect of strain Level on effective diffusion coefficient 
 
Table 7.1 lists the parameters used in the simulations using fentanyl as a model drug. 
However first we conduct a parametric study to see how the diffusion coefficient 
varies with each geometry parameter; length (L), tip radius (r), base radius (R) and 
number of microneedles (n). 
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Table 7.1. Values for parameters used in this study except where stated otherwise. 
The drug properties used are similar to that of fentanyl. 
Parameter Value 
Porosity of viable epidermis, ε  
Tortuosity, τ 
0.00002 (Kushner et al, 2007) 
2.5 (Kushner et al, 2007) 
Thickness of viable epidermis, h (m) 0.00018 (Hwang et al, 2002) 
Radius of viable epidermal pore, rs (m) 0.00000088 (Kushner et al, 2007) 
Hydrodynamic radius, rp (m) 0.00000026 (Tezel et al, 2002) 
Diffusion coefficient at infinite dilution, D∞ 
(m2/s) 
9.75 x 10-6 (Peck et al, 1996) 
Volume of distribution, Vb (ml) 731000 (Tojo, 2005) 
Elimination rate constant, ke (s-1) 0.0000284 (Tojo, 2005) 
Concentration of drug on skin surface, C (μg/ml) 15800 (Tojo, 2005) 
 
7.5.2. Effect of MN design on Effective Diffusion Coefficient 
Here the effects of the geometry parameters on the diffusion coefficient through the 
skin are discussed. Values of the diffusion coefficient were calculated using the 
formulae described above (Equations 7.1-7.9), while varying each design parameter 
of microneedle; r, R, n and L in turn, keeping other variables constant while varying 
one. Unless otherwise stated, the needle geometry used is as follows:  
A=6250000µm2, R=80μm, r=50μm, L=150μm and n=25. The results are shown in 
Figures 7.4 and 7.5. As evident, the effective diffusion coefficient decreases as the 
base radius, tip radius number of microneedles and length of microneedle are 
increased. The diffusion coefficient decreased as the size of the simulated 
microneedles was increased. This is due to the increased compressive force on the 
skin as the needle gets bigger and the pore sizes gets smaller. 
The effective diffusion coefficient decreased within the same order of magnitude 
when the size of the microneedles was increased. Therefore the significance of these 
results depends on the level of accuracy required. For example, when the length was 
increased from 0.0001m to 0.000115m (Figure 7.5), the calculated diffusion 
coefficient decreased from 1.153x 10-12 m2/s to 5.993 x 10-13 m2/s. Furthermore, 
increasing the tip radius from 0.000005m to 0.00002m resulted in a decrease in 
diffusion coefficient from 3.092 x 10-12 m2/s to 2.885 x 10-12 m2/s (Figure 7.4) and the 
diffusion coefficient decreased from 3.092 x 10-12 m2/s to 2.726 x 10-12 m2/s when the 
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base radius was increased from 0.00008m to 0.00095m. Increasing the number of 
microneedles from 25 to 100 (Figure 7.5) caused a change in diffusion coefficient 
from 3.364 x 10-12 m2/s to 1.152 x 10 -12m2/s. 
 
 
Figure 7.3 3D model showing diffusion of drugs (indicated by red arrows) from 
microneedle into skin 
 
 
Figure 7.4 Effect of base and tip radii on effective diffusive coefficient. 
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Figure 7.5 Effect of length and number of microneedles on effective diffusion 
coefficient. 
 
7.5.3. Effect of Geometry of Microneedle Array Design on Diffusive Flux  
To further determine the effect of the compressive force exerted by the needle on the 
diffusivity of the drug in the skin the diffusive flux and peak drug concentration in 
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are:  1) the diffusion coefficient calculated using Equation (7.9), 2) diffusion 
coefficient remaining constant despite inserted microneedles. Diffusive flux at the 
epidermal/dermal junction was obtained for different microneedle geometries by 
varying the length of microneedle (L), the tip radius (r) and base radius (R).  
It is expected that if the size of MNs are increased, this will allow more surface for 
drug loading for solid MNs. This expected pattern is seen when the diffusion 
coefficient is assumed to be independent of the inserted microneedles as the 
simulation results from previous studies indicated (Davidson et al, 2008; Al-Qallaf et 
al, 2009). However, the theory available suggests that this might not be the case when 
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presented in this study to determine the diffusion coefficient with microneedles 
inserted. From the results shown in Figures 7.6-7.9, it is evident that the flux is higher 
for the case where diffusion coefficient is assumed to be constant. In Figures 7.7 and 
7.8, increasing the tip and base radius decreased the flux when the effect of 
compression was accounted for using the presented model. However results shown in 
Figure 7.6 suggest that increasing the length of the microneedle has less effect on the 
diffusion coefficient of the drug such that the advantage of decreasing the path length 
by increasing the penetration depth manifests as an increase in flux. The results in 
Figure 7.9 show the effect of increasing number of microneedles on drug flux through 
skin, is in accordance with the results from experiments done by Yan et al (2010). In 
the said study it was shown that when the density of microneedles in an array is 
increased, the flux of acyclovir through human cadaver epidermis decreases. It was 
also shown that increasing the length of the microneedles resulted in increased flux 
however further results from the same study (Yan et al, 2010) showed that this isn’t 
always the case. . The results The simulations carried out here indicates that this 
pattern observed in the experimental results may be explained by the proposed theory 
which suggest permeability to be an interplay between decreased  skin thickness and 
increased strain on skin leading to altered diffusion coefficient. This indicates a 
threshold beyond which increasing the size of microneedles will result in decreased 
permeability of the skin due to decreased diffusion coefficient. 
 
Figure 7.6 Effect of the length of microneedles on diffusive flux of fentanyl 
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Figure 7.7 Effect of tip radius of microneedles on diffusive flux of fentanyl 
 
 
Figure 7.8 Effect of base radius of microneedles on diffusive flux of fentanyl 
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Figure 7.9 Effect of the number of microneedles on diffusive flux of fentanyl 
 
Figure 7.6-7.9 are presented with two vertical axes in order to show the change in flux 
for the two cases considered, the significance of these differences depends on the 
level of precision required for individual cases. 
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concentration of the drug in the blood. Although increasing the size and number of 
microneedles in an array decreases the average path length of diffusion, it may still 
cause a drop in the diffusion coefficient to an extent where the advantage of 
increasing the size and density of microneedles may become obsolete. This is evident 
in the results displayed in Figure 7.13. Increasing the number of microneedles 
increased the peak concentration of the drug in the blood, however increasing the 
number of microneedles beyond 75 resulted in a decreased peak concentration.  
 
Figure 7.10 Effect of base radius of microneedles on peak blood concentration of 
fentanyl. 
 
 
Figure 7.11 Effect of tip radius on peak blood concentration of fentanyl 
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Figure 7.12 Effect of length of microneedles on peak blood concentration of fentanyl 
 
 
Figure 7.13 Effect of Number of microneedles on Peak blood concentration of 
fentanyl. 
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controlled drug delivery while taking into account the change in the diffusion 
coefficient due to the strain exerted on the skin.  
 
7.6. Chapter Summary 
A theoretical method for design based predictive assessment of transdermal drug 
delivery from microneedles has been studied in this chapter. The presented model 
takes into consideration possible change in diffusion coefficient of the skin due to 
insertion of microneedle and the significant of accounting for the change in diffusion 
coefficient due to strain exerted on the skin as illustrated in the presented case studies. 
Simulation results obtained indicate that increasing the size and density of 
microneedles in an array would increase the compressive force exerted by the 
microneedles on the skin and this leads to decreased drug permeability. This has been 
compared with experimental results which show a decrease in the diffusion 
coefficient of glucose through AF as strain level increases. The presented model and 
simulations is useful for combining the mechanical and diffusion property of the skin 
when predicting the drug delivery rate. This is discussed further in chapter 9. 
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8. Investigation of the influence of array interspacing upon force required 
for successful microneedle skin penetration: Theoretical and Practical 
Approaches 
 
8.1.Overview 
The insertion force of microneedle arrays depends upon the mechanical properties of 
the skin and geometry and distribution of microneedles in an array. This chapter looks 
at insertion of microneedle into skin aiming to provide a quantitative basis to relate 
insertion force with the distance between each microneedle in an array. Theoretical 
analysis and FEM simulations indicate that insertion force should decrease as 
interspacing is increased. To assess the validity of the proposed model, a series of 
experiments were carried out to determine the force required for skin insertion of 
microneedle. The results from the theoretical analysis and FEM simulations agree 
with experimental results, which show that microneedle interspacing only begins to 
affect insertion force at low interspacing values (< 150 µm interspacing at 
microneedle base for the conical shaped microneedle arrays studied). The developed 
model is useful in providing a framework for optimising an overall microneedle 
device. 
 
8.2.Introduction 
The enhanced drug delivery which microneedles offer over conventional TDD 
patches relies on their ability to successfully pierce the SC barrier in a minimally 
invasive manner. microneedles between 50-900μm in height and up to 20,000 MNs 
cm-2 in diverse geometries have been produced from silicon, metal, carbohydrates and 
polymers using various microfabrication techniques (Henry et al, 1998; Prausnitz, 
2004; Crichton et al, 2010). Recently, there has been an increasing interest in 
investigating the influence of a variety of variables related to the use of microneedle, 
in order to reach an optimum microneedle design for transdermal drug delivery 
(Aggarwal et al, 2004; Davis et al, 2004; Verbaan et al., 2008). In particular it has 
been shown that the height and density of microneedles on an array can affect the rate 
and extent of drug delivery achieved (Verbaan et al, 2008; Oh et al, 2008; Yan et al, 
2010).  
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In order for the microneedle technology to become a clinical reality, there are a 
number of challenges that need to be overcome. Microneedle arrays should be able to 
demonstrate sufficient strength to penetrate into the skin or other biological tissue 
without breaking before or during insertion (Aggarwal et al, 2004). The major factors 
accountable for microneedle performance are type of material, needle height, tip-
radius, base diameter, needle geometry and needle density, which, in turn, determine 
the overall insertion and fracture force of the microneedle (Davis et al, 2004). The 
inherent elasticity and irregular surface of the skin remains a major challenge to the 
reproducibility of microneedle penetration. It has been shown that the skin can 
become folded around microneedles, which results in either partial or incomplete 
piercing depending upon microneedle height (Verbaan et al, 2008). As such, there is a 
greater need to understand the force required for reproducible skin penetration to be 
achieved for a given microneedle design. Recently, it has been shown that the depth 
of microneedle penetration into the skin is critically dependent upon the force used for 
microneedle application (Donnelly et al, 2010). This finding suggests that to ensure 
consistent microneedle penetration on a patient – to – patient basis, it may be 
necessary to develop a suitable application method and device, rather than relying on 
manual insertion of microneedles. Indeed, the use of applicator devices has been 
shown to provide superior microneedle penetration into skin in comparison to manual 
application (Verbaan et al, 2008). 
 
 In order to fully understand the microneedle insertion process, and how this is 
influenced by the density of microneedle on an array, it is necessary to develop a 
model that identifies each of the forces and stages that are involved in the penetration 
of microneedle into skin. Soft tissue such as skin, in reality, is an inhomogeneous 
material that exhibits non-linear anisotropic, elastic and viscous behaviour. These 
properties make the modelling of skin deformation rather complex. This is an area of 
research that has attracted a considerable amount of attention in recent years 
(Okamura et al, 2004; Simone and Okamura, 2002, Simone, 2002, DiMaio and 
Salcudeen, 2002; DiMaio and Salcudeen, 2005; DiMaio, 2005), with accurate 
modelling of needle insertion useful for medical purposes such as training through 
realistic surgical simulation and planning prior to surgery and monitoring of robot 
assisted surgeries (Yan et al, 2009).  
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A novel approach to modelling and simulation of needle insertion into soft tissue was 
presented by DiMaio and Salcudean (2003). The authors inserted a needle into 
marked and calibrated artificial tissue. Using computer visualization, they measured 
the needle and tissue deformation on insertion. The force distribution along the needle 
shaft was then estimated through computer aided visual observation. This was then 
followed up by their work to present a novel interactive virtual needle insertion 
simulation. The deformation of both the tissue and needle was modelled in 3D and 
solved using fast numerical techniques which they developed (DiMaio and Salcudean, 
2003). The findings from this study highlighted a relationship between force applied 
to the needle and tissue deformation and presents a method to analyse tissue 
deformation based on needle forces. 
 
In other studies (Marvarsh and Hayward, 2001; Maurin et al, 2004), needle insertion 
was separated into 3 phases based on results obtained from experiments performed on 
bovine liver tissue. These forces include deformation (without penetration), steady 
state penetration, relaxation and extraction. Azar and Hayward (2008) related crack 
size, needle diameter and tip geometry to insertion force. The process of insertion was 
accounted for as an interchange of energy between work done by the needle, work of 
fracture of tissue, work against friction and change in recoverable strain energy.  In a 
separate study, Yan et al(2009) proposed a spring beam damper model to describe 
needle-tissue interaction during insertion. The work was aimed towards developing 
physically based needle steering systems to achieve more accurate needle placement 
during medical procedures such as biopsies and treatment injections, by taking into 
consideration the needle deflection during insertion and the in-homogeneity of tissue. 
The developed model creates an online parameter estimation that allows the depth 
varying parameter to be controlled, thereby preventing inaccurate targeting.  
 
All the studies discussed above focus on modelling the insertion of a single needle 
into soft tissue. However, in reality most microneedle devices consist of an array of 
regularly spaced microneedles that are inserted into skin. For optimum drug delivery, 
and clinician/ patient acceptability, it is important that the microneedles are capable of 
inserting into skin, reliably and reproducibly. On this basis, this study aims to provide 
a fundamental framework that relates the distribution of microneedles within an array, 
in terms of microneedle interspacing, with the insertion mechanism of a microneedle 
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array into skin. In doing so, this study proposes mathematical models to relate 
microneedle interspacing to microneedle insertion force by isolating the forces that 
exists in the different phases of insertion, using constitutive equations. Furthermore, 
to assess the validity of the proposed model a series of in vitro experiments were 
conducted to determine the force required for microneedle insertion into neonatal 
porcine skin, over a range of microneedle interspacing. This model is useful for the 
early stages of microneedle device development, enabling a prediction of the optimum 
array density for a given microneedle design such that the potential for enhanced drug 
delivery is not compromised by the ability of the microneedle to penetrate into skin. 
 
8.3.Materials and Methods 
 
8.3.1. Materials 
Gantrez® AN-139, a copolymer of methylvinylether and maleic anhydride 
(PMVE/MA) was provided by ISP Co. Ltd, Guildford, UK). Methylene blue was 
obtained from Sigma Aldrich, Dorset, UK. Silicone elastomer LSR9-9508-30 was 
obtained from Polymer Systems Technology, Wycombe, UK. Silastic® 9280/60E 
silicone elastomer was obtained from Dow Corning, Wiesbaden, Germany.  
 
8.3.2. Fabrication of microneedles 
A 20% w/w aqueous solution of PMVE/MA was prepared by adding the required 
mass of PMVE/MA to ice cold deionised water, followed by vigorous stirring and 
heating at 95.0oC until a clear gel was obtained, due to hydrolysis of the anhydride 
form of the copolymer to the corresponding acid. Upon cooling, the blend was then 
readjusted to the final concentration of 20% w/w by addition of an appropriate 
amount of deionised water. Microneedle arrays were prepared from aqueous blends of 
20% w/w PMVE/MA using laser engineered silicone micromould templates, as 
described previously (Donnelly et al, 2011). Briefly, silicone elastomer (Silastic® 
9280/60E, obtained from Dow Corning, Wiesbaden, Germany) was poured into a 
custom-made aluminium mould and cured overnight at 40°C. A laser-machine tool 
(BluLase Micromachning System, Blueacre Technology, Dundalk, Ireland) with a 
laser (Coherent Avia, Coherent Inc., Pittsburgh, USA) emitting a beam having a 
wavelength of 355 nm and a pulse length of 30 ns (variable from 1 – 100 kHz), was 
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then employed to produce microneedle moulds with a definable height, width and 
interspacing at microneedle base (Figure 8.1).The 20% w/w PMVE/MA solution was 
poured into laser engineered silicone micromould templates, centrifuged for 15.0 
minutes at 3500 rpm and allowed to dry under ambient conditions for 24 hours. A 
total of 5 microneedle geometries were prepared for subsequent characterisation 
(Table 8.1).  
 
 
 
 
 
 
 
Figure 8.1. Diagrammatic representation of a microneedle array and its geometrical 
parameters (a) Height of MN in array (b) Interspacing of microneedle base (c) Width 
of MN in array 
 
Table 8.1. Geometries of PMVE/MA microneedle arrays produced using laser 
engineered micromoulds. 
MN 
Type 
Height 
(µm) 
Width at base 
(µm) 
Interspacing at base 
(µm) 
Interspacing at tip 
(µm) 
MN / 
array 
1 600 300 30 165 16 
2 600 300 50 185 16 
3 600 300 150 285 9 
4 600 300 300 435 9 
5 600 300 600 735 4 
 
8.3.3. Measurement of MN insertion force into excised neonatal porcine skin. 
The force required to insert PMVE/MA microneedle array at two different insertion 
speeds, 0.5 mm s-1 and 1.0 mm s-1, into excised neonatal porcine skin was determined 
using a TA.XT-plus Texture Analyser (Stable Micro Systems, Surrey, UK), as 
described previously (Donnelly et al, 2011). Neonatal porcine skin, a good model for 
human skin in terms of hair sparseness and physical properties (Woolfson et al, 1995; 
b Microneedle array 
 a 
c Microneedle base plate 
Microneedle array 
b 
 132 
 
Fourtanier and Berrebi, 1989), was obtained from stillborn piglets and immediately 
(<24h after birth) excised and trimmed to a thickness of 700 µm using an electric 
dermatome (Integra Life Sciences™, Padgett Instruments, NJ, USA). Skin was then 
stored in aluminium foil at -20oC until further use. Using double sided adhesive tape, 
microneedle arrays were carefully attached to the moveable cylindrical probe. The 
stratum corneum surface of the skin was dried with tissue paper, and the skin was 
placed, dermis side down, on a 500 µm thick sheet of dental wax, and this assembly 
was then secured on a wooden block for support. The probe was lowered onto the skin 
at a speed of either 0.5 mm s-1 or 1.0 mm s-1 until the desired force was exerted. 
Forces were held for 30 s and were increased gradually from a force of 0.0056 N per 
microneedle (obtained by dividing the applied force by the number of microneedle in 
an array) to the force at which microneedle penetration into skin was observed. After 
removal of microneedle arrays, 30 µl of methylene blue solution (1 mg ml-1) was 
applied to the upper surface (0.5 cm2) of the epidermis for 20 mins so microneedle 
created pores within the skin could be visualised. Excess solution was gently wiped 
off from the skin surface with dry tissue paper and then with normal saline solution. 
Subsequently, skin was imaged using a digital camera to assess for the presence of 
visible holes created by microneedle arrays. 
The experimental data for the determination of microneedle insertion force into 
excised neonatal porcine skin were analysed using a one-way analysis of variance 
(ANOVA), with post hoc comparisons performed using Tukey’s HSD test. In all 
cases, p < 0.05 denoted significance. 
 
8.4.Insertion Force Models 
 
8.4.1.  Mechanics of needle insertion into skin. 
We start by comparing the process of single needle insertion with the insertion of two 
needles into the skin, thereby identifying the forces acting in both cases. These forces 
are then defined separately and estimated using applicable equations. The insertion 
process for a single needle into soft tissue has been defined as comprising of three 
main phases – stiffness, friction and cutting (Okamura et al, 2004). The stiffness 
force, cutting force and friction force will be depend upon the type and nature of the 
tissue that the needle is being inserted into, and the estimation of these forces will also 
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be dependent upon the modelling approach involved for the tissue evaluation 
(Okamura et al, 2004; Davis et al, 2004; Ankersen et al, 1999). 
 
Whilst previous models have focused on modelling the insertion of a single needle 
into tissue, in reality most microneedle devices comprise of an array of multiple, 
regularly spaced needles. As such, in order to fully understand and predict the 
insertion process into skin, it is necessary that an appropriate model is employed to 
consider that the presence of multiple needles will contribute to additional forces 
involved in the insertion process. This study hypothesizes that microneedle 
interspacing, i.e. the distance at the base between two consecutive microneedles, will 
introduce additional forces that should be considered. We define these forces as 
indentation (stiffness), cutting, bending, friction and buckling forces. 
 Finsertion = Fbending + Fstiffness + Fbuckling + Ffriction+Fcutting    (8.1)  
The combination of these forces acting during needle insertion is shown in Figure 8.2, 
with each force being described in detail in the following section.  
 
Figure 8.2. The forces in various directions acting on the skin during needle insertion 
prior to piercing. 
 
 
 
Skin resistance to 
deformation 
MN indents skin 
downwards 
Skin 
Needle 
The skin here is 
bending as the 
needles are vertically 
displaced 
Applied 
forces 
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Bending Forces 
Consider two MNs at a known distance apart; inserted into the skin such that the skin 
in the space between them is displaced vertically in the direction of the applied force. 
To represent this, the skin is modelled as a beam on an elastic foundation and, as the 
stratum corneum (SC) is much stiffer than the other layers of the skin, it is modelled 
as the beam (Magnenat-Thalmann et al, 2002). The lower layers of the skin are, 
therefore, represented as the elastic foundation. Since the aim here is to develop a 
quantitative basis to relate microneedle interspacing and insertion mechanism of 
microneedles, each layer will be assumed to be homogeneous, isotropic and elastic 
(Kuwazuru et al, 2008). Prior to insertion, the skin is modelled as an infinitely long 
beam on an elastic foundation with two concentrated loads, as shown in Figure 8.3. 
                                    
 
Figure 8.3. The skin represented as an infinitely long beam on elastic foundation with 
2 concentrated loads. 
The bending equation accounts for the one dimensional bending of the skin along the 
vertical axis. To calculate the bending force the equation for a beam on an elastic 
foundation allows us to combine the bending force of the beam with the reaction of 
the foundation as the beam bends along its length (Astapov et al, 1994). Where b= 
foundation width, ν=Poisson ratio, Es=young modulus of foundation, E= Young 
modulus of SC, I=moment of inertia of the cross section of SC, S is the interspacing 
between two microneedles, s is the distance from microneedle and C3 and C4 are 
integration constants, the equation for the deflection curve of a beam under transverse 
loading is given as (Hetenyi, 1964; Astapov and Kornev, 1994)  
)ssinCscosC(sey f4f3
Sf λ+λ= λ−            (8.2) 
For a beam on elastic foundation of unlimited length with a single concentrated load 
Fso (i.e. force exerted by first microneedle) the solution (detailed in Appendix 2) 
becomes;   
)SsinS(cose
2
Fy ff
x
f
f0s f λ+λ
β
λ
= λ−      (8.3) 
V.E + Dermis represented 
as the elastic foundation 
 
SC represented as the 
b  
Needle force 
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The deflection directly underneath the load is given by; 
f
f0s
0 2
Fy
β
λ
=                 (8.4)  
Where λf is a notation for the following 
4 f
f EI4
β
=λ        (8.5) 
The modulus of foundation, βf, is obtained from the equation introduced by Vesic 
(Vesic, 1963; Cheng-Zhong, 2009)   
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The procedure to obtain a value for bending force during the insertion of two MNs 
with an interspacing S at the tip is as follows. The equation was solved for a single 
concentrated force and then the second concentrated force was superimposed, more 
specifically, the force required to cause the maximum deflection underneath the first 
needle was calculated by rearranging Equation (8.4). The initial deflection at distance 
S where the next needle is placed is then calculated using Equation (8.3). The 
additional force required to cause the maximum deflection at distance S is then 
calculated using Equation (8.4) making y0 the initial deflection caused by the first 
needle. The two forces where averaged to calculate the force, Fbending, required by 
each needle to bend the skin to allow the vertical deformation prior to penetration 
(Astapov et al, 1994). 
 
Indentation (stiffness) force. 
Following the bending of the skin, the needle tip starts to compress the stratum 
corneum. The vertical force exerted by the needle tip causes deformation of the skin, 
leading to piercing. This is the displacement that takes place prior to the breaking of 
the bond between the skin fibres as the needle pierces through the skin structure. The 
stiffness model derived by Okamura et al, (2004) is based on the experimental 
condition employed; we use a more general model here to describe the force required 
for the needle to indent the skin before piercing. The force between the needle tip and 
skin surface during compression has been represented by Hertz as follows (Yuan and 
Verma, 2006); 
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2/3
2nindentatio )v1(3
rE4F δ
−
=     (8.7) 
E= elastic modulus, r= tip radius of needle, v= Poisson ratio, δ= indentation depth 
 
This equation was obtained from analysing the force acting between a spherical 
indenter and the tip of the indenter (Yuan and Verma, 2006). As the main barrier is 
the stratum corneum, with the underlying layers having a much lower stress limit 
(Kuwazuru et al, 2008; Cua et al 1990), we take E and ν to be the young modulus and 
Poisson ratio of the stratum corneum, respectively. The indentation depth is assumed 
to be 100% of the thickness of the stratum corneum, this is considering the fact that 
some compression also occur during cutting (Okamura et al, 2004). The Hertz model 
assumes the materials in contact are smooth and linearly elastic. The advantage of 
using this model is that it takes into account the shape of the needle tip.  
 
 Cutting Force  
After the pre puncture forces (bending and indentation) have been applied to the skin, 
a force is required to cut through the tissue fibre, thus initiating microneedle 
penetration. Once the skin has been compressed to its minimum thickness, an 
additional force is required to enable the microneedle array to cut through the skin. 
The cutting force can be envisaged as the bond energy which integrates the tissue 
structure (Okamura et al, 2004). This energy must, therefore, be exceeded in order to 
puncture the skin. The cutting force is a constant and its value is determined by 
factors such as sharpness of the penetrating needle and the type and nature of the 
tissue under consideration (Davis et al, 2004; Okamura et al, 2004; Sharaf et al, 
2003). 
 
Buckling Force 
As the needle cuts through the skin tissue the needle inserts into the stratum corneum. 
The skin between the needles must therefore buckle to allow for this insertion to 
occur; hence cutting and buckling occur simultaneously. The resistance offered by the 
lower layer of the skin as the SC buckles is represented by the foundation modulus 
(Kuwazuru et al, 2008). The buckling of the skin during MN insertion is illustrated in 
Figure 8.4.    
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Figure 8.4. Diagrammatic representation of the cutting and buckling forces acting on 
the skin during needle insertion. 
 
The minimum force required to cause skin buckling depends on the interspacing 
between the microneedles. The force causing this deformation is the lateral force 
exerted by the needles on the skin; the beam in this case therefore has a finite length, 
S which is the interspacing between the microneedles at the tips. The minimum force 
(Fbuckling) required for causing skin buckling is an additional force necessary to insert 
an array of microneedles at an interspacing S at the tip. This is given by Equation 8.8 
(Timoshenko, 1936). 
2
22
buckling S
EIm2F π=
     (8.8) 
Where m is the number of half sine wave of the bent bar which depends on the 
material properties and is given by:  
f
4 EI
Sm
β
π
=
               (8.9)
 
The concept of buckling in the skin has previously been considered by Kuwazuru et al 
(2008). The group applied a multistage buckling model to analyse the mechanism of 
wrinkle formation as a result of buckling of different layers of the skin, relative to age 
related changes in skin structure. The skin will deform linearly under relatively low 
stress (Diridollou et al, 2000, Fung, 1993), and in this study as we aim to quantify the 
effect of spacing on insertion force, the equations based on assumption of linear 
behaviour for a beam on an elastic foundation are adaptable for this purpose.  
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Frictional force 
As the needle inserts into the skin, further resistance occurs in the form of friction 
generated as a result of the needle rubbing against the skin surface. Here the friction 
force was modelled using the equation presented by Okamura et al (2004). The group 
obtained the damping coefficient by fitting the results from needle insertion 
experiments on liver tissue to Karnopp’s modified friction model (Kirnopp, 1985). 
The linear model obtained was solved to account for the friction force during needle 
insertion. The friction force is determined by the friction damping parameter bp 
(Ns/m2), the insertion depth l [m] and the speed of insertion v [ms-1] 
lvb)x(f p=      (8.10) 
In the following section we use the framework presented above to predict insertion 
force for different skin types and we show the effect of interspacing on insertion 
force. Two dimensional simulation of microneedles inserted in the skin are used to 
show the effect of interspacing on skin deformation and stress at needle tip. 
 
8.4.2. Finite Element Modelling (FEM) modelling of Microneedle insertion 
2D FEM simulations were performed for the numerical analysis of microneedle 
insertion into skin at various interspacing. The simulations were carried out using 
COMSOL (Comsol, 2005), modelling the skin as an isotropic elastic material with the 
aforementioned mechanical properties and the needles as tapered metallic structures 
made of titanium. COMSOL has been applied in previous studies for biomedical 
studies on microneedles (Al Qallaf et al, 2009). The software has a user friendly 
graphical interface that allows solution of contact problems in 1 to 3-D mode. Plane 
stress analysis was carried out while assuming linear deformation of skin and 
microneedles and, the constitutive equation for linear materials is used to model the 
deformation of the skin  given as; 
fuV.u)uuVc.(V =β+α+γ+α−−                                                      (8.11) 
Where c, α, a, β are constants and γ and f are source terms which depend on the 
boundary conditions imposed. In this particular case, c is the elasticity matrix 
consisting of poison ratio (v) and Young modulus (E), the values for these are 
discussed later. α is the stress tensor, γ is the initial strain vector which is 0 in the 
simulations presented, a is the mass damping parameter (1 Ns/m), β is the stiffness 
damping parameter (0.01 N/m), u is the vector of dependent variable such as 
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displacement in this case f is the force term which is the load applied at the 
microneedle base as discussed in the following section. The boundary conditions are 
defined such that the base on which the skin is placed is rigid and the skin surface is 
movable in all direction. The solutions obtained from numerical simulations are 
discussed in the next section. 
 
8.5.Results and Discussions 
It is known that the mechanical properties of skin vary with respect to different factors 
such as anatomical region, age, gender and individual phenotype (Escoffier et al, 
1988; Cua et al, 1990; Agache et al, 2004; Gambichler et al, 2006). Yuan and Verma 
(2006) revealed that the Young modulus for stratum corneum of porcine skin was 
dependent upon the moisture content of the skin, ranging from 26 – 120 MPa, for wet 
and dry skin, respectively. It has been suggested that this range of values may be 
representative of how the mechanical properties of the skin varies with age. In 
particular, the lower value of Young modulus seen for wet skin may be taken to 
represent skin from a young adult, whilst the values for the dry skin may represent 
that of an elderly adult. As such, the theoretical model is applied to both the upper and 
lower limit of the reported young modulus values, applying the following 
assumptions. The Young modulus of the viable epidermis for skin from a young adult 
was assumed to be half of that from an elderly adult (Agache et al, 1980; Kuwazuru et 
al, 2008). Therefore, 0.272MPa was  defined for the viable epidermis of an elderly 
adult since young modulus for epidermis of skin from a young adult has been reported 
as 0.136MPa (Maemo et al, 1997; Kuwazuru et al, 2008). The thickness of the viable 
epidermis also varies with age. The viable epidermis is taken to be 51μm for a young 
adult and 37µm for an elderly adult (Gambicher et al, 2006).  
 
8.5.1. FEM Modelling of Microneedle insertion 
Stress and displacement values where obtained from the numerical simulations in 
COMSOL. Analysing the stress and displacement of the microneedles prior to 
insertion serves as a measure of resistance offered by the skin prior to insertion at 
various interspacing as discussed in the following subsections.  
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8.5.1.a. Effect of interspacing on stress at Microneedle Tip 
Simulations in 2-D were carried out using COMSOL, of microneedles pressed against 
the skin surface with an equal predetermined force of 0.0027N at the base of each 
microneedle (Figure 8.5). The upper layer, the stratum corneum was given a young 
modulus of 26MPa while the lower layer was given a young modulus of 136KPa 
(Yuan and Verma, 2006) and the Poisson ratio was taken as 0.49 for both layers 
(Magnenat-Thalmann, 2002). The interspacing was then varied between 25μm and 
315μm increasing by 10μm for two different geometries. Figure 8.6 shows results 
obtained when the microneedles were modelled as 400μm long tapered microneedles 
with a base radius of 60µm and tip radius of 30µm. This small geometry (relative to 
the microneedle sizes used in the experiment) has been used in order to achieve close 
interspacing at the tip and this allows us to obtain a wider range of results, prior to 
experimental verification of the proposed model, which was adjusted to match the 
shape and dimensions of the microneedle arrays used in the study. The stress at the 
microneedle tips was calculated for 30 different values of interspacing. The results 
shown in Figure 8.6 indicate a decrease in stress at microneedle tip as the interspacing 
is increased.  
In another simulation a row of 3 microneedles attached to an array with an applied 
load of 0.00576N was inserted into skin using the same microneedle geometry and 
skin properties listed above. The normal stress on each microneedle was then obtained 
as an average of normal stress on all three microneedles (Figure 8.7). This was then 
repeated for the microneedle geometry that has been used in the in vitro insertion 
experiment (Figure 8.8). The results, as shown in Figures 8.7-8.8, indicate higher 
normal stress on the microneedles at small interspacing and lower normal stress at 
wider interspacing. These results are in line with our proposed theory since the 
decrease in stress at the tip indicates that the microneedles face less resistance as the 
needles are placed farther apart.  
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Figure 8.5 Simulation showing microneedles inserted into a two layer model of skin. 
Showing A) 10µm B) 300μm interspacing and C) Principal strain 
 
                                                       
Figure 8.6 Stress at microneedle tip for different inter-spacing. a) 35μm to 305µm b) 
10μm to 305µm 
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Figure 8.7. Normal stress on MN for the geometry used within the in vitro insertion 
force determination experiments. 
 
 
Figure 8.8. Normal stress on theoretical MN design of 400 µm height and a smaller 
wall angle than the polymeric conical shape MNs employed in the experimental 
section.  
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
0 100 200 300 400 500 600 700 
N
or
m
al
 S
tr
es
s 
on
 M
N
 (m
N
/m
2 )
 
Interspacing (μm) 
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
0 100 200 300 400 500 600 
N
or
m
al
 S
tr
es
s 
on
 M
N
 (m
N
/m
2 )
 
Interspacing (μm) 
 143 
 
  
8.5.1.b. Vertical Displacement of MNs prior to insertion 
The vertical displacement of the needle acts as an indicator of the manner in which 
the skin deforms as a result of lateral stress distribution. A force of 2.7N was applied 
at the base of each needle and the vertical displacement of the needles was measured 
for different interspacing (Figure 8.9). The results show a decrease in vertical 
displacement as the interspacing increases, with a sharper decrease between 10 and 
150μm. This may be explained by the fact that the stress distribution around each 
needle intercept becomes less as the interspacing increases (compare Figures 8.5).  
 
Figure 8.9. The vertical displacement decreases as the spacing is increased indicating 
that spacing has a significant impact on the manner in which skin deforms.  
 
8.5.2. Insertion force estimation 
First we calculate the bending, indentation, cutting, buckling and friction forces 
separately at different microneedle interspacing. The total insertion force is then 
estimated based on the presented framework. The parameters for ‘old’ and ‘young’ 
skin have been used here for the purpose of comparing two different types of skin. In 
order to assess the validity of the results suggested by the model, a series of in vitro 
experiments were conducted to determine the insertion force for conical shaped 
microneedles of 600 µm height and 300 µm width at base, with varying microneedle 
interspacing distances. These experimental results were then compared with the 
theoretical values.  
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Bending Forces 
Using Equations (8.3) – (8.6), the bending force was calculated for a range of varying 
microneedle interspacing. The results, as shown in Figure 8.10, predict that the force 
required for bending the skin before puncture will increase as the spacing between the 
needles increases, showing a much steeper increase for lower interspacing. Bending 
force for the skin of an elderly adult (termed “aged” skin) is higher than that for the 
skin of a young adult (termed “young” skin). This is expected due to the difference in 
the mechanical properties of the skin as a function of age (Agache et al, 1980).  
 
 
Figure 8.10. The force required to cause skin bending as a function of MN 
interspacing. 
  
Indentation Force  
The force required for the needle to indent the surface of the stratum corneum before 
piercing through is calculated using Equation (8.7). Using a tip radius of 15 microns 
the indentation force estimated for young skin was 0.007345N, and for older skin 
0.047375N. The needle was assumed to compress the stratum corneum by 60% of its 
thickness prior to insertion. This assumption is based on the theory that skin consists 
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of pore spaces (Tezel, 2002) such that the compression causes realignment of the skin 
fibre (Leddy and Guilak 2008; Leddy et al, 2006) causing the spaces to close. The 
indentation force is not affected by interspacing therefore the effect of tip radius is 
plotted in Figure 8.11. The dependence of insertion force on radius of needle was also 
investigated by Okamura et al (2004) and Davis et al (2004). Both studies indicated 
that the insertion force increases as the needle tip radius increases. 
  
 
Figure 8.11. Indentation force for different needle tip geometry 
 
 Cutting Force 
The theoretical pressure to pierce human skin is reported as 3.183x106 Pa (Aggarwal 
and Johnston, 2004). However this force is a combination of pre puncture and post 
puncture forces. Okamura (2004) isolated the forces during needle insertion into liver 
tissue and obtained a cutting force of 0.94 N for a needle with tip diameter of 1.27 
mm at a speed of 0.003 m s-1. By calculating the kinetic energy, the pressure of 
insertion was obtained and in turn used to approximate the insertion force for a MN 
with a tip radius of 15µm giving a value of 0.019 N. This force is assumed to be 
instantaneous and independent of depth and is the same for young and old skin. 
However, as these experiments were performed on bovine liver tissue, the value 
determined by this model is used here only as an estimate for MN penetration into 
skin. 
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Buckling Force 
The skin is modeled as a beam on an elastic foundation under two axial loads to 
obtain the minimum force required to buckle  the skin at different spacings between 
the loads. The analysis predicts a general decrease in the buckling force as the 
interspacings at the needle tips increase for both old and young skin (Figure 8.12). 
The oscilating nature of the result suggests an optimum value within  a given range 
but in general buckling force decreases as interspacing increases. 
 
 
Figure 8.12. Effect of MN interspacing on buckling force  
 
Frictional force 
The frictional force, like the indentation and cutting forces, is independent of 
interspacing; however it is included here nonetheless. Figure 8.13 shows friction force 
calculated over a range of velocities for old and young skin. The distance travelled by 
the needle l, in this case is the thickness of the skin before puncture which is assumed 
to be 40% of the original thickness of the stratum corneum. The friction force values 
obtained here is relatively low, for example at 0.5 mm/s the estimated friction force is 
5.03 µN.  
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Figure 8.13. Force applied against friction increasing as the velocity of needle through 
the skin. 
 
Total insertion force  
Summing up these forces gives the total force required to insert each microneedle 
having accounted for the effect of the microneedle interspacing. Theoretical analysis 
indicates that the cutting force accounts for much of the microneedle penetration, 
whilst the bending force of the skin contributes the least. The total insertion forces at 
different interspacing are plotted in Figure 8.14 showing a combined effect of 
microneedle interspacing on bending and buckling forces. At lower spacing the effect 
of interspacing on insertion force should be more noticeable, and as the spacing 
increases, the effect on insertion force becomes less prominent or almost absent.  
The interspacing between the needles has an effect on the buckling and bending force 
but no effect on the indentation, friction and cutting forces. Therefore, to obtain a 
direct relationship between insertion force and interspacing, regression analysis was 
carried out on the variable forces (bending and buckling). Regression analysis of 
Figure 8.14 shows the effect of interspacing on insertion force to be well represented 
by a power law equation (R2 = 0.63) of the form in Equation (12). Fbending+buckling is the 
sum of the bending and buckling force per unit area for each microneedle, a and b are 
constants that are obtained by fitting the equation with experimental values as 
discussed in the following sections.  
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b
cuttingbending aSF
−
+ =      (8.12) 
 
 
Figure 8.14. Effect of MN interspacing on the force required microneedle insertion 
into skin.  
 
8.5.2. In vitro determination of insertion force required for Microneedle 
penetration into neonatal porcine skin using Texture Anlayser. 
In order to assess the validity of the proposed mathematical model, a series of in vitro 
experiments were performed to determine the force required for microneedle insertion 
into neonatal porcine skin for microneedle arrays with varying microneedle 
interspacing. The polymeric microneedle arrays employed within this study were 
conical in shape, with a microneedle height of 600 µm and base width of 300 µm. The 
laser-engineering process used during the production of these microneedles, enabled 
arrays of microneedle interspacing from 30–600 µm to be designed for testing. It was 
found that for all microneedle interspacing values, the speed at which they were 
inserted had a significant effect (p < 0.001) upon the force required for microneedle 
insertion. In particular, an increase in the speed at which microneedle (MN) were 
applied to the skin surface resulted in a decrease in the force required for insertion 
into the skin. It can be seen from Table 8.2 that the force required for microneedle 
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insertion ranged from 0.0216 N/MN to 0.0214 N/MN at an insertion speed of 1.0 mm 
s-1, and 0.03 N/MN to 0.028 N/MN at an insertion speed of 0.5 mm s-1 for a 
microneedle array of interspacing 30 µm and >150 µm, respectively. This is in 
agreement with previously reported findings, where it has been shown that the use of 
a high velocity (1-3 m s-1) applicator enabled more reproducible microneedle insertion 
into dermatomed human skin when compared to manual microneedle insertion 
(Verbaan et al, 2008). It has been suggested that the natural elasticity of the skin may 
counteract the penetration of MNs into the skin when the microneedles are inserted 
slowly into the skin (Verbaan et al, 2008; Crichton et al, 2010).  Furthermore, it has 
been shown that increasing the velocity of microneedle application led to an increase 
in the transport rate of a model compound, cascade blue, across dermatomed human 
skin (Verbaan et al, 2008). This suggests that the speed of application is important for 
both the insertion and penetration of microneedles into the skin.  
In regards to the effect of microneedle interspacing upon the force required for 
microneedle insertion into skin, it was found that only the microneedle arrays with 
interspacing values ≤ 150 µm had a significantly different (p < 0.001) insertion force 
per microneedle, in comparison to the arrays of microneedle interspacing 150-600 
µm. Whilst it has been shown that increasing the density of a microneedle array can 
lead to an increase in the rate of transdermal drug delivery (Oh et al, 2008; Yan et al, 
2010), it appears that there will be an optimum density for any given microneedle 
design and application (Widera et al, 2006; Verbaan et al, 2008; Yan et al, 2010). Yan 
et al, (2010) observed lower drug permeation results for very high microneedle array 
densities (> 20,000 MN cm2). This was attributed to the fact that each microneedle 
array was inserted at the same force per unit area (44.5 N), rather than the same force 
per actual microneedle, such that the depth of penetration of these high density arrays 
may have been reduced in comparison to arrays of lower microneedle density.  To 
ensure that the forces determined here would be applicable to an array with a larger 
number of microneedle, but the same microneedle interspacing, confirmation studies 
were performed to assess if a force of 0.0214 N/MN would enable successful skin 
insertion of a microneedle array with 121 microneedles (microneedle height 600 µm, 
microneedle width 300 µm and microneedle interspacing 300 µm). This confirmed 
that the insertion force was dependent upon microneedle interspacing and not 
microneedle number, with the same insertion force per microneedle required to insert 
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a microneedle array with 9 MNs in total and an array with 121 MNs (i.e. insertion 
force of 0.0214 N/MN at a speed of 1.0 mm/s). Representative digital images used as 
confirmation of microneedle insertion are shown in Figure 8.15.  These experimental 
findings are in agreement with the predictions based upon the theoretical model 
proposed within this study (Figure 8.14) as the results show a decrease in insertion 
force as the interspacing is increased. Further analysis are carried out to obtan a 
quantitative relationship between interspacing and insertion force. This is discussed in 
the next section.  
 
Table 8.2. Experimental determination of the force required for successful 
microneedle penetration, as a function of microneedle interspacing and the speed of 
microneedle insertion. 
  Velocity of insertion 
 
0.5 mm s-1 1.0 mm s-1 
 
Insertion Force Insertion Force 
Interspacing 
at Base (N/MN array) (N/MN) (N/MN array) (N/MN) 
30 0.4800 ± 0.0017 0.0300 ± 0.0001 0.3456 ± 0.0002 0.0216 ± 0.00001 
 
50 0.4648 ± 0.0023 0.0291 ± 0.0001 0.3442 ± 0.0003 0.0215 ± 0.00001 
 
150 0.2524 ± 0.0017 0.0280 ± 0.0002 0.1926 ± 0.0001 0.0214 ± 0.00001 
 
300 0.2524 ± 0.0019 0.0280 ± 0.0002 0.1926 ± 0.0002 0.0214 ± 0.00001 
 
600 0.1122 ± 0.0014 0.0280 ± 0.0003 0.0856 ± 0.0001 0.0214 ± 0.00001 
 
 
Figure 8.15. Representative digital images highlighting the penetration of a MN array 
with 4 MNs / array on the left, and 121 MNs / array on the right. 
400μm 1000μm 
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8.5.3. Tuned Model based on Experimental Results    
To obtain a direct relationship between insertion force and interspacing, regression 
analysis was carried out on the results based on the theoretical analysis. The buckling 
and bending forces at each interspacing was summed up and plotted against 
corresponding interspacing to obtain a direct relationship between additional forces 
required for insertion due to interspacing. From regression analysis, the effect of 
interspacing on insertion force F was best described by a Power law equation. This 
derived equation was then tuned with the experimental results (Table 8.2) obtained 
giving the following equation for additional force required due to interspacing as: 
 289.1bucklingbending S538.2F
−
+ =     (8.13) 
The force value obtained from the experiment is divided by the area of the 
microneedle base to give the force per unit area such that the total force for a given 
microneedle can be expressed as: 
 289.12p
2/3
2cuttinginsertion Sr35905lb)1(3
rE4FF −π+ν+δ
ν−
+=  (8.14) 
The model presented here is valid within the range 30 to 150μm interspacing at 
microneedle base since the experimental results show no variation in insertion force 
beyond 150μm. In addition to this, since the skin property varies for different species 
and sites of the body, it should be considered that Equation 8.14 is derived from 
experiments carried out on neonatal porcine skin. 
 
  
Figure 8.16. Buckling and bending forces Fbuckling+bending at different interspacing. 
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8.6.Chapter Summary 
In this study, we have presented experimental results and theoretical analysis which 
provide a quantitative basis for relating the arrangement of MNs in terms of 
interspacing with the insertion force of MNs. The results indicate that the overall 
framework is useful in calculating insertion force, as the predicted pattern is 
comparable with experimental results. This model is expected to be useful for 
planning the optimum design of a MN device, with consideration given to maximising 
the number of MNs within a given area in order to enhance the rate of drug delivery 
whilst negating against any potential “bed of nails” effect. Furthermore, by predicting 
the minimum force required for MN insertion this model may aid in the development 
of an appropriate applicator for reproducible MN penetration into skin. 
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9. Optimization of Microneedle Design to Obtain Desired 
Peak Blood Concentration 
 
9.1.Overview 
The main focus of this research is to develop a framework that allows the design 
parameters (L, r, R, n and S) to be optimized in order to predetermine the optimum 
design of a microneedle array to achieve controlled drug delivery. In the previous 
chapters, a series of models have been presented to relate the design parameters to the 
permeability, diffusion coefficient and insertion force. In the present chapter an 
algorithm is provided for solving these equations within a single framework to obtain 
the optimum design which satisfies all constraints within the framework.  
 
9.2.Introduction  
For clinical and commercial application of microneedles it is necessary to have a 
quantifiable means of predicting the drug delivery rate following administration of 
drug patch. This research presents a framework to relate microneedle design to the 
drug delivery rate in terms of permeability and drug concentration in blood. In this 
Chapter the presented models are combined into a single framework and an algorithm 
for obtaining solutions of optimum microneedle design to obtain desired peak drug 
concentration is demonstrated. For this purpose fentanyl is used as a model drug. 
fentanyl is an analgesic synthetic opioid administered to patients with chronic pain 
where milder forms of pain killers will not suffice (Marier et al, 2006; Jeal and 
Benfield, 1995; Fiset et al, 1995). It is delivered in a transdermal patch to provide a 
controlled delivery for up to 72 hours with an initially steep increase in blood 
concentration but dropping steadily over a longer period of time (Tojo, 2005; Marier 
et al, 2006).   
In previous chapters mathematical models have been developed to relate the 
microneedle geometry with permeability while accounting for the compressive force 
exerted as the microneedles are inserted into the skin. A model is also presented in 
chapter 8 to predict insertion force while accounting for the effect of interspacing 
within the microneedle array. In this section, optimization is carried out using the 
developed framework with the aim of obtaining an optimum microneedle design that 
can achieve therapeutic values of drug concentration in blood similar to that reached 
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following application of a conventional transdermal patch on full thickness skin. For 
this purpose fentanyl is used as a model drug and the concentration is based on a 
commercially available formulation known as the Duragesic® patch (Mehdizadeh et 
al, 2004). 
 
9.3.Method of solution 
In this study the dimensions of the microneedles defined are those of the portion of 
the microneedle that has inserted into the viable epidermis and Figure 9.1 shows 
schematics of microneedle inserted into the skin compared with a conventional TDD 
system. In both cases the drug ADME is similar except that the orientation of the drug 
loaded surface in contact with the skin differs. Furthermore the microneedle system 
bypasses the SC. 
 
a.  
 
b.  
Figure 9.1 Schematic of (a) Microneedles inserted into the viable epidermis (VE) and 
(b) conventional drug patch placed on full thickness skin 
 
9.3.1 Theoretical Model of Drug transport through Skin Using Microneedles 
Drug transport through the VE is modelled as diffusion through the porous pathway 
within the tissue since λ<0.4 and a full description of the model is provided in chapter 
7. Where diffusion coefficient with microneedle inserted is given as; 
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The values for the necessary parameters used in this study are listed in Table 9.1. Skin 
thickness varies in different parts of the skin (Hwang et al, 2002) the value used here 
is the skin thickness in the arm which is a practical region for placing a microneedle 
array. 
 
Table 9.1 Skin and fentanyl properties used in this study. 
Parameter Value (Reference) 
Porosity of viable epidermis, ε ** 
Tortuosity, τ ^ 
0.55 (Tezel et al, 2002) 
6 (Tezel et al, 2002) 
Radius of available viable epidermal pore, rs (m) 3.6 x 10-9 (Tezel et al, 2002) 
Hydrodynamic radius of fentanyl, rp (m)^ 4.4 x 10-10 (Tezel et al, 2002) 
Diffusion coefficient at infinite solution, D(m2/s)^ 9.06 x 10-10 (Peck et al, 1994) 
 fentanyl concentration on  skin surface Cs (g/m3) 
Thickness of Epidermis (arm of human skin) (μm) 
Thickness of stratum corneum (arm of human 
skin)(μm) 
15800 (Tojo et al, 1996) 
79 (Lee and Hwang, 2002) 
10 (Holbrook, 1974) 
** Based on value given for the Dermis ^ Based on value given for a compound 
of similar size (Manitol) 
 
9.3.2. Optimization Strategy 
From the presented equation thus far, it is clear that the permeability is interplay 
between the diffusion path length (זh) and the Diffusion property (εDr). Therefore an 
optimum design should be achieved for the highest diffusion coefficient value and the 
lowest diffusion path length. However since according to the proposed theory, the 
diffusion coefficient is expected to be affected by the size and number of 
microneedles, an optimum permeability may not always be indicated by a decreased 
diffusion path length due to using the highest value of r, R, L and n. Therefore an 
optimization strategy is required. 
 156 
 
The optimization is carried out based on an estimated path length as follows: There 
have been studies which used 3D simulations based on the finite element method to 
obtain the effective skin thickness with microneedles inserted into skin (e.g. Al-Qallaf 
et al, 2008). However carrying out 3D simulation for all possible values of these 
parameters in order to obtain the effective skin thickness for steady state flux will be 
time consuming and impractical, a formula is therefore derived to estimate the 
effective skin thickness as an average distance between the microneedle surface area 
and base of the epidermis. Although this estimated diffusion path length heff* given in 
Equation (9.2) is not to be taken for the real path length, it may be used to estimate the 
peak blood concentration in order to obtain the optimum microneedle geometry. 
Similar method has been used by McAllister et al (2003) although the group 
visualized the holes created by microneedles as cylindrical such that the tip radius was 
not included. This method is logical as the equation indicates that the effective skin 
thickness decreases as the size and number of microneedle increases.  
  
n
needle*
eff A
nVxA
h
−
=     (9.2) 
A is the area of patch, and An is the total surface area of the microneedles in the array. 
This is then substituted into Fick’s equation to obtain an estimated steady state flux 
Jss* . 
 *
eff
r*
ss h
CDJ ε=      (9.3) 
The steady state flux is used as the penetration rate into the microcirculation therefore 
the peak blood concentration in the blood at this steady state can be estimated. 
Assuming a one compartment model for ADME of a model drug, fentanyl, the peak 
blood concentration can be calculated from Equation (9.4) (Tojo, 2005; Hacker et al, 
2009).  
dben
b
d VCkAdt
dQ
dt
dC
V −=
    (9.4)
 
Vd is the volume of distribution in the blood, Cb is the concentration of the drug in the 
blood at time t, Ke is the elimination rate constant, dQ/dt is the rate of skin penetration 
and this is taken as the steady state flux Jss assuming a constant penetration rate since 
sink condition is assumed in the dermis and the concentration at the skin surface is 
assumed to remain constant. An is the area of the drug releasing surface of the 
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delivery system which in this case is the total surface area of microneedles inserted 
into the skin (excluding the base area).  
 
At the peak concentration the concentration gradient becomes 0: 
0
dt
dCb =  at Cb =Cmax     (9.5) 
Peak concentration in the blood can therefore be calculated as: 
 
de
nss
max VK
AJC =      (9.6) 
These equations are then implemented in excel using the solver functions to find an 
optimum microneedle geometry to achieve the desired peak blood concentration using 
the range of microneedle array parameters listed in Table 9.2 and the drug and skin 
properties from Table 9.1. The maximum concentration was selected from all the 
tested values using the MAXA function and the microneedle geometry that 
corresponds to this value is found by using Conditional formatting which highlights 
the desired value. The optimization has been done manually here to show how the 
equations are  solved however a VBA program has been written to carry out this 
optimization automatically and this is provided in appendix 1 of this thesis. 
 
Table 9.2 range of values of the parameters used 
Parameters Range  Step scale (μm) 
Number of microneedles per row √𝑛 (-) 30 – 5 5 
Radius at base of microneedle R (μm) 50 – 10  10 
Radius at tip of microneedle r (μm) 10 - 2 2 
Penetrated Length of microneedle L (μm) 65 - 45 5 
Area of patch A (cm2) 1 Constant  
  
9.3.3. Obtaining desired Peak Blood Concentration 
In order to demonstrate the use of the developed framework to optimize MN array 
design, simulation are carried out based on a commercially available Fentanyl patch, 
Duragesic® with known composition: 10mg of Fentanyl in a liquid reservoir 
containing ethanol and hydrooxylethyl cellulose gel (Tojo et al, 2005; Mehdizadeh et 
al, 2004). Using the method described in Section 9.3.2 the peak blood concentration 
was calculated for various microneedle geometries in the range listed in Table 9.2. 
The desired blood concentration was then selected using conditional formatting in 
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Microsoft Excel (Microsoft Office 2010), whereby a range of acceptable values are 
searched and the program highlights the desired Peak drug concentration in blood and 
the corresponding microneedle array parameters. Simulations are then carried out in 
COMSOL and SKIN-CAD to compare the peak blood concentration obtained from 
this model to values obtained from Clinical studies by Gupta et al (1992).  
 
9.3.6. Constrains and Limitations  
The maximum amount of microneedles that can be packed into the patch of 1cm2 is 
calculated from the aspects ratio (Al-Qallaf and Das, 2008). In all simulations the 
aspect ratio α is always greater than 2 in order to prevent overlapping of the MNs. For 
convenience the microneedle array used here were chosen to have a square 
arrangement such that the following constraint can be applied:. 
R
n
A
α≥
        (9.7)
 
In addition to this constraint, the geometry of microneedle that can be used is limited 
such that the volume of microneedles, Vneedle, does not exceed the volume of pores, 
Vpore, in the skin.  
poreneedle VnV <       (9.8) 
The surface area of drug application is the total surface area of the microneedles 
excluding the area of the base; the microneedle design chosen were conical shaped 
with flat tips. Furthermore, the length considered here is the length that penetrates the 
viable epidermis. The penetrated length L may not be the full design length of the 
microneedle since the insertion of microneedle is limited by the irregularity of the 
skin surface (Henry et al, 1998). In a similar way the base radius R considered here is 
the base radius at the top of the penetrated length of the microneedles (Figure 9.1). 
The tip radius r is the same as the design radius of the microneedle. 
In the previous chapter a model was derived to predict the insertion force for a given 
microneedle geometry. An additional constraint is included here indicating that the 
insertion force should be less than the failure force of the microneedle. The different 
failure forces have been evaluated by Aggarwal and Johnston (2004). The failure 
forces of the microneedles were identified as compressive force, shear force, bending 
and buckling force. The buckling and bending force was found to be the minimum 
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forces to cause failure, however in this particular study (Aggarwal and Johnston, 
2004) the geometry considered were long straight walled needles with the base radius 
equal to the tip radius. For the geometry considered in the present work, i.e. tapered 
microneedles, the most likely failure is at the sharp tip and this has been shown in 
experiments carried out by Davis et al (2003) and another by Donnelly et al (2010), 
tapered microneedles were shown to be more likely to fail at the tip. For this reason 
the minimum failure is defined here as the minimum compressive force, Ffracture that 
can be applied to the tip (the weakest point) without breakage and this is expressed as: 
tipyfracture AF σ=       (9.9) 
Where Atip is the area of the microneedle tip and σy is the yield stress of the 
microneedle material. The constraint imposed here is therefore that the insertion force 
should be less than the minimum force to cause microneedle failure: 
fracture
904.0
p
2/3
2cuttinginsertion FS4664lb)1(3
rE4FF <+ν+δ
ν−
+= −  (9.10) 
The value of porosity and tortuosity used in this study is based on the assumption that 
the conditions in the viable epidermis are similar to that in the dermis. However 
results from Tezel et al (2002) and Kushner et al (2007) suggests that the Dermis may 
have a different porosity from that of the average porosity and tortuosity of the 
epidermis (stratum corneum + Viable epidermis). The values given by Kushner et al 
(2007) and Tezel et al (2007) give porosity and tortuosity values in the epidermis with 
the stratum corneum included. However for this study the value of porosity and 
tortuosity required is that of the viable epidermis alone, for this reason that of the 
Dermis is used as it is expected to be closer estimate. Furthermore the hydrodynamic 
radius and diffusion coefficient used here is based on that of Manitol (182.2Da) as it 
has a similar molecular size as fentanyl (336.5Da) although other properties may also 
influence the hydrodynamic radius. Other relevant properties that have been used in 
this study are listed in Table 9.1. It is also important to note that the use of this 
framework to predict the blood concentration profile is limited to the one 
compartment model which is applicable for most transdermal drug delivery. 
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Figure 9.3 Algorithm used to solve the Framework Presented in this study. A VBA 
program has been developed based on this algorithm and is provided in appendix 1. 
λ < 0.4 
A
nVAhh *eff
−
=
>0
 
nVneedle < Vporei  Adjust Needle Dimensions 
R=R*; L=L*;  r=r*;  
n=n* 
 rsi > 0   
R
n
A
α≥
  
 
Dr = D H( rp
� Vpore−nVneedleπnpx ) 
Jss = εDrCheff∗
 
  Cmax =  JssAnKeVd   
Use Fick’s model 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
Yes Cmax =  Cmaxdesired
  
Cmax output 
needleVV =∆  
)q1(DDr φ−=
 
skin
needleskin
V
VV −
=φ
 
A
nVAhh *eff
−
=
>0
 
Obtain skin and MN 
parameters 
Finsertion = Fcutting + 2/32 )v1(3 rE4 δ− + bplv + 4664S−0.904  < Ffracture 
Yes 
No 
 161 
 
9.4.Results and Discussions  
Based on clinical values reported by Gupta et al (1992) the blood concentration 
profile was calculated for a fentanyl patch with a skin surface concentration of 
15.8mg/ml. The desired blood concentration profile is that achieved using a 40cm2 
Duragesic® patch containing 10mg of fentanyl in a liquid reservoir system. This type 
of transdermal patch is commercially available and is usually prescribed to patients to 
treat chronic pains following surgery or pain associated with conditions such as 
cancer (Roy et al, 1996; Adams, 1975). The presented framework is solved to find the 
corresponding microneedle geometry to obtain the maximum and desired peak blood 
concentration. Finally the blood concentration profile obtained while varying each of 
the parameters, R, r, L and n is shown to demonstrate the use of microneedles for 
controlled drug delivery. It should be noted that by varying the number of 
microneedle in the array, the interspacing is in effect also varied in doing so.  
 
9.4.1. Optimization of Microneedle Array to obtain Maximum blood 
Concentration 
The optimization is carried out using solver functions in Microsoft excel (Office 
2010). The equations where implemented in excel and values of diffusion coefficients 
were obtained for over two hundred (precisely 206) MN geometries. The maximum 
peak blood concentration value is then selected by using the MAX function in 
Microsoft Excel. For the range selected (Table 9.2), the optimum parameters are 
shown in Table 9.3. The blood concentration at this optimum point is 11.68ng/mL 
which is a relatively high concentration since the therapeutic range for fentanyl is 
between 0.1 and 2ng/mL (Dasgupta, 2010).  
 
Table 9.3 Optimum parameter based on the values from Table 9.1 and 9.2 (ε=0.55)  
Parameters Optimum value 
Base radius R (μm) 50 
Length L (μm) 65 
Tip radius r (μm) 10 
Number of microneedle (-) 900 
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The optimum parameters obtained here are the maximum size and number of 
microneedles. This is explained by the fact that a relatively high value of porosity had 
been chosen therefore the increase in size of microneedles has less effect on 
decreasing the diffusion coefficient and more effect on decreasing the effective skin 
thickness. If the porosity is lower a different optimum is expected to be obtained and 
to illustrate this the optimization is repeated using a porosity of 0.00001 similar to that 
obtained from epidermis with the stratum corneum intact (Tezel et al, 2002). The 
optimum values obtained are listed in Table 9.4. The predicted peak blood 
concentration of fentanyl at this optimum was 0.00019ng/mL which is much lower 
than the typical peak blood concentration of fentanyl. 
 
Table 9.4 Optimum parameter using ε=0.001.  
Parameters Optimum value 
Base radius R (μm) 10 
Length L (μm) 45 
Tip radius r (μm) 
Number of microneedle (-) 
2 
900 
    
9.4.2. Optimization of MN Array to obtain a desired Peak Concentration  
For practical application of microneedles, it is necessary to be able to predict the 
concentration profile that will be reached for a particular microneedle design. This 
will allow adequate dosage and prediction of the peak blood concentration. The 
effective skin thickness obtained from 3-D finite element simulations is higher when 
compared with that obtained from Equation (9.2). This difference is accounted for by 
calculating the error factor which is consistent for all simulations. This can be 
explained by the fact that the effective skin thickness obtained from Equation (9.2) 
simply considers the average distance from the microneedle surface to the region 
where sink condition exists. However the FEM simulation is based on the 
concentration gradient on each element. The effective skin thickness in both cases 
decreases as the size of microneedles increases. Similar observations of simulated 
effective skin thickness have also been reported by (Al-Qallaf et al, 2008). This 
limitation can be addressed by first obtaining the error between simulated and 
predicted values for specific case study prior to optimization. 
 163 
 
Using the method described above the estimated Peak blood concentration was 
obtained and the corresponding geometry was incorporated into SKIN-CAD using heff 
as the skin thickness rather than heff*. Therefore heff* is used simply to locate the 
optimum after which the effective skin thickness heff is then obtained from 3-D 
simulations. As shown in Figure 9.4, the predicted Cmax and simulated blood 
concentration profile of fentanyl are similar to that of the desired clinical value. 
 
 
Figure 9.4 fentanyl concentrations in blood: Comparing clinical and values predicted 
from model and from simulations 
 
For this particular case the desired blood concentration profile was achieved by using 
an array containing 400 microneedles, 65μm long (L), 6μm at the tip (r) and, a radius 
of 50μm at the base (R). The results shown here are based on the concentration of 
fentanyl in the Duragesic® patch.  
Figure 9.5-9..8 shows the values obtained for different microneedle geometries while 
varying n, L, R and r. It can be seen from these simulation results that by varying 
these parameters, the peak blood concentration can be varied as desired. Increasing 
the penetrated depth of microneedles from 50μm to 65μm increased the peak blood 
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concentration from 1.62ng/mL to 2.50ng/mL (Figure 9.5) and when the base radius R 
was increased from 20μm to 50μm, the peak blood concentration increased from 
2.05ng/mL to 10.63ng/mL this is shown in Figure 9.6. An increment of 6μm in the tip 
radius of the microneedles from 4μm also caused the blood concentration to increase 
from 0.10ng/mL to 0.12ng/mL (Figure 9.7) and increasing the number of 
microneedles from 100 to 900 increased the simulated blood concentration profile 
from 0.53ng/mL to 8.43ng/mL (Figure 9.8). The therapeutic concentration of Fentanyl 
in the blood is usually between 0.1 and 2ng/mL (Dasgupta, 2010). This precise 
variation in peak blood concentration by altering the microneedle design further 
elucidates the applicability of microneedles to provide more controlled drug delivery. 
It is also significant to note that a 1cm2 microneedle patch was required to achieve the 
same blood concentration profile as a 40cm2 transdermal patch; hence indicating that 
TDD devices which incorporate microneedles could provide less bulky and more 
compact drug delivery devices.  
 
Figure 9.5 Effect of penetrated length L of microneedles on fentanyl concentration in 
blood over 72 hours 
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Figure 9.6 Effect of base radius R of microneedles on fentanyl concentration in blood 
over 72 hours 
 
 
Figure 9.7 Effect of tip radius r of microneedles on fentanyl concentration in blood 
over 72 hours 
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Figure 9.8 Effect of number of microneedles on fentanyl concentration in blood over 
72 hours 
 
9.5.Conclusion 
In this chapter an algorithm for combining and solving the developed framework has 
been demonstrated. An optimized microneedle array has been designed to obtain a 
desired peak blood concentration of fentanyl. The optimized array design was able to 
achieve a similar blood concentration profile to that obtained from a commercially 
available transdermal patch (Duragesic®) with the same fentanyl concentration using a 
smaller patch area (1cm2). The proposed framework allows the optimum microneedle 
geometry to be chosen and it also gives a prediction of the peak blood concentration 
in the blood. This has been illustrated by comparing concentration profile obtained 
using a microneedle array to the concentration profile obtained from clinical studies 
following administration of a conventional fentanyl patch. Using this method allows a 
microneedle geometry required to achieve a desired peak blood concentration to be 
determined prior to fabrication. It has also shown how by varying the geometry 
parameters of the microneedle, precise control of drug delivery can be achieved using 
microneedles. Such framework is essential in the clinical and commercial application 
of microneedle based drug delivery devices. 
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10. Conclusions and Recommendations 
10.1. Conclusions 
Microneedle arrays can be designed in various dimensions and arrangements in the 
array could vary from a densely packed array to one sparsely arranged. This offers the 
advantage of controlling the drug delivery rate through varying the design of the 
microneedle array. In this study frameworks have been presented which relate the 
design parameters with the drug transport through the skin and it’s concentration in 
blood such that the drug delivery efficiency to be predicted prior to microneedle 
fabrication. 
To rationalize the choice of studying drug delivery via diffusion through the skin 
using solid microneedles over pressure driven infusion using hollow microneedles, 
experimental studies were carried out on laboratory fabricated glass hollow 
microneedles. Using a pipette puller to pull micro-capillaries to obtain sharp tipped 
structures which serve as microneedles, pressure driven flow through hollow 
microneedles into a skin model was observed. At a flow rate of 10ml/hr a solution of 
nile red in acetone was delivered into the annular space between the microneedle and 
Agarose gel. However after delivery of about 0.9mm3 nile red solution leakage was 
observed. Partially retracting the microneedles from the Agarose gel increased the 
amount delivered without leaking to 1.2mm3. When microneedles where inserted into 
Agarose gel without applying pressure, the nile red solution was absorbed into 
Agarose gel within 20mins from a 60μm tip diameter and within 65mins from a 40μm 
tip diameter. This shows that drug transport by passive diffusion into skin is more 
practical than infusion in hollow microneedles.   
The understand the rationale behind connection the design parameters of microneedle 
array with the drug delivery efficiency, models for transdermal drug delivery are 
presented and numerically solved for various microneedle geometry and distribution. 
The permeability and blood concentration profile were obtained from 3D simulations 
using Comsol; a FEM solver which is widely used in transport studies in biomedical 
applications and SKIN-CAD which is a program designed to simulate transdermal 
drug delivery from the skin surface into the blood stream. The permeability and blood 
concentration profile varied as the design parameters; tip radius, base radius, number 
of microneedles and penetrated length, were varied.  
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In order to quantify the effect of the design parameters on permeability, a framework 
is presented which relates the tip radius, base radius, penetrated length and number of 
microneedles to the permeability function g. Microneedle design within a given range 
was then optimized to obtain the maximum permeability and drug concentration in 
blood.  
Transport property of skin is affected by mechanical strain and when microneedles are 
inserted they exert pressure on the skin. This results in a change in diffusion 
coefficient and should therefore be included in the model. A model was therefore 
derived to relate the microneedle geometry to the diffusion coefficient. Simulations 
carried out showed that the simulated permeability and blood concentration profile is 
significantly affected by inclusion of the pressure exerted by the microneedle on the 
skin into the framework.     
Although the Fick’s laws model is widely used to describe drug transport into skin 
and it has been shown to be well fitted with experimental results, the porous pathway 
model has also been presented to provide a better description of transdermal drug 
transport. The drug molecule is assumed to diffuse through hypothesized pores in the 
skin such that the diffusion distance is much longer than the thickness of the skin. The 
model was then modified by including parameters such as porosity and tortuousity 
and a new quantitative relationship between permeability and microneedle array 
design was obtained. 
The design of microneedle is also important in ensuring the insertion of microneedles 
into the skin. This research also included theoretical and experimental studies on the 
influence of microneedle array arrangement on the insertion force. Theoretical 
analysis of the skin deformation and microneedle insertion mechanics showed that 
insertion force will decrease as the interspacing between microneedles is increased 
until a threshold is reached beyond which the insertion force is no longer affected by 
interspacing. This theory was validated by experiments which involved insertion of 
polymer microneedle array into neonatal porcine skin. At insertion velocity of 
0.5mm/s, insertion force decreased from 0.03N at 30μm interspacing to 0.028N at 
150μm interspacing at the base of the microneedle. However the insertion force did 
not vary when the interspacing was increased further; insertion force at 300 and 
600μm was also 0.028N. The theoretical model was tuned with the experimental 
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results and a model was obtained to relate the insertion force with interspacing. Such 
model is useful in the development of an insertion device for microneedle devices 
which is important in the practical application of microneedles.  
For any drug delivery device, it is important to be able to predict the drug 
concentration in the blood following administration. Therefore the model is extended 
to include the peak blood concentration such that the microneedle array design 
parameters are directly related to the peak blood concentration of the drug. The 
equations and constraints are inputted into excel (Office 2010) and using the inbuilt 
functions a range of peak blood concentration are calculated. To obtain the optimum 
microneedle design to achieve a desired peak blood concentration, the value is entered 
and the program searches all the calculated values and finds a value which matches 
the desired peak blood concentration. The corresponding geometry which gives this 
peak concentration is thereby obtained. This has been demonstrated by simulation 
microneedle mediated transdermal delivery of fentanyl. A microneedle array was 
designed to deliver fentanyl to achieve the same blood concentration profile as that 
obtained from experiments on human subjects. Further to this, this study shows how 
by varying the design parameters of a microneedle array, precise dose variation can be 
achieved. For example a 5 micron increase in the tip radius resulted in a 0.018ng/ml 
increase in peak blood concentration. Precision in drug delivery rate enhances the 
effectiveness of the drug and limits the chances of side effects.        
   
10.2. Recommendations 
This research presents a theoretical framework for optimizing microneedle design 
which can be followed up by experimental studies which look into providing in vivo 
values of parameters for microneedle mediated drug delivery. This includes 
experiments to observe the influence of microneedle design and skin properties on the 
penetrated length of the microneedle array as much of the theoretical analysis is based 
on the part of the microneedle structure which is embedded into the skin. Such studies 
could allow the current framework to be expanded to include a quantitative measure 
of the penetrated length. 
Further studies could also explore minimally invasive means of measuring skin 
thickness and providing a quantitative relationship between skin thickness and certain 
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classifications which are usually; gender, age, race and anatomical site. Such studies 
can be linked with the presented framework to obtain a more robust optimization. 
The formulation of the drugs delivered using microneedles is vital as it determines the 
partitioning between the MNs and the viable epidermis. Much of the present data in 
literature on transdermal drug transport is based on experiments carried out on full 
thickness skin such that the partitioning between the drug and SC is considered. With 
the advent of microneedle based drug delivery, other studies are required to obtain 
values for parameters such as partition coefficient and diffusion coefficient for the 
viable epidermis.  
Fabrication process of microneedle arrays are yet to be fully optimized and this poses 
a limitation on the commercialization of microneedle based drug delivery devices. 
Therefore studies focusing on process design optimization would be significant 
contribution to the development of microneedles towards mass production. 
Various techniques for applying microneedles have been proposed and these include; 
poke with patch, coat and poke and phase transition hydrogel system. Further studies 
into techniques of microneedles could focus on evaluating effect of factors such as 
application site, drug type and duration of medication. The relevance of such study 
would be to obtain criteria for determining microneedle techniques for specific 
scenarios. For example the poke and patch approach might suffice for instantaneous 
delivery of vitamins or vaccine to the skin while the hydrogel system might be 
required for controlled delivery of insulin over longer periods. 
This study elucidates the need for experimental studies on the effect of compressive 
force on the diffusion properties of skin. Such data would be useful to obtain more 
accurate analysis of blood concentration profile following MN delivery. Other 
parameters for drug transport such as porosity and tortuousity of the viable epidermis 
will also so be significant.  
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 A.2 
 
Appendix 1 
 
VBA program for MN optimization 
 The equations presented in the framework (Figure 8.3, Chapter 8) are implemented 
into a single program in excel as described below. The program implements the GRG 
(Generalized reduced gradient) non linear solver in Microsoft excel 2007 that 
searches through all possible solutions and returns the value for the optimum tip 
radius, base radius, penetrated length and number of microneedles in the array. The 
program requires the user to input the skin and MN parameters such as the skin 
thickness as the yield stress of the MN material. The framework is then used to find 
the best MN geometry which can insert into the skin without breaking and also result 
in the highest peak blood concentration. The solver is set to make up to 200 iterations 
with a 5% tolerance and a 0.0001 convergence with a maximum solution time of 100 
seconds. All lengths are defined in μm, forces in N and the concentration in pg/μm. 
 
Figure A-1 
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Figure A-3 
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Figure A-5 
Program prompts user to 
enter lower and upper 
limit of variables to be 
tested; n, r, R and L 
The solver returns a 
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 A.5 
 
 
Code for optimization program 
Sub MN_Optimization() 
Range("A2") = InputBox("Enter Viable Epidermis Thickness") 
Range("B2") = InputBox("Enter Area of Patch") 
Range("C2") = InputBox("Enter Aspect ration") 
Range("D2") = InputBox("Enter tip radius") 
Range("E2") = InputBox("Enter Base raidius") 
Range("F2") = InputBox("Enter Penetrated Length") 
Range("G2") = InputBox("Enter number of microneedles") 
Range("S2") = InputBox("Enter max base radius") 
Range("T2") = InputBox("Enter max penetrated length") 
Range("U2") = InputBox("Enter max number of microneedles") 
Range("R2") = InputBox("Enter max tip radius") 
 
Range("V2") = InputBox("Enter min penetrated length") 
Range("w2") = InputBox("Enter min base radius") 
Range("x2") = InputBox("Enter min tip radius") 
Range("Y2") = InputBox("Enter min number of microneedles") 
Range("AA2") = InputBox("Enter hydrodynamic radius of drug molecule") 
Range("AB2") = InputBox("enter pore radius of viable epidermis") 
Range("Q2") = InputBox("Enter Stratum corneum thickness") 
Range("k2") = InputBox("Enter yield stress of MN material") 
Range("O2") = InputBox("Entr Young modulus of MN material") 
Range("M2") = InputBox("Enter poison ration of MN material") 
Range("J2") = InputBox("Enter insertion velocity") 
Range("AI2") = InputBox("Enter tortuosity of Viable Epidermis") 
Range("AK2") = InputBox("Enter Porosity of Viable epidermis") 
Range("AP2") = InputBox("Enter diffusion coefficient at infinite dillution") 
Range("N2") = InputBox("Enter cutting force of skinm tissue") 
Range("Z2") = InputBox("Enter young modulus of Stratum corneum") 
Range("AW2") = InputBox("Enter drug concentration on skin surface") 
Range("AY2") = InputBox("Enter elimination rate constant") 
Range("AZ2") = InputBox("Enter volume of distribution") 
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'Surface area of MNs 
Range("AC2") = "=(G2 * Pi() * D2 * D2) + (Pi() * (D2 + E2) * (Sqrt(((E2 - D2) ^ 2) 
+ (F2 ^ 2))))" 
'effectiveskin thickness 
Range("As2") = "=((AI2*A2*B2)-AD2)/AC2" 
'np; number of pores 
Range("AJ2") = "=AK2*B2/(Pi()*AI2*AB2*AB2)" 
'Friction coefficient 
Range("L2") = "=1327 / 1000000000000" 
'hinderance ratio 
Range("AE2") = "=AA2/AB2" 
'hinderance factor 
Range("AF2") = "=((1-AE2)^2)*(1-(2.104*AE2)+ (2.09*(AE2)^3)-(0.95*(AE2^5)))" 
'Vneedle 
Range("AD2") = "= g2*(Pi()*F2/3)*((E2*2)+(E2*D2)+(D2^2))" 
'Vpore 
Range("AL2") = "=Pi()*AB2*AB2*AJ2*AI2*A2" 
'vporei 
Range("BC2") = "=AL2-AD2" 
'rsi 
Range("AM2") = "=sqrt((AL2-AD2)/(AJ2*Pi()*AI2*A2))" 
'Pitch 
Range("H2") = "=Sqrt(B2) / Sqrt(G2)" 
'Interspacing at tip 
Range("I2") = "=H2-(2*D2)" 
'I 
Range("P2") = "=(pi()*((2*D2)^4))/64" 
'Ffailure 
Range("AG2") = "=(K2*P2)/(D2*F2)" 
'Finsertion 
'Range("AH2") = "=N2+(4*z2*SQRT(E2)/(3*(1-(M2^2))))*(Q2^1.5))+(L2*Q2*J2)+ 
35905*(I2^(0-0.904))" 
Range("AT2") = "=4*z2*(SQRT(E2))*(Q2^1.5)/(3*(1-(M2^2)))" 
Range("AU2") = "=0.000000035905*(pi()*D2*D2)*(I2^(0-0.904))" 
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Range("AV2") = "=L2*Q2*J2" 
Range("AH2") = "=N2+AT2+Au2+Av2" 
'insertion contraint 
Range("AR2") = "=If(AH2<AG2,1,0)" 
'Radius constraint 
Range("BB2") = "=IF(H2>C2*E2,1,0)" 
'Hinderance ratio inserted 
Range("AN2") = "=AA2/AM2" 
If Range("AN2") > 0.4 Then 
'strain ratio 
Range("BD2") = ((A2 * B2) - AD2) / (A2 * B2) 
Range("BE2") = InputBox("Enter strained diffusion coefficient constant (suggested 
value = 0.014)") 
Range("AQ2") = AP2 * (1 - (BE2 * BD2)) 
'Cmax 
Range("BA2") = "=AX2*AC2/(AY2*AZ2)" 
SolverReset 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverAdd CellRef:="$D$2", Relation:=1, FormulaText:="$R$2" 
    SolverAdd CellRef:="$E$2", Relation:=1, FormulaText:="$S$2" 
    SolverAdd CellRef:="$F$2", Relation:=1, FormulaText:="$T$2" 
    SolverAdd CellRef:="$G$2", Relation:=1, FormulaText:="$U$2" 
    SolverAdd CellRef:="$D$2", Relation:=3, FormulaText:="$X$2" 
    SolverAdd CellRef:="$E$2", Relation:=3, FormulaText:="$w$2" 
    SolverAdd CellRef:="$F$2", Relation:=3, FormulaText:="$V$2" 
    SolverAdd CellRef:="$G$2", Relation:=3, FormulaText:="$Y$2" 
    SolverAdd CellRef:="$D$2", Relation:=3, FormulaText:="$R$2" 
    SolverAdd CellRef:="$BB$2", Relation:=2, FormulaText:="1" 
    'SolverAdd CellRef:="$AN$2", Relation:=1, FormulaText:="0.4" 
    SolverAdd CellRef:="$AR$2", Relation:=2, FormulaText:="1" 
    SolverAdd CellRef:="$E$2", Relation:=3, FormulaText:="$D$2" 
    SolverAdd CellRef:="$A$2", Relation:=3, FormulaText:="$F$2" 
    SolverAdd CellRef:="$D$2:$G$2", Relation:=4, FormulaText:="integer" 
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    SolverAdd CellRef:="$AL$2", Relation:=3, FormulaText:="$AD$2" 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverSolve 
     SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverOptions MaxTime:=100, Iterations:=100, Precision:=0.000001, 
AssumeLinear _ 
        :=False, StepThru:=False, Estimates:=1, Derivatives:=1, SearchOption:=1, _ 
        IntTolerance:=5, Scaling:=False, Convergence:=0.0001, AssumeNonNeg:=False 
Dim opt As Integer 
Dim strPrompt As Variant 
Dim strTitle As String 
strTitle = "Cmax" 
strtPrompt = Range("BA2") 
opt = MsgBox(strtPrompt, vbOKOnly, strTitle) 
Dim opt_tip_r As Integer 
Dim strtprompt_tip As Variant 
Dim strttitle_tip As String 
strtitle_tip = "optimum Tip radius" 
strtprompt_tip = Range("$D$2") 
opt_tip_r = MsgBox(strtprompt_tip, vbOKOnly, strtitle_tip) 
Dim opt_base_r As Integer 
Dim strtprompt_base As Variant 
Dim strttitle_base As String 
strtitle_base = "optimum Base radius" 
strtprompt_base = Range("$E$2") 
opt_base_r = MsgBox(strtprompt_base, vbOKOnly, strtitle_base) 
Dim opt_n As Integer 
Dim strtprompt_n As Variant 
Dim strttitle_n As String 
strtitle_n = "optimum number of microneedles per array" 
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strtprompt_n = Range("$G$2") 
opt_n = MsgBox(strtprompt_n, vbOKOnly, strtitle_n) 
Dim opt_L As Integer 
Dim strtprompt_L As Variant 
Dim strttitle_L As String 
strtitle_L = "optimum Penetrated Length" 
strtprompt_L = Range("$F$2") 
opt_L = MsgBox(strtprompt_L, vbOKOnly, strtitle_L) 
Else 
'Hinderance factor inserted 
Range("AO2") = "=((1-AN2)^2)*(1-(2.104*AN2)+ (2.09*(AN2)^3)-
(0.95*(AN2^5)))" 
'D inserted 
Range("AQ2") = "=AP2*AO2" 
Range("AX2") = "=AK2*AQ2*AW2/AS2" 
'Cmax 
Range("BA2") = "=AX2*AC2/(AY2*AZ2)" 
SolverReset 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverAdd CellRef:="$D$2", Relation:=1, FormulaText:="$R$2" 
    SolverAdd CellRef:="$E$2", Relation:=1, FormulaText:="$S$2" 
    SolverAdd CellRef:="$F$2", Relation:=1, FormulaText:="$T$2" 
    SolverAdd CellRef:="$G$2", Relation:=1, FormulaText:="$U$2" 
    SolverAdd CellRef:="$D$2", Relation:=3, FormulaText:="$X$2" 
    SolverAdd CellRef:="$E$2", Relation:=3, FormulaText:="$w$2" 
    SolverAdd CellRef:="$F$2", Relation:=3, FormulaText:="$V$2" 
    SolverAdd CellRef:="$G$2", Relation:=3, FormulaText:="$Y$2" 
    SolverAdd CellRef:="$D$2", Relation:=3, FormulaText:="$R$2" 
    SolverAdd CellRef:="$BB$2", Relation:=2, FormulaText:="1" 
    SolverAdd CellRef:="$AN$2", Relation:=1, FormulaText:="0.4" 
    SolverAdd CellRef:="$AR$2", Relation:=2, FormulaText:="1" 
    SolverAdd CellRef:="$E$2", Relation:=3, FormulaText:="$D$2" 
    SolverAdd CellRef:="$A$2", Relation:=3, FormulaText:="$F$2" 
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    SolverAdd CellRef:="$D$2:$G$2", Relation:=4, FormulaText:="integer" 
    SolverAdd CellRef:="$AL$2", Relation:=3, FormulaText:="$AD$2" 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverSolve 
     SolverOk SetCell:="$BA$2", MaxMinVal:=1, ValueOf:="0", 
ByChange:="$D$2:$G$2" 
    SolverOptions MaxTime:=100, Iterations:=100, Precision:=0.000001, 
AssumeLinear _ 
        :=False, StepThru:=False, Estimates:=1, Derivatives:=1, SearchOption:=1, _ 
        IntTolerance:=5, Scaling:=False, Convergence:=0.0001, AssumeNonNeg:=False 
Dim opt2 As Integer 
Dim strPrompt2 As Variant 
Dim strTitle2 As String 
strTitle2 = "Cmax" 
strtPrompt2 = Range("BA2") 
opt2 = MsgBox(strtPrompt2, vbOKOnly, strTitle2) 
Dim opt_tip_r2 As Integer 
Dim strtprompt_tip2 As Variant 
Dim strttitle_tip2 As String 
strtitle_tip2 = "optimum Tip radius" 
strtprompt_tip2 = Range("$D$2") 
opt_tip_r2 = MsgBox(strtprompt_tip2, vbOKOnly, strtitle_tip2) 
Dim opt_base_r2 As Integer 
Dim strtprompt_base2 As Variant 
Dim strttitle_base2 As String 
strtitle_base2 = "optimum Base radius" 
strtprompt_base2 = Range("$E$2") 
opt_base_r2 = MsgBox(strtprompt_base2, vbOKOnly, strtitle_base2) 
Dim opt_n2 As Integer 
Dim strtprompt_n2 As Variant 
Dim strttitle_n2 As String 
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strtitle_n2 = "optimum number of microneedles per array" 
strtprompt_n2 = Range("$G$2") 
opt_n2 = MsgBox(strtprompt_n2, vbOKOnly, strtitle_n2) 
Dim opt_L2 As Integer 
Dim strtprompt_L2 As Variant 
Dim strttitle_L2 As String 
strtitle_L2 = "optimum Penetrated Length" 
 
strtprompt_L2 = Range("$F$2") 
opt_L2 = MsgBox(strtprompt_L2, vbOKOnly, strtitle_L2) 
End If 
 
End Sub 
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Appendix 2 
 
Solution of Bending Force Equation 
 
Reaction force at every point in the foundation (Viable epidermis) acts directly in 
opposition to the vertical deflection of the beam (stratum corneum) and is proportion 
to the deflection at that point .i.e. 
 yF fr β=      (A-1) 
Where y is the deflection in the vertical direction fβ is the foundation modulus and Fr 
is the reaction force. It is assumed that skin is linearly elastic and there is no friction 
force between the stratum corneum and viable epidermis  
The equation for the deflection line  
For a beam on an elastic foundation, where the SC is represented as the beam and the 
VE as the elastic foundation, is obtained as follows: By cutting a section of an 
infinitely small element with length dx in the horizontal direction and assuming a 
distributed load acting on the section and the foundation exerts a reaction force at this 
point. An equilibrium sum of the vertical force can be written in the form: 
0dsqyds)dQQ(Q dfshshsh =−β++−     (A-2) 
Where s is the distance from the force applied by the needle, qd is the distributed load 
and Qsh is the shear force acting on the section where: 
df2
2
sh qy
ds
Md
ds
dQ
−β==      (A-3) 
Given that 
ds
dMQsh =        (A-4) 
Where M is the bending moment and inserting this into (A-3) gives: 
df2
2
sh qy
ds
Md
ds
dQ
−β==       (A-5) 
The equation of a beam in bending is given as (Hearn, 1997; Hetenyi, 1964, 
Timoshenko, 1936): 
M
ds
ydEI 2
2
−=       (A-6) 
Such that  
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4
4
2
2
ds
ydEI
ds
Md
−=      (A-7) 
df4
4
qy
ds
ydEI +β−=      (A-8) 
At the sections of the beam where there is no distributed force acting, (A-8) can be 
rewritten as: 
y
ds
ydEI f4
4
β−=      (A-9) 
Using a general solution of  
msey =      (A-10) 
The characteristic equation is given as 
EI
m f4 β−=      (A-11) 
Solving (A-11) gives the roots as: 
4
f
f
31 )i1()i1(EI4
mm +λ=+β=−=     (A-12) 
And 
4
f
f
42 )i1()i1(EI4
mm +−λ=+−β=−=    (A-13) 
Where 
4 f
f EI4
β
=λ
     (A-14) 
A general solution for (A-9) takes the following form: 
sm
4
sm
3
sm
2
sm
1
4321 eAeAeAeAy ++=      (A-15) 
Using  
ssiniscose ff
si f λ+λ=λ  `    (A-16) 
ssiniscose ff
si f λ−λ=λ−      (A-17) 
Where 
141 C)AA( =+      (A-18) 
241 C)AA(i =+      (A-19) 
332 C)AA( =+      (A-20) 
432 C)AA(i =+      (A-21) 
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Incorporating (A-16) –(A-21) into (A-15) gives 
)ssinCscosC(e)ssinCscosC(ey f4f3
s
f2f1
s ff λ+λ+λ+λ= λ−λ   (A-22) 
 
Bending of beam on unlimited length  
For an infinitely long beam with a concentrated load (i.e. microneedle), it can be 
assumed that at an infinite distance from the concentrated load the deflection y begins 
to disappear. Therefore the terns of (A-16) can be removed from (A-22) such that the 
equation becomes: 
)ssinCscosC(ey f4f3
sf λ+λ= λ−    (A-23) 
At s=0 (i.e directly underneath each microneedle): 
o
ds
dy
=      (A-24) 
Applying this to (A-23) results in C3=C4=C giving: 
 )ssins(cosCey ff
sf λ+λ= λ−     (A-25) 
Equating the sum of reaction force to the applied load Fs0  
∫
∞
=β
0
0sf Fyds2       (A-26) 
Solving and substituting into (A-25) gives the equation for the deflection curve at a 
known position  
)ssins(cose
2
Fy ff
s
f
f0s f λ+λ
β
λ
= λ−     (A-27) 
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